uridine triphosphate profile

Uridine Triphosphate: Uridine 5'-(tetrahydrogen triphosphate). A uracil nucleotide containing three phosphate groups esterified to the sugar moiety. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Pathways (62)

uridine triphosphate is involved in 62 pathway(s), involving a total of 813 unique proteins and 2118 unique compounds

ID Source	ID
PubMed CID	6133
CHEMBL ID	336296
CHEBI ID	15713
SCHEMBL ID	76682
MeSH ID	M0022361

Synonym
ins-316
[(2r,3s,4r,5r)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl (hydroxy-phosphonooxyphosphoryl) hydrogen phosphate
gtpl1734
uridine 5'-triphosphoric acid
CHEBI:15713 ,
h4utp
5'-utp
KBIO1_000269
DIVK1C_000269
[[[5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxyphosphonic acid
2,4(1h,3h)-pyrimidinedione, 1-[5-o-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-.beta.-d-ribofuranosyl]-
[[(2r,3s,4r,5r)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate
SPECTRUM_001697
SPECTRUM5_001167
BSPBIO_003192
uridine 5'-(tetrahydrogen triphosphate)
uteplex
uridine, mono(tetrahydrogen triphosphate) (ester)
uridine 5'-(tetrahydrogen triphosphate) (8ci,9ci)
63-39-8
uridine triphosphate
UTP ,
uridine 5'-triphosphate
uridine-5'-triphosphate
C00075
DB04005
IDI1_000269
NCGC00163323-01
einecs 200-558-7
brn 0071520
ins316
KBIO2_007313
KBIOSS_002177
KBIO2_004745
KBIO2_002177
KBIOGR_001481
KBIO3_002692
NINDS_000269
SPECTRUM2_000525
SPBIO_000509
SPECTRUM4_000851
SPECTRUM3_001596
DC99D596-4755-4E87-B3AA-F1D6CFEDCE9A
uridine 5''-triphosphoric acid
chembl336296 ,
bdbm50118213
uridine 5''-(tetrahydrogen triphosphate)
5''-utp
BMSE000295
AKOS016011172
4-24-00-01222 (beilstein handbook reference)
ut0s826z60 ,
unii-ut0s826z60
uridine 5'-triphosphate tris salt
uridine triphosphate [who-dd]
uridine 5'-triphosphate [mi]
SCHEMBL76682
PGAVKCOVUIYSFO-XVFCMESISA-N
CS-7777
DTXSID0041147
uridine 5'-triphosphate sodium salt, aldrichcpr
uridintriphosphat
uridine mono(tetrahydrogen triphosphate)
uridine5'-triphosphate
3h-uridine triphosphate
HY-107372
Q32904692
(((2r,3s,4r,5r)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)triphosphoric acid
((2r,3s,4r,5r)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate
utp;uridine 5'-triphosphate
F85566

Excerpt	Reference
"Uridine triphosphate (UTP) plays a biological role in increasing indirectly the level of intracellular Ca2+."	( Dai, L; Feng, F; Liu, H; Wang, L; Xiao, Y, 2021)

Role	Description
Escherichia coli metabolite	Any bacterial metabolite produced during a metabolic reaction in Escherichia coli.
mouse metabolite	Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Class	Description
pyrimidine ribonucleoside 5'-triphosphate
uridine 5'-phosphate
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathway	Proteins	Compounds
Pyrimidine Metabolism	23	53
Amino Sugar Metabolism	17	31
Galactose Metabolism	12	34
Nucleotide Sugars Metabolism	8	17
Lactose Synthesis	10	15
Sialuria or French Type Sialuria	17	31
Salla Disease/Infantile Sialic Acid Storage Disease	17	31
Starch and Sucrose Metabolism	16	26
beta-Ureidopropionase Deficiency	23	53
UMP Synthase Deficiency (Orotic Aciduria)	23	53
Dihydropyrimidinase Deficiency	23	53
MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy)	23	53
Galactosemia	12	34
Tay-Sachs Disease	17	31
Galactosemia II (GALK)	8	17
Galactosemia III	8	17
G(M2)-Gangliosidosis: Variant B, Tay-Sachs Disease	17	31
Glycogen Synthetase Deficiency	16	26
Glycogenosis, Type III. Cori Disease, Debrancher Glycogenosis	16	26
Glycogenosis, Type IV. Amylopectinosis, Anderson Disease	16	26
Glycogenosis, Type VI. Hers Disease	16	26
Mucopolysaccharidosis VII. Sly Syndrome	16	26
Sucrase-Isomaltase Deficiency	16	26
Congenital Disorder of Glycosylation CDG-IId	10	15
GLUT-1 Deficiency Syndrome	10	15
Lamivudine Metabolism Pathway	18	16
Lipopolysaccharide Biosynthesis	41	53
Galactose Degradation/Leloir Pathway	13	18
Amino Sugar and Nucleotide Sugar Metabolism I	17	33
Amino Sugar and Nucleotide Sugar Metabolism III	23	40
Peptidoglycan Biosynthesis I	30	36
Colanic Acid Building Blocks Biosynthesis	17	23
Lipopolysaccharide Biosynthesis II	40	53
Lipopolysaccharide Biosynthesis III	33	52
Peptidoglycan Biosynthesis II	30	37
1,6-Anhydro-N-acetylmuramic Acid Recycling	9	20
O-Antigen Building Blocks Biosynthesis	9	22
Leloir Pathway	6	12
Amino Sugar and Nucleotide Sugar Metabolism	22	29
Aminosugars metabolism ( Aminosugars metabolism )	15	29
UTP + N-Acetyl-D-glucosamine 1-phosphate = Pyrophosphate + UDP-N-acetyl-D-glucosamine ( Aminosugars metabolism )	1	4
Galactose metabolism ( Galactose metabolism )	9	13
UTP + D-Glucose 1-phosphate = Pyrophosphate + UDP-D-glucose ( Glycolysis and Gluconeogenesis )	1	4
Pyrimidine Nucleotides and Nucleosides metabolism ( Pyrimidine Nucleotides and Nucleosides metabolism )	45	49
UTP + AMP = UDP + ADP ( Pyrimidine Nucleotides and Nucleosides metabolism )	1	4
ATP + UDP = ADP + UTP ( Pyrimidine Nucleotides and Nucleosides metabolism )	7	4
Chitin Biosynthesis	9	21
The impact of Nsp14 on metabolism (COVID-19 Disease Map)	0	84
Pyrimidine synthesis and deprivation pathway (COVID-19 Disease Maps)	13	29
Purinergic signaling	0	53
superpathway of histidine, purine and pyrimidine biosynthesis	0	31
N-acetylglucosamine N-acetylmannosamine and N-acetylneuraminic acid dissimilation	0	12
galactose degradation	0	6
UDP-glucose conversion	0	4
Sucrose biosynthesis	0	6
Glycerol teichoic acid biosynthesis	0	6
De novo biosynthesis of pyrimidine ribonucleotides	0	9
Sucrose metabolism	14	13
Biochemical pathways: part I	0	466
Pyrimidine metabolism	0	38
DNA replication	0	2
Glucuronidation	0	14
UDP-L-arabinose biosynthesis (salvage pathway)	0	7

Protein	Taxonomy	Measurement	Average (µ)	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE	Homo sapiens (human)	Potency	2.8184	0.0032	45.4673	12,589.2998	AID2517
Chain A, TYROSYL-DNA PHOSPHODIESTERASE	Homo sapiens (human)	Potency	39.8107	0.0040	23.8416	100.0000	AID485290
regulator of G-protein signaling 4	Homo sapiens (human)	Potency	1.6834	0.5318	15.4358	37.6858	AID504845
Inositol monophosphatase 1	Rattus norvegicus (Norway rat)	Potency	28.1838	1.0000	10.4756	28.1838	AID1457
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Protein	Taxonomy	Measurement	Average	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
P2Y purinoceptor 2	Mus musculus (house mouse)	IC50 (µMol)	1.5100	1.5100	1.5100	1.5100	AID436592
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Protein	Taxonomy	Measurement	Average	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
P2Y purinoceptor 4	Rattus norvegicus (Norway rat)	EC50 (µMol)	2.6000	2.6000	2.8000	3.0000	AID150634
Thromboxane A2 receptor	Homo sapiens (human)	EC50 (µMol)	0.1000	0.0240	0.9810	2.4000	AID89271
Sodium-dependent dopamine transporter	Rattus norvegicus (Norway rat)	EC50 (µMol)	0.0070	0.0007	0.1791	1.4500	AID305248
P2Y purinoceptor 2	Mus musculus (house mouse)	EC50 (µMol)	1.2600	1.2600	1.2600	1.2600	AID436591
P2Y purinoceptor 2	Homo sapiens (human)	EC50 (µMol)	8.2682	0.0056	0.6828	10.0000	AID1372689; AID1372691; AID1372692; AID1372693; AID1372695; AID1465366; AID1465367; AID1465368; AID1465369; AID150321; AID261699; AID272716; AID280297; AID302989; AID304928; AID305248; AID350668; AID350672; AID350677; AID350678; AID350679; AID350683; AID350686; AID350688; AID350690; AID350692; AID350694; AID350696; AID350698; AID373707; AID404832; AID460573; AID484783; AID593124; AID600862; AID600875; AID647894; AID648182; AID682413; AID89269
P2Y purinoceptor 2	Rattus norvegicus (Norway rat)	EC50 (µMol)	0.1300	0.1300	0.1300	0.1300	AID261697
P2Y purinoceptor 1	Homo sapiens (human)	EC50 (µMol)	34.6667	0.0013	0.4202	7.2000	AID150331; AID304929; AID305249
P2Y purinoceptor 4	Homo sapiens (human)	EC50 (µMol)	0.3758	0.0230	1.3623	10.0000	AID150627; AID272719; AID280298; AID304930; AID305250; AID373708; AID404834; AID460576; AID484777; AID593125; AID600863; AID600876; AID647895; AID682414; AID89271
P2Y purinoceptor 6	Homo sapiens (human)	EC50 (µMol)	7.8030	0.0130	2.3930	20.0000	AID150636; AID280301; AID304931; AID404830; AID484784; AID593126; AID600864; AID89273
P2Y purinoceptor 11	Homo sapiens (human)	EC50 (µMol)	100.0000	0.0631	3.7704	9.0000	AID150489
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Protein	Taxonomy	Measurement	Average	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
RNA-directed RNA polymerase		Km	10.2950	0.1800	2.9600	6.0000	AID261436; AID261437; AID261438; AID278952
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Process	via Protein(s)	Taxonomy
G protein-coupled receptor signaling pathway	Muscarinic acetylcholine receptor M2	Homo sapiens (human)
adenylate cyclase-modulating G protein-coupled receptor signaling pathway	Muscarinic acetylcholine receptor M2	Homo sapiens (human)
phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway	Muscarinic acetylcholine receptor M2	Homo sapiens (human)
G protein-coupled acetylcholine receptor signaling pathway	Muscarinic acetylcholine receptor M2	Homo sapiens (human)
nervous system development	Muscarinic acetylcholine receptor M2	Homo sapiens (human)
regulation of heart contraction	Muscarinic acetylcholine receptor M2	Homo sapiens (human)
response to virus	Muscarinic acetylcholine receptor M2	Homo sapiens (human)
G protein-coupled serotonin receptor signaling pathway	Muscarinic acetylcholine receptor M2	Homo sapiens (human)
presynaptic modulation of chemical synaptic transmission	Muscarinic acetylcholine receptor M2	Homo sapiens (human)
regulation of smooth muscle contraction	Muscarinic acetylcholine receptor M2	Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway	Muscarinic acetylcholine receptor M2	Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger	Muscarinic acetylcholine receptor M2	Homo sapiens (human)
chemical synaptic transmission	Muscarinic acetylcholine receptor M2	Homo sapiens (human)
signal transduction	Muscarinic acetylcholine receptor M4	Homo sapiens (human)
cell surface receptor signaling pathway	Muscarinic acetylcholine receptor M4	Homo sapiens (human)
G protein-coupled acetylcholine receptor signaling pathway	Muscarinic acetylcholine receptor M4	Homo sapiens (human)
regulation of locomotion	Muscarinic acetylcholine receptor M4	Homo sapiens (human)
G protein-coupled serotonin receptor signaling pathway	Muscarinic acetylcholine receptor M4	Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway	Muscarinic acetylcholine receptor M4	Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger	Muscarinic acetylcholine receptor M4	Homo sapiens (human)
chemical synaptic transmission	Muscarinic acetylcholine receptor M4	Homo sapiens (human)
positive regulation of monoatomic ion transport	Muscarinic acetylcholine receptor M1	Homo sapiens (human)
signal transduction	Muscarinic acetylcholine receptor M1	Homo sapiens (human)
G protein-coupled receptor signaling pathway	Muscarinic acetylcholine receptor M1	Homo sapiens (human)
protein kinase C-activating G protein-coupled receptor signaling pathway	Muscarinic acetylcholine receptor M1	Homo sapiens (human)
phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway	Muscarinic acetylcholine receptor M1	Homo sapiens (human)
G protein-coupled acetylcholine receptor signaling pathway	Muscarinic acetylcholine receptor M1	Homo sapiens (human)
neuromuscular synaptic transmission	Muscarinic acetylcholine receptor M1	Homo sapiens (human)
nervous system development	Muscarinic acetylcholine receptor M1	Homo sapiens (human)
regulation of locomotion	Muscarinic acetylcholine receptor M1	Homo sapiens (human)
saliva secretion	Muscarinic acetylcholine receptor M1	Homo sapiens (human)
cognition	Muscarinic acetylcholine receptor M1	Homo sapiens (human)
regulation of postsynaptic membrane potential	Muscarinic acetylcholine receptor M1	Homo sapiens (human)
regulation of glial cell proliferation	Muscarinic acetylcholine receptor M1	Homo sapiens (human)
positive regulation of intracellular protein transport	Muscarinic acetylcholine receptor M1	Homo sapiens (human)
G protein-coupled serotonin receptor signaling pathway	Muscarinic acetylcholine receptor M1	Homo sapiens (human)
postsynaptic modulation of chemical synaptic transmission	Muscarinic acetylcholine receptor M1	Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger	Muscarinic acetylcholine receptor M1	Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway	Muscarinic acetylcholine receptor M1	Homo sapiens (human)
chemical synaptic transmission	Muscarinic acetylcholine receptor M1	Homo sapiens (human)
smooth muscle contraction	Thromboxane A2 receptor	Homo sapiens (human)
G protein-coupled receptor signaling pathway	Thromboxane A2 receptor	Homo sapiens (human)
response to nutrient	Thromboxane A2 receptor	Homo sapiens (human)
response to xenobiotic stimulus	Thromboxane A2 receptor	Homo sapiens (human)
positive regulation of blood coagulation	Thromboxane A2 receptor	Homo sapiens (human)
response to testosterone	Thromboxane A2 receptor	Homo sapiens (human)
thromboxane A2 signaling pathway	Thromboxane A2 receptor	Homo sapiens (human)
response to ethanol	Thromboxane A2 receptor	Homo sapiens (human)
positive regulation of angiogenesis	Thromboxane A2 receptor	Homo sapiens (human)
positive regulation of smooth muscle contraction	Thromboxane A2 receptor	Homo sapiens (human)
cellular response to lipopolysaccharide	Thromboxane A2 receptor	Homo sapiens (human)
negative regulation of cell migration involved in sprouting angiogenesis	Thromboxane A2 receptor	Homo sapiens (human)
inflammatory response	Thromboxane A2 receptor	Homo sapiens (human)
positive regulation of blood pressure	Thromboxane A2 receptor	Homo sapiens (human)
positive regulation of vasoconstriction	Thromboxane A2 receptor	Homo sapiens (human)
positive regulation of cytosolic calcium ion concentration	Thromboxane A2 receptor	Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathway	Thromboxane A2 receptor	Homo sapiens (human)
intracellular monoatomic ion homeostasis	P2Y purinoceptor 2	Homo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathway	P2Y purinoceptor 2	Homo sapiens (human)
G protein-coupled purinergic nucleotide receptor signaling pathway	P2Y purinoceptor 2	Homo sapiens (human)
positive regulation of mucus secretion	P2Y purinoceptor 2	Homo sapiens (human)
cellular response to ATP	P2Y purinoceptor 2	Homo sapiens (human)
blood vessel diameter maintenance	P2Y purinoceptor 2	Homo sapiens (human)
G protein-coupled receptor signaling pathway	P2Y purinoceptor 2	Homo sapiens (human)
positive regulation of protein phosphorylation	P2Y purinoceptor 1	Homo sapiens (human)
G protein-coupled adenosine receptor signaling pathway	P2Y purinoceptor 1	Homo sapiens (human)
monoatomic ion transport	P2Y purinoceptor 1	Homo sapiens (human)
cell surface receptor signaling pathway	P2Y purinoceptor 1	Homo sapiens (human)
G protein-coupled receptor signaling pathway	P2Y purinoceptor 1	Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway	P2Y purinoceptor 1	Homo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathway	P2Y purinoceptor 1	Homo sapiens (human)
positive regulation of cytosolic calcium ion concentration	P2Y purinoceptor 1	Homo sapiens (human)
glial cell migration	P2Y purinoceptor 1	Homo sapiens (human)
regulation of cell shape	P2Y purinoceptor 1	Homo sapiens (human)
response to mechanical stimulus	P2Y purinoceptor 1	Homo sapiens (human)
negative regulation of norepinephrine secretion	P2Y purinoceptor 1	Homo sapiens (human)
signal transduction involved in regulation of gene expression	P2Y purinoceptor 1	Homo sapiens (human)
platelet activation	P2Y purinoceptor 1	Homo sapiens (human)
positive regulation of inositol trisphosphate biosynthetic process	P2Y purinoceptor 1	Homo sapiens (human)
G protein-coupled purinergic nucleotide receptor signaling pathway	P2Y purinoceptor 1	Homo sapiens (human)
eating behavior	P2Y purinoceptor 1	Homo sapiens (human)
positive regulation of monoatomic ion transport	P2Y purinoceptor 1	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	P2Y purinoceptor 1	Homo sapiens (human)
positive regulation of hormone secretion	P2Y purinoceptor 1	Homo sapiens (human)
establishment of localization in cell	P2Y purinoceptor 1	Homo sapiens (human)
positive regulation of penile erection	P2Y purinoceptor 1	Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascade	P2Y purinoceptor 1	Homo sapiens (human)
response to growth factor	P2Y purinoceptor 1	Homo sapiens (human)
cellular response to ATP	P2Y purinoceptor 1	Homo sapiens (human)
cellular response to purine-containing compound	P2Y purinoceptor 1	Homo sapiens (human)
protein localization to plasma membrane	P2Y purinoceptor 1	Homo sapiens (human)
relaxation of muscle	P2Y purinoceptor 1	Homo sapiens (human)
blood vessel diameter maintenance	P2Y purinoceptor 1	Homo sapiens (human)
regulation of presynaptic cytosolic calcium ion concentration	P2Y purinoceptor 1	Homo sapiens (human)
regulation of synaptic vesicle exocytosis	P2Y purinoceptor 1	Homo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathway	P2Y purinoceptor 4	Homo sapiens (human)
positive regulation of cytosolic calcium ion concentration	P2Y purinoceptor 4	Homo sapiens (human)
transepithelial chloride transport	P2Y purinoceptor 4	Homo sapiens (human)
G protein-coupled purinergic nucleotide receptor signaling pathway	P2Y purinoceptor 4	Homo sapiens (human)
cellular response to ATP	P2Y purinoceptor 4	Homo sapiens (human)
cellular response to prostaglandin E stimulus	P2Y purinoceptor 4	Homo sapiens (human)
regulation of presynaptic cytosolic calcium ion concentration	P2Y purinoceptor 4	Homo sapiens (human)
regulation of synaptic vesicle exocytosis	P2Y purinoceptor 4	Homo sapiens (human)
G protein-coupled receptor signaling pathway	P2Y purinoceptor 4	Homo sapiens (human)
phagocytosis	P2Y purinoceptor 6	Homo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathway	P2Y purinoceptor 6	Homo sapiens (human)
activation of phospholipase C activity	P2Y purinoceptor 6	Homo sapiens (human)
positive regulation of smooth muscle cell migration	P2Y purinoceptor 6	Homo sapiens (human)
transepithelial chloride transport	P2Y purinoceptor 6	Homo sapiens (human)
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity	P2Y purinoceptor 6	Homo sapiens (human)
positive regulation of inositol trisphosphate biosynthetic process	P2Y purinoceptor 6	Homo sapiens (human)
G protein-coupled purinergic nucleotide receptor signaling pathway	P2Y purinoceptor 6	Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascade	P2Y purinoceptor 6	Homo sapiens (human)
cellular response to prostaglandin E stimulus	P2Y purinoceptor 6	Homo sapiens (human)
cellular response to purine-containing compound	P2Y purinoceptor 6	Homo sapiens (human)
positive regulation of vascular associated smooth muscle cell proliferation	P2Y purinoceptor 6	Homo sapiens (human)
cellular response to pyrimidine ribonucleotide	P2Y purinoceptor 6	Homo sapiens (human)
G protein-coupled receptor signaling pathway	P2Y purinoceptor 6	Homo sapiens (human)
defense response	P2Y purinoceptor 11	Homo sapiens (human)
G protein-coupled receptor signaling pathway	P2Y purinoceptor 11	Homo sapiens (human)
activation of adenylate cyclase activity	P2Y purinoceptor 11	Homo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathway	P2Y purinoceptor 11	Homo sapiens (human)
calcium-mediated signaling	P2Y purinoceptor 11	Homo sapiens (human)
neuronal signal transduction	P2Y purinoceptor 11	Homo sapiens (human)
G protein-coupled purinergic nucleotide receptor signaling pathway	P2Y purinoceptor 11	Homo sapiens (human)
cellular response to ATP	P2Y purinoceptor 11	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Process	via Protein(s)	Taxonomy
G protein-coupled acetylcholine receptor activity	Muscarinic acetylcholine receptor M2	Homo sapiens (human)
arrestin family protein binding	Muscarinic acetylcholine receptor M2	Homo sapiens (human)
G protein-coupled serotonin receptor activity	Muscarinic acetylcholine receptor M2	Homo sapiens (human)
G protein-coupled serotonin receptor activity	Muscarinic acetylcholine receptor M4	Homo sapiens (human)
G protein-coupled acetylcholine receptor activity	Muscarinic acetylcholine receptor M4	Homo sapiens (human)
phosphatidylinositol phospholipase C activity	Muscarinic acetylcholine receptor M1	Homo sapiens (human)
protein binding	Muscarinic acetylcholine receptor M1	Homo sapiens (human)
G protein-coupled acetylcholine receptor activity	Muscarinic acetylcholine receptor M1	Homo sapiens (human)
G protein-coupled serotonin receptor activity	Muscarinic acetylcholine receptor M1	Homo sapiens (human)
thromboxane A2 receptor activity	Thromboxane A2 receptor	Homo sapiens (human)
guanyl-nucleotide exchange factor activity	Thromboxane A2 receptor	Homo sapiens (human)
protein binding	Thromboxane A2 receptor	Homo sapiens (human)
protein binding	P2Y purinoceptor 2	Homo sapiens (human)
signaling receptor activity	P2Y purinoceptor 2	Homo sapiens (human)
G protein-coupled purinergic nucleotide receptor activity	P2Y purinoceptor 2	Homo sapiens (human)
A1 adenosine receptor binding	P2Y purinoceptor 2	Homo sapiens (human)
G protein-coupled UTP receptor activity	P2Y purinoceptor 2	Homo sapiens (human)
G protein-coupled ADP receptor activity	P2Y purinoceptor 1	Homo sapiens (human)
protein binding	P2Y purinoceptor 1	Homo sapiens (human)
ATP binding	P2Y purinoceptor 1	Homo sapiens (human)
signaling receptor activity	P2Y purinoceptor 1	Homo sapiens (human)
ADP binding	P2Y purinoceptor 1	Homo sapiens (human)
G protein-coupled purinergic nucleotide receptor activity	P2Y purinoceptor 1	Homo sapiens (human)
G protein-coupled ATP receptor activity	P2Y purinoceptor 1	Homo sapiens (human)
protein heterodimerization activity	P2Y purinoceptor 1	Homo sapiens (human)
scaffold protein binding	P2Y purinoceptor 1	Homo sapiens (human)
A1 adenosine receptor binding	P2Y purinoceptor 1	Homo sapiens (human)
protein binding	P2Y purinoceptor 4	Homo sapiens (human)
ATP binding	P2Y purinoceptor 4	Homo sapiens (human)
G protein-coupled purinergic nucleotide receptor activity	P2Y purinoceptor 4	Homo sapiens (human)
G protein-coupled UTP receptor activity	P2Y purinoceptor 4	Homo sapiens (human)
G protein-coupled ADP receptor activity	P2Y purinoceptor 6	Homo sapiens (human)
G protein-coupled receptor activity	P2Y purinoceptor 6	Homo sapiens (human)
protein binding	P2Y purinoceptor 6	Homo sapiens (human)
G protein-coupled UDP receptor activity	P2Y purinoceptor 6	Homo sapiens (human)
G protein-coupled UTP receptor activity	P2Y purinoceptor 6	Homo sapiens (human)
neurotransmitter receptor activity	P2Y purinoceptor 11	Homo sapiens (human)
signaling receptor activity	P2Y purinoceptor 11	Homo sapiens (human)
G protein-coupled ATP receptor activity	P2Y purinoceptor 11	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Process	via Protein(s)	Taxonomy
plasma membrane	Muscarinic acetylcholine receptor M2	Homo sapiens (human)
membrane	Muscarinic acetylcholine receptor M2	Homo sapiens (human)
clathrin-coated endocytic vesicle membrane	Muscarinic acetylcholine receptor M2	Homo sapiens (human)
asymmetric synapse	Muscarinic acetylcholine receptor M2	Homo sapiens (human)
symmetric synapse	Muscarinic acetylcholine receptor M2	Homo sapiens (human)
presynaptic membrane	Muscarinic acetylcholine receptor M2	Homo sapiens (human)
neuronal cell body	Muscarinic acetylcholine receptor M2	Homo sapiens (human)
axon terminus	Muscarinic acetylcholine receptor M2	Homo sapiens (human)
postsynaptic membrane	Muscarinic acetylcholine receptor M2	Homo sapiens (human)
glutamatergic synapse	Muscarinic acetylcholine receptor M2	Homo sapiens (human)
cholinergic synapse	Muscarinic acetylcholine receptor M2	Homo sapiens (human)
plasma membrane	Muscarinic acetylcholine receptor M2	Homo sapiens (human)
synapse	Muscarinic acetylcholine receptor M2	Homo sapiens (human)
dendrite	Muscarinic acetylcholine receptor M2	Homo sapiens (human)
plasma membrane	Muscarinic acetylcholine receptor M4	Homo sapiens (human)
postsynaptic membrane	Muscarinic acetylcholine receptor M4	Homo sapiens (human)
dendrite	Muscarinic acetylcholine receptor M4	Homo sapiens (human)
plasma membrane	Muscarinic acetylcholine receptor M4	Homo sapiens (human)
synapse	Muscarinic acetylcholine receptor M4	Homo sapiens (human)
plasma membrane	Muscarinic acetylcholine receptor M1	Homo sapiens (human)
membrane	Muscarinic acetylcholine receptor M1	Homo sapiens (human)
presynaptic membrane	Muscarinic acetylcholine receptor M1	Homo sapiens (human)
axon terminus	Muscarinic acetylcholine receptor M1	Homo sapiens (human)
Schaffer collateral - CA1 synapse	Muscarinic acetylcholine receptor M1	Homo sapiens (human)
postsynaptic density membrane	Muscarinic acetylcholine receptor M1	Homo sapiens (human)
glutamatergic synapse	Muscarinic acetylcholine receptor M1	Homo sapiens (human)
cholinergic synapse	Muscarinic acetylcholine receptor M1	Homo sapiens (human)
synapse	Muscarinic acetylcholine receptor M1	Homo sapiens (human)
dendrite	Muscarinic acetylcholine receptor M1	Homo sapiens (human)
plasma membrane	Muscarinic acetylcholine receptor M1	Homo sapiens (human)
acrosomal vesicle	Thromboxane A2 receptor	Homo sapiens (human)
plasma membrane	Thromboxane A2 receptor	Homo sapiens (human)
nuclear speck	Thromboxane A2 receptor	Homo sapiens (human)
plasma membrane	Thromboxane A2 receptor	Homo sapiens (human)
plasma membrane	P2Y purinoceptor 2	Homo sapiens (human)
plasma membrane	P2Y purinoceptor 2	Homo sapiens (human)
plasma membrane	P2Y purinoceptor 1	Homo sapiens (human)
cilium	P2Y purinoceptor 1	Homo sapiens (human)
cell surface	P2Y purinoceptor 1	Homo sapiens (human)
postsynaptic density	P2Y purinoceptor 1	Homo sapiens (human)
basolateral plasma membrane	P2Y purinoceptor 1	Homo sapiens (human)
apical plasma membrane	P2Y purinoceptor 1	Homo sapiens (human)
dendrite	P2Y purinoceptor 1	Homo sapiens (human)
cell body	P2Y purinoceptor 1	Homo sapiens (human)
postsynaptic membrane	P2Y purinoceptor 1	Homo sapiens (human)
presynaptic active zone membrane	P2Y purinoceptor 1	Homo sapiens (human)
glutamatergic synapse	P2Y purinoceptor 1	Homo sapiens (human)
plasma membrane	P2Y purinoceptor 1	Homo sapiens (human)
plasma membrane	P2Y purinoceptor 4	Homo sapiens (human)
basolateral plasma membrane	P2Y purinoceptor 4	Homo sapiens (human)
apical plasma membrane	P2Y purinoceptor 4	Homo sapiens (human)
presynaptic active zone membrane	P2Y purinoceptor 4	Homo sapiens (human)
glutamatergic synapse	P2Y purinoceptor 4	Homo sapiens (human)
plasma membrane	P2Y purinoceptor 4	Homo sapiens (human)
plasma membrane	P2Y purinoceptor 6	Homo sapiens (human)
basolateral plasma membrane	P2Y purinoceptor 6	Homo sapiens (human)
apical plasma membrane	P2Y purinoceptor 6	Homo sapiens (human)
plasma membrane	P2Y purinoceptor 6	Homo sapiens (human)
plasma membrane	P2Y purinoceptor 11	Homo sapiens (human)
plasma membrane	P2Y purinoceptor 11	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (148)

Assay ID	Title	Year	Journal	Article
AID1465396	Selectivity ratio of EC50 for P2Y2 receptor Y114F mutant (unknown origin) to EC50 for wild type P2Y2 receptor (unknown origin)	2017	Journal of medicinal chemistry, 10-26, Volume: 60, Issue:20	Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y
AID593125	Agonist activity at human recombinant P2Y4 receptor expressed in human 1321N1 cells assessed as [3H]inositol phosphate intracellular accumulation by scintillation proximity assay	2011	Journal of medicinal chemistry, Apr-28, Volume: 54, Issue:8	Structural modifications of UMP, UDP, and UTP leading to subtype-selective agonists for P2Y2, P2Y4, and P2Y6 receptors.
AID1465382	Selectivity ratio of EC50 for P2Y2 receptor F261A mutant (unknown origin) to EC50 for wild type P2Y2 receptor (unknown origin)	2017	Journal of medicinal chemistry, 10-26, Volume: 60, Issue:20	Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y
AID272716	Agonist activity at human P2Y2 receptor expressed in 1321N1 cells assessed as IP accumulation by SPA	2006	Journal of medicinal chemistry, Nov-30, Volume: 49, Issue:24	Synthesis and structure-activity relationships of uracil nucleotide derivatives and analogues as agonists at human P2Y2, P2Y4, and P2Y6 receptors.
AID350677	Agonist activity at N-terminal HA epitope-tagged wild type 1 human P2Y2 receptor expressed in human 1321N1 cells assessed as increase in intracellular calcium level	2009	Journal of medicinal chemistry, May-14, Volume: 52, Issue:9	Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.
AID350708	Agonist activity at N-terminal HA epitope-tagged human P2Y2 receptor C278S mutant expressed in human 1321N1 cells assessed as increase in intracellular calcium level relative to carbachol	2009	Journal of medicinal chemistry, May-14, Volume: 52, Issue:9	Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.
AID600875	Agonist activity at human P2Y2	2011	Journal of medicinal chemistry, Jun-23, Volume: 54, Issue:12	Pyrimidine nucleotides with 4-alkyloxyimino and terminal tetraphosphate δ-ester modifications as selective agonists of the P2Y(4) receptor.
AID404834	Agonist activity at human P2Y4 receptor expressed in human 1321N1 cells assessed as [3H]inositol phosphate accumulation by scintillation proximity assay	2008	Bioorganic & medicinal chemistry, Jun-15, Volume: 16, Issue:12	Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonists.
AID1465374	Agonist activity at P2Y2 receptor R194H mutant (unknown origin) expressed in human 1321N1 astrocytoma cells assessed as increase in intracellular calcium mobilization after 1 hr by Fluo-4 AM dye based fluorescence assay	2017	Journal of medicinal chemistry, 10-26, Volume: 60, Issue:20	Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y
AID647895	Agonist activity at human P2Y purinoceptor 4 expressed in human 1321N1 cells assessed as increase in intracellular calcium concentration by spectrofluorimetry	2012	Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1	Boranophosphate isoster controls P2Y-receptor subtype selectivity and metabolic stability of dinucleoside polyphosphate analogues.
AID1372692	Agonist activity at P2Y2 receptor in human CF/T43 cells	2018	Bioorganic & medicinal chemistry, 01-15, Volume: 26, Issue:2	Current knowledge on the nucleotide agonists for the P2Y2 receptor.
AID436591	Agonist activity at mouse P2Y2 receptor expressed in NG108-15 hybrid cells assessed as increase in intracellular calcium release by fluorescence assay	2009	Bioorganic & medicinal chemistry, Jul-15, Volume: 17, Issue:14	Synthesis of uracil nucleotide analogs with a modified, acyclic ribose moiety as P2Y(2) receptor antagonists.
AID302989	Agonist activity at P2Y2 receptor expressed in 1321N1 cells assessed as cytosolic calcium level	2007	Journal of medicinal chemistry, Nov-15, Volume: 50, Issue:23	New iantherans from the marine sponge Ianthella quadrangulata: novel agonists of the P2Y(11) receptor.
AID350678	Agonist activity at N-terminal HA epitope-tagged wild type 3 human P2Y2 receptor expressed in human 1321N1 cells assessed as increase in intracellular calcium level	2009	Journal of medicinal chemistry, May-14, Volume: 52, Issue:9	Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.
AID89269	Agonist activity evaluated as change in the level of cytosolic calcium in 1321N astrocytoma cells infected with a retrovirus encoding the human P2Y2 receptor	2001	Bioorganic & medicinal chemistry letters, Jan-22, Volume: 11, Issue:2	Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5'-polyphosphates.
AID600863	Agonist activity at human recombinant P2Y4 receptor expressed in human 1321N1 cells assessed as [3H]inositol phosphate production after 30 mins by scintillation proximity assay	2011	Journal of medicinal chemistry, Jun-23, Volume: 54, Issue:12	Pyrimidine nucleotides with 4-alkyloxyimino and terminal tetraphosphate δ-ester modifications as selective agonists of the P2Y(4) receptor.
AID1370003	Drug metabolism at 2 mM at pH 1.7 at room temperature after 20 days by 31P NMR method	2018	Journal of medicinal chemistry, 05-10, Volume: 61, Issue:9	Highly Selective and Potent Ectonucleotide Pyrophosphatase-1 (NPP1) Inhibitors Based on Uridine 5'-P
AID350692	Agonist activity at N-terminal HA epitope-tagged human P2Y2 receptor R272A mutant expressed in human 1321N1 cells assessed as increase in intracellular calcium level	2009	Journal of medicinal chemistry, May-14, Volume: 52, Issue:9	Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.
AID460573	Agonist activity at human P2Y2 receptor expressed in human 1321N1 cells assessed as calcium elevation by fura2/AM assay	2010	Journal of medicinal chemistry, Feb-25, Volume: 53, Issue:4	5-OMe-UDP is a potent and selective P2Y(6)-receptor agonist.
AID1369982	Drug metabolism at 2 mM at acidic pH after 5 days by 31P NMR method	2018	Journal of medicinal chemistry, 05-10, Volume: 61, Issue:9	Highly Selective and Potent Ectonucleotide Pyrophosphatase-1 (NPP1) Inhibitors Based on Uridine 5'-P
AID436594	Agonist activity at mouse P2Y2 receptor expressed in NG108-15 hybrid cells assessed as increase in intracellular calcium release at 100 uM by fluorescence assay relative to UTP	2009	Bioorganic & medicinal chemistry, Jul-15, Volume: 17, Issue:14	Synthesis of uracil nucleotide analogs with a modified, acyclic ribose moiety as P2Y(2) receptor antagonists.
AID304928	Agonist activity at human P2Y2 receptor expressed in human 1321N1 by FLIPR assay	2007	Bioorganic & medicinal chemistry letters, Jan-15, Volume: 17, Issue:2	Novel nucleotide triphosphates as potent P2Y2 agonists.
AID404832	Agonist activity at human P2Y2 receptor expressed in human 1321N1 cells assessed as [3H]inositol phosphate accumulation by scintillation proximity assay	2008	Bioorganic & medicinal chemistry, Jun-15, Volume: 16, Issue:12	Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonists.
AID150627	The compound was evaluated for antagonist activity against phospholipase C coupled recombinant human P2Y purinoceptor 4 (P2Y4)	2002	Journal of medicinal chemistry, Sep-12, Volume: 45, Issue:19	Purine and pyrimidine (P2) receptors as drug targets.
AID600868	Ratio of EC50 for human recombinant P2Y2 receptor expressed in human 1321N1 cells to EC50 for human recombinant P2Y4 receptor expressed in human 1321N1 cells	2011	Journal of medicinal chemistry, Jun-23, Volume: 54, Issue:12	Pyrimidine nucleotides with 4-alkyloxyimino and terminal tetraphosphate δ-ester modifications as selective agonists of the P2Y(4) receptor.
AID593126	Agonist activity at human recombinant P2Y6 receptor expressed in human 1321N1 cells assessed as [3H]inositol phosphate intracellular accumulation by scintillation proximity assay	2011	Journal of medicinal chemistry, Apr-28, Volume: 54, Issue:8	Structural modifications of UMP, UDP, and UTP leading to subtype-selective agonists for P2Y2, P2Y4, and P2Y6 receptors.
AID460812	Agonist activity at human P2Y6 receptor expressed in human 1321N1 cells assessed as calcium elevation by fura2/AM assay	2010	Journal of medicinal chemistry, Feb-25, Volume: 53, Issue:4	5-OMe-UDP is a potent and selective P2Y(6)-receptor agonist.
AID1465369	Agonist activity at P2Y2 receptor H184A mutant (unknown origin) expressed in human 1321N1 astrocytoma cells assessed as increase in intracellular calcium mobilization after 1 hr by Fluo-4 AM dye based fluorescence assay	2017	Journal of medicinal chemistry, 10-26, Volume: 60, Issue:20	Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y
AID280297	Agonist activity at human recombinant P2Y2 receptor expressed in 1321N1 cells assessed as stimulation of phospholipase C	2007	Journal of medicinal chemistry, Mar-22, Volume: 50, Issue:6	Molecular modeling of the human P2Y2 receptor and design of a selective agonist, 2'-amino-2'-deoxy-2-thiouridine 5'-triphosphate.
AID304929	Agonist activity at human cloned P2Y1 receptor expressed in human 1321N1 by FLIPR assay	2007	Bioorganic & medicinal chemistry letters, Jan-15, Volume: 17, Issue:2	Novel nucleotide triphosphates as potent P2Y2 agonists.
AID350690	Agonist activity at N-terminal HA epitope-tagged human P2Y2 receptor R180A mutant expressed in human 1321N1 cells assessed as increase in intracellular calcium level	2009	Journal of medicinal chemistry, May-14, Volume: 52, Issue:9	Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.
AID1465368	Agonist activity at P2Y2 receptor Y288F mutant (unknown origin) expressed in human 1321N1 astrocytoma cells assessed as increase in intracellular calcium mobilization after 1 hr by Fluo-4 AM dye based fluorescence assay	2017	Journal of medicinal chemistry, 10-26, Volume: 60, Issue:20	Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y
AID1372695	Agonist activity at human P2Y2 receptor expressed in 1321N1 cells assessed as [3H]-inositol phosphate accumulation measured after 90 mins by anion exchange chromatographic method	2018	Bioorganic & medicinal chemistry, 01-15, Volume: 26, Issue:2	Current knowledge on the nucleotide agonists for the P2Y2 receptor.
AID1465388	Selectivity ratio of EC50 for P2Y2 receptor F111A mutant (unknown origin) to EC50 for wild type P2Y2 receptor (unknown origin)	2017	Journal of medicinal chemistry, 10-26, Volume: 60, Issue:20	Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y
AID89271	Agonist activity evaluated as change in the level of cytosolic calcium in 1321N astrocytoma cells infected with a retrovirus encoding the human P2Y4 receptor	2001	Bioorganic & medicinal chemistry letters, Jan-22, Volume: 11, Issue:2	Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5'-polyphosphates.
AID350679	Agonist activity at N-terminal HA epitope-tagged wild type 4 human P2Y2 receptor expressed in human 1321N1 cells assessed as increase in intracellular calcium level	2009	Journal of medicinal chemistry, May-14, Volume: 52, Issue:9	Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.
AID600864	Agonist activity at human recombinant P2Y6 receptor expressed in human 1321N1 cells assessed as [3H]inositol phosphate production after 30 mins by scintillation proximity assay	2011	Journal of medicinal chemistry, Jun-23, Volume: 54, Issue:12	Pyrimidine nucleotides with 4-alkyloxyimino and terminal tetraphosphate δ-ester modifications as selective agonists of the P2Y(4) receptor.
AID1465367	Agonist activity at wild type P2Y2 receptor (unknown origin) expressed in human 1321N1 astrocytoma cells assessed as increase in intracellular calcium mobilization after 1 hr by Fluo-4 AM dye based fluorescence assay	2017	Journal of medicinal chemistry, 10-26, Volume: 60, Issue:20	Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y
AID373707	Agonist activity at human P2Y2 receptor expressed in human 1321N1 cells assessed as increase in intracellular calcium concentration by dual-excitation spectrofluorimetric analysis	2009	European journal of medicinal chemistry, Apr, Volume: 44, Issue:4	Identification of hydrolytically stable and selective P2Y(1) receptor agonists.
AID304930	Agonist activity at human cloned P2Y4 receptor expressed in human 1321N1 by FLIPR assay	2007	Bioorganic & medicinal chemistry letters, Jan-15, Volume: 17, Issue:2	Novel nucleotide triphosphates as potent P2Y2 agonists.
AID350683	Agonist activity at N-terminal HA epitope-tagged human P2Y2 receptor Y114A mutant expressed in human 1321N1 cells assessed as increase in intracellular calcium level	2009	Journal of medicinal chemistry, May-14, Volume: 52, Issue:9	Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.
AID350686	Agonist activity at N-terminal HA epitope-tagged human P2Y2 receptor R177A_R180A double mutant expressed in human 1321N1 cells assessed as increase in intracellular calcium level	2009	Journal of medicinal chemistry, May-14, Volume: 52, Issue:9	Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.
AID280298	Agonist activity at human recombinant P2Y4 receptor expressed in 1321N1 cells assessed as stimulation of phospholipase C	2007	Journal of medicinal chemistry, Mar-22, Volume: 50, Issue:6	Molecular modeling of the human P2Y2 receptor and design of a selective agonist, 2'-amino-2'-deoxy-2-thiouridine 5'-triphosphate.
AID278952	Activity of HCV NS5B RNA polymerase S282T assessed as incorporation of 32P-UMP into RNA	2007	Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2	Mechanism of activation of beta-D-2'-deoxy-2'-fluoro-2'-c-methylcytidine and inhibition of hepatitis C virus NS5B RNA polymerase.
AID593124	Agonist activity at human recombinant P2Y2 receptor expressed in human 1321N1 cells assessed as [3H]inositol phosphate intracellular accumulation by scintillation proximity assay	2011	Journal of medicinal chemistry, Apr-28, Volume: 54, Issue:8	Structural modifications of UMP, UDP, and UTP leading to subtype-selective agonists for P2Y2, P2Y4, and P2Y6 receptors.
AID1465366	Agonist activity at P2Y2 receptor S193A mutant (unknown origin) expressed in human 1321N1 astrocytoma cells assessed as increase in intracellular calcium mobilization after 1 hr by Fluo-4 AM dye based fluorescence assay	2017	Journal of medicinal chemistry, 10-26, Volume: 60, Issue:20	Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y
AID278943	Ratio of Kcat to Km for HCV NS5B RNA polymerase S282T mutant	2007	Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2	Mechanism of activation of beta-D-2'-deoxy-2'-fluoro-2'-c-methylcytidine and inhibition of hepatitis C virus NS5B RNA polymerase.
AID1370008	Drug metabolism at 2 mM at pH 11.7 at room temperature after 20 days by 31P NMR method	2018	Journal of medicinal chemistry, 05-10, Volume: 61, Issue:9	Highly Selective and Potent Ectonucleotide Pyrophosphatase-1 (NPP1) Inhibitors Based on Uridine 5'-P
AID305251	Agonist activity at human cloned P2Y6 receptor expressed in human 1321N1 by FLIPR assay	2007	Bioorganic & medicinal chemistry letters, Jan-15, Volume: 17, Issue:2	Novel nucleotide triphosphates as potent P2Y2 agonists with enhanced stability over UTP.
AID1465387	Selectivity ratio of EC50 for P2Y2 receptor S193A mutant (unknown origin) to EC50 for wild type P2Y2 receptor (unknown origin)	2017	Journal of medicinal chemistry, 10-26, Volume: 60, Issue:20	Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y
AID484776	Stability assessed as half life by HPLC in presence of human 1321N1 cell membranes	2010	Journal of medicinal chemistry, Jun-10, Volume: 53, Issue:11	Pyrimidine ribonucleotides with enhanced selectivity as P2Y(6) receptor agonists: novel 4-alkyloxyimino, (S)-methanocarba, and 5'-triphosphate gamma-ester modifications.
AID1372693	Agonist activity at P2Y2 receptor in BEA cells (unknown origin)	2018	Bioorganic & medicinal chemistry, 01-15, Volume: 26, Issue:2	Current knowledge on the nucleotide agonists for the P2Y2 receptor.
AID350684	Agonist activity at N-terminal HA epitope-tagged wild type 4 human P2Y2 receptor expressed in human 1321N1 cells assessed as increase in intracellular calcium level relative to carbachol	2009	Journal of medicinal chemistry, May-14, Volume: 52, Issue:9	Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.
AID261436	Activity against HCV 1b BK NS5B deltaC55 RNA polymerase	2006	Journal of medicinal chemistry, Mar-09, Volume: 49, Issue:5	2-(2-Thienyl)-5,6-dihydroxy-4-carboxypyrimidines as inhibitors of the hepatitis C virus NS5B polymerase: discovery, SAR, modeling, and mutagenesis.
AID1465385	Selectivity ratio of EC50 for P2Y2 receptor R194H mutant (unknown origin) to EC50 for wild type P2Y2 receptor (unknown origin)	2017	Journal of medicinal chemistry, 10-26, Volume: 60, Issue:20	Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y
AID1465378	Agonist activity at P2Y2 receptor Y269F mutant (unknown origin) expressed in human 1321N1 astrocytoma cells assessed as increase in intracellular calcium mobilization after 1 hr by Fluo-4 AM dye based fluorescence assay	2017	Journal of medicinal chemistry, 10-26, Volume: 60, Issue:20	Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y
AID280301	Agonist activity at human recombinant P2Y6 receptor expressed in 1321N1 cells assessed as intracellular calcium mobilization	2007	Journal of medicinal chemistry, Mar-22, Volume: 50, Issue:6	Molecular modeling of the human P2Y2 receptor and design of a selective agonist, 2'-amino-2'-deoxy-2-thiouridine 5'-triphosphate.
AID272719	Agonist activity at human P2Y4 receptor expressed in 1321N1 cells assessed as IP accumulation by SPA	2006	Journal of medicinal chemistry, Nov-30, Volume: 49, Issue:24	Synthesis and structure-activity relationships of uracil nucleotide derivatives and analogues as agonists at human P2Y2, P2Y4, and P2Y6 receptors.
AID305250	Agonist activity at human cloned P2Y4 receptor expressed in human 1321N1 by FLIPR assay	2007	Bioorganic & medicinal chemistry letters, Jan-15, Volume: 17, Issue:2	Novel nucleotide triphosphates as potent P2Y2 agonists with enhanced stability over UTP.
AID150321	Evaluated for agonist activity against phospholipase C coupled recombinant human P2Y purinoceptor 2 (P2Y2)	2002	Journal of medicinal chemistry, Sep-12, Volume: 45, Issue:19	Purine and pyrimidine (P2) receptors as drug targets.
AID648184	Agonist activity at human P2Y4 receptor expressed in human 1321N1 cells assessed as stimulation of PLC-induced [3H]inositol phosphate production at 100 uM after 30 mins by scintillation counting	2012	Bioorganic & medicinal chemistry, Apr-01, Volume: 20, Issue:7	Synthesis and P2Y₂ receptor agonist activities of uridine 5'-phosphonate analogues.
AID600862	Agonist activity at human recombinant P2Y2 receptor expressed in human 1321N1 cells assessed as [3H]inositol phosphate production after 30 mins by scintillation proximity assay	2011	Journal of medicinal chemistry, Jun-23, Volume: 54, Issue:12	Pyrimidine nucleotides with 4-alkyloxyimino and terminal tetraphosphate δ-ester modifications as selective agonists of the P2Y(4) receptor.
AID89273	Agonist activity evaluated as change in the level of cytosolic calcium in 1321N astrocytoma cells infected with a retrovirus encoding the human P2Y6 receptor	2001	Bioorganic & medicinal chemistry letters, Jan-22, Volume: 11, Issue:2	Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5'-polyphosphates.
AID150331	Evaluated for agonist activity against phospholipase C coupled P2Y purinoceptor 1 (P2Y1) of human erythrocytes	2002	Journal of medicinal chemistry, Sep-12, Volume: 45, Issue:19	Purine and pyrimidine (P2) receptors as drug targets.
AID350687	Agonist activity at N-terminal HA epitope-tagged human P2Y2 receptor R177A_R180A double mutant expressed in human 1321N1 cells assessed as increase in intracellular calcium level relative to carbachol	2009	Journal of medicinal chemistry, May-14, Volume: 52, Issue:9	Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.
AID304931	Agonist activity at human cloned P2Y6 receptor expressed in human 1321N1 by FLIPR assay	2007	Bioorganic & medicinal chemistry letters, Jan-15, Volume: 17, Issue:2	Novel nucleotide triphosphates as potent P2Y2 agonists.
AID386066	Inhibition of RNA synthesis activity of HSV 1b Con1 NS5B polymerase	2007	The Journal of biological chemistry, Oct-12, Volume: 282, Issue:41	Characterization of the metabolic activation of hepatitis C virus nucleoside inhibitor beta-D-2'-Deoxy-2'-fluoro-2'-C-methylcytidine (PSI-6130) and identification of a novel active 5'-triphosphate species.
AID350671	Agonist activity at N-terminal HA epitope-tagged human P2Y2 receptor S296A mutant expressed in human 1321N1 cells assessed as increase in intracellular calcium level relative to carbachol	2009	Journal of medicinal chemistry, May-14, Volume: 52, Issue:9	Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.
AID1465389	Selectivity ratio of EC50 for P2Y2 receptor Y269F mutant (unknown origin) to EC50 for wild type P2Y2 receptor (unknown origin)	2017	Journal of medicinal chemistry, 10-26, Volume: 60, Issue:20	Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y
AID350699	Agonist activity at N-terminal HA epitope-tagged human P2Y2 receptor Y198A mutant expressed in human 1321N1 cells assessed as increase in intracellular calcium level relative to carbachol	2009	Journal of medicinal chemistry, May-14, Volume: 52, Issue:9	Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.
AID1465411	Agonist activity at P2Y2 receptor Y114F mutant (unknown origin) expressed in human 1321N1 astrocytoma cells assessed as increase in intracellular calcium mobilization after 1 hr by Fluo-4 AM dye based fluorescence assay	2017	Journal of medicinal chemistry, 10-26, Volume: 60, Issue:20	Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y
AID1465381	Selectivity ratio of EC50 for P2Y2 receptor Y114A mutant (unknown origin) to EC50 for wild type P2Y2 receptor (unknown origin)	2017	Journal of medicinal chemistry, 10-26, Volume: 60, Issue:20	Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y
AID1465386	Selectivity ratio of EC50 for P2Y2 receptor Y268F mutant (unknown origin) to EC50 for wild type P2Y2 receptor (unknown origin)	2017	Journal of medicinal chemistry, 10-26, Volume: 60, Issue:20	Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y
AID1465383	Selectivity ratio of EC50 for P2Y2 receptor H184A mutant (unknown origin) to EC50 for wild type P2Y2 receptor (unknown origin)	2017	Journal of medicinal chemistry, 10-26, Volume: 60, Issue:20	Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y
AID1465380	Agonist activity at P2Y2 receptor R292A mutant (unknown origin) expressed in human 1321N1 astrocytoma cells assessed as increase in intracellular calcium mobilization after 1 hr by Fluo-4 AM dye based fluorescence assay	2017	Journal of medicinal chemistry, 10-26, Volume: 60, Issue:20	Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y
AID350668	Agonist activity at N-terminal HA epitope-tagged human P2Y2 receptor C278S mutant expressed in human 1321N1 cells assessed as increase in intracellular calcium level	2009	Journal of medicinal chemistry, May-14, Volume: 52, Issue:9	Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.
AID350696	Agonist activity at N-terminal HA epitope-tagged human P2Y2 receptor R194H mutant expressed in human 1321N1 cells assessed as increase in intracellular calcium level	2009	Journal of medicinal chemistry, May-14, Volume: 52, Issue:9	Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.
AID350693	Agonist activity at N-terminal HA epitope-tagged human P2Y2 receptor R272A mutant expressed in human 1321N1 cells assessed as increase in intracellular calcium level relative to carbachol	2009	Journal of medicinal chemistry, May-14, Volume: 52, Issue:9	Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.
AID350674	Effect on intracellular calcium level in non transfected human 1321N1 cells	2009	Journal of medicinal chemistry, May-14, Volume: 52, Issue:9	Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.
AID310935	Inhibition of adenylyl cyclase	2007	Bioorganic & medicinal chemistry, Apr-15, Volume: 15, Issue:8	A conformational transition in the adenylyl cyclase catalytic site yields different binding modes for ribosyl-modified and unmodified nucleotide inhibitors.
AID350669	Ratio of EC50 for N-terminal HA epitope-tagged human P2Y2 receptor Y118A mutant to EC50 for wild type 3 human P2Y2 receptor	2009	Journal of medicinal chemistry, May-14, Volume: 52, Issue:9	Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.
AID600876	Agonist activity at human P2Y4	2011	Journal of medicinal chemistry, Jun-23, Volume: 54, Issue:12	Pyrimidine nucleotides with 4-alkyloxyimino and terminal tetraphosphate δ-ester modifications as selective agonists of the P2Y(4) receptor.
AID350665	Ratio of EC50 for N-terminal HA epitope-tagged human P2Y2 receptor C278S mutant to EC50 for wild type 3 human P2Y2 receptor	2009	Journal of medicinal chemistry, May-14, Volume: 52, Issue:9	Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.
AID350697	Agonist activity at N-terminal HA epitope-tagged human P2Y2 receptor R194H mutant expressed in human 1321N1 cells assessed as increase in intracellular calcium level relative to carbachol	2009	Journal of medicinal chemistry, May-14, Volume: 52, Issue:9	Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.
AID1369991	Drug metabolism at 2 mM at basic pH after 5 days by 31P NMR method	2018	Journal of medicinal chemistry, 05-10, Volume: 61, Issue:9	Highly Selective and Potent Ectonucleotide Pyrophosphatase-1 (NPP1) Inhibitors Based on Uridine 5'-P
AID89268	Agonist activity evaluated as change in the level of cytosolic calcium in 1321N astrocytoma cells infected with a retrovirus encoding the human P2Y1 receptor at 100 uM; IA is inactive	2001	Bioorganic & medicinal chemistry letters, Jan-22, Volume: 11, Issue:2	Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5'-polyphosphates.
AID261438	Activity against HCV 1b BK NS5B deltaC55-R158K mutant RNA polymerase	2006	Journal of medicinal chemistry, Mar-09, Volume: 49, Issue:5	2-(2-Thienyl)-5,6-dihydroxy-4-carboxypyrimidines as inhibitors of the hepatitis C virus NS5B polymerase: discovery, SAR, modeling, and mutagenesis.
AID1465410	Selectivity ratio of EC50 for P2Y2 receptor R272A mutant (unknown origin) to EC50 for wild type P2Y2 receptor (unknown origin)	2017	Journal of medicinal chemistry, 10-26, Volume: 60, Issue:20	Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y
AID272722	Agonist activity at human P2Y6 receptor expressed in 1321N1 cells assessed as IP accumulation by SPA	2006	Journal of medicinal chemistry, Nov-30, Volume: 49, Issue:24	Synthesis and structure-activity relationships of uracil nucleotide derivatives and analogues as agonists at human P2Y2, P2Y4, and P2Y6 receptors.
AID648182	Agonist activity at human P2Y2 receptor expressed in human 1321N1 cells assessed as stimulation of PLC-induced [3H]inositol phosphate production after 30 mins by scintillation counting	2012	Bioorganic & medicinal chemistry, Apr-01, Volume: 20, Issue:7	Synthesis and P2Y₂ receptor agonist activities of uridine 5'-phosphonate analogues.
AID350676	Agonist activity at N-terminal HA epitope-tagged wild type human P2Y2 receptor expressed in human 1321N1 cells assessed as increase in intracellular calcium level	2009	Journal of medicinal chemistry, May-14, Volume: 52, Issue:9	Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.
AID261697	Activity against rat P2Y2-GFP transfected in HEK293 cells by intracellular calcium increase	2006	Journal of medicinal chemistry, Mar-23, Volume: 49, Issue:6	Diadenosine and diuridine poly(borano)phosphate analogues: synthesis, chemical and enzymatic stability, and activity at P2Y1 and P2Y2 receptors.
AID682414	Agonist activity at human GFP-tagged P2Y4 receptor expressed in human 1321N1 cells assessed as intracellular calcium mobilization by fura2/AM-based fluorescence spectrophotometry	2012	Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18	UDP made a highly promising stable, potent, and selective P2Y6-receptor agonist upon introduction of a boranophosphate moiety.
AID350694	Agonist activity at N-terminal HA epitope-tagged human P2Y2 receptor Y118A mutant expressed in human 1321N1 cells assessed as increase in intracellular calcium level	2009	Journal of medicinal chemistry, May-14, Volume: 52, Issue:9	Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.
AID350672	Agonist activity at N-terminal HA epitope-tagged human P2Y2 receptor S296A mutant expressed in human 1321N1 cells assessed as increase in intracellular calcium level	2009	Journal of medicinal chemistry, May-14, Volume: 52, Issue:9	Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.
AID404830	Agonist activity at human P2Y6 receptor expressed in human 1321N1 cells assessed as [3H]inositol phosphate accumulation by scintillation proximity assay	2008	Bioorganic & medicinal chemistry, Jun-15, Volume: 16, Issue:12	Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonists.
AID1372691	Agonist activity at P2Y2 receptor in NG108-15 cells (unknown origin)	2018	Bioorganic & medicinal chemistry, 01-15, Volume: 26, Issue:2	Current knowledge on the nucleotide agonists for the P2Y2 receptor.
AID1465365	Selectivity ratio of EC50 for P2Y2 receptor Y288F mutant (unknown origin) to EC50 for wild type P2Y2 receptor (unknown origin)	2017	Journal of medicinal chemistry, 10-26, Volume: 60, Issue:20	Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y
AID1465379	Agonist activity at P2Y2 receptor Y288A mutant (unknown origin) expressed in human 1321N1 astrocytoma cells assessed as increase in intracellular calcium mobilization after 1 hr by Fluo-4 AM dye based fluorescence assay	2017	Journal of medicinal chemistry, 10-26, Volume: 60, Issue:20	Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y
AID305249	Agonist activity at human cloned P2Y1 receptor expressed in human 1321N1 by FLIPR assay	2007	Bioorganic & medicinal chemistry letters, Jan-15, Volume: 17, Issue:2	Novel nucleotide triphosphates as potent P2Y2 agonists with enhanced stability over UTP.
AID647894	Agonist activity at human P2Y purinoceptor 2 expressed in human 1321N1 cells assessed as increase in intracellular calcium concentration by spectrofluorimetry	2012	Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1	Boranophosphate isoster controls P2Y-receptor subtype selectivity and metabolic stability of dinucleoside polyphosphate analogues.
AID484777	Agonist activity at human recombinant P2Y4 receptor expressed in human 1321N1 cells assessed as [3H]inositol phosphate production by scintillation proximity assay	2010	Journal of medicinal chemistry, Jun-10, Volume: 53, Issue:11	Pyrimidine ribonucleotides with enhanced selectivity as P2Y(6) receptor agonists: novel 4-alkyloxyimino, (S)-methanocarba, and 5'-triphosphate gamma-ester modifications.
AID373708	Agonist activity at human P2Y4 receptor expressed in human 1321N1 cells assessed as increase in intracellular calcium concentration by dual-excitation spectrofluorimetric analysis	2009	European journal of medicinal chemistry, Apr, Volume: 44, Issue:4	Identification of hydrolytically stable and selective P2Y(1) receptor agonists.
AID350689	Agonist activity at N-terminal HA epitope-tagged human P2Y2 receptor R177A mutant expressed in human 1321N1 cells assessed as increase in intracellular calcium level relative to carbachol	2009	Journal of medicinal chemistry, May-14, Volume: 52, Issue:9	Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.
AID1465376	Agonist activity at P2Y2 receptor R265A mutant (unknown origin) expressed in human 1321N1 astrocytoma cells assessed as increase in intracellular calcium mobilization after 1 hr by Fluo-4 AM dye based fluorescence assay	2017	Journal of medicinal chemistry, 10-26, Volume: 60, Issue:20	Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y
AID278951	Activity of HCV NS5B RNA polymerase assessed as incorporation of 32P-UMP into RNA	2007	Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2	Mechanism of activation of beta-D-2'-deoxy-2'-fluoro-2'-c-methylcytidine and inhibition of hepatitis C virus NS5B RNA polymerase.
AID1372689	Agonist activity at P2Y2 receptor (unknown origin) assessed as reduction in inositol phosphate accumulation	2018	Bioorganic & medicinal chemistry, 01-15, Volume: 26, Issue:2	Current knowledge on the nucleotide agonists for the P2Y2 receptor.
AID350688	Agonist activity at N-terminal HA epitope-tagged human P2Y2 receptor R177A mutant expressed in human 1321N1 cells assessed as increase in intracellular calcium level	2009	Journal of medicinal chemistry, May-14, Volume: 52, Issue:9	Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.
AID682413	Agonist activity at human GFP-tagged P2Y2 receptor expressed in human 1321N1 cells assessed as intracellular calcium mobilization by fura2/AM-based fluorescence spectrophotometry	2012	Bioorganic & medicinal chemistry, Sep-15, Volume: 20, Issue:18	UDP made a highly promising stable, potent, and selective P2Y6-receptor agonist upon introduction of a boranophosphate moiety.
AID352541	Agonist activity at human P2Y6 receptor expressed in human 1321N1 cells coexpressing phospholipase C-activating G protein assessed as inositol phosphate production at 10 uM by scintillation proximity assay	2009	Bioorganic & medicinal chemistry letters, Jun-01, Volume: 19, Issue:11	Synthesis and P2Y receptor activity of nucleoside 5'-phosphonate derivatives.
AID350691	Agonist activity at N-terminal HA epitope-tagged human P2Y2 receptor R180A mutant expressed in human 1321N1 cells assessed as increase in intracellular calcium level relative to carbachol	2009	Journal of medicinal chemistry, May-14, Volume: 52, Issue:9	Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.
AID261699	Activity against human P2Y2-GFP expressed in A549 cells by intracellular calcium increase	2006	Journal of medicinal chemistry, Mar-23, Volume: 49, Issue:6	Diadenosine and diuridine poly(borano)phosphate analogues: synthesis, chemical and enzymatic stability, and activity at P2Y1 and P2Y2 receptors.
AID261696	Activity against rat P2Y1-GFP transfected in HEK293 cells by intracellular calcium increase	2006	Journal of medicinal chemistry, Mar-23, Volume: 49, Issue:6	Diadenosine and diuridine poly(borano)phosphate analogues: synthesis, chemical and enzymatic stability, and activity at P2Y1 and P2Y2 receptors.
AID484784	Agonist activity at human recombinant P2Y6 receptor expressed in human 1321N1 cells assessed as [3H]inositol phosphate production by scintillation proximity assay	2010	Journal of medicinal chemistry, Jun-10, Volume: 53, Issue:11	Pyrimidine ribonucleotides with enhanced selectivity as P2Y(6) receptor agonists: novel 4-alkyloxyimino, (S)-methanocarba, and 5'-triphosphate gamma-ester modifications.
AID350698	Agonist activity at N-terminal HA epitope-tagged human P2Y2 receptor Y198A mutant expressed in human 1321N1 cells assessed as increase in intracellular calcium level	2009	Journal of medicinal chemistry, May-14, Volume: 52, Issue:9	Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.
AID484783	Agonist activity at human recombinant P2Y2 receptor expressed in human 1321N1 cells assessed as [3H]inositol phosphate production by scintillation proximity assay	2010	Journal of medicinal chemistry, Jun-10, Volume: 53, Issue:11	Pyrimidine ribonucleotides with enhanced selectivity as P2Y(6) receptor agonists: novel 4-alkyloxyimino, (S)-methanocarba, and 5'-triphosphate gamma-ester modifications.
AID1465372	Agonist activity at P2Y2 receptor Y114A mutant (unknown origin) expressed in human 1321N1 astrocytoma cells assessed as increase in intracellular calcium mobilization after 1 hr by Fluo-4 AM dye based fluorescence assay	2017	Journal of medicinal chemistry, 10-26, Volume: 60, Issue:20	Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y
AID484775	Stability assessed as half life in aqueous acidic solution at pH 1.2 by HPLC	2010	Journal of medicinal chemistry, Jun-10, Volume: 53, Issue:11	Pyrimidine ribonucleotides with enhanced selectivity as P2Y(6) receptor agonists: novel 4-alkyloxyimino, (S)-methanocarba, and 5'-triphosphate gamma-ester modifications.
AID1465370	Agonist activity at P2Y2 receptor R110A mutant (unknown origin) expressed in human 1321N1 astrocytoma cells assessed as increase in intracellular calcium mobilization after 1 hr by Fluo-4 AM dye based fluorescence assay	2017	Journal of medicinal chemistry, 10-26, Volume: 60, Issue:20	Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y
AID1465375	Agonist activity at P2Y2 receptor F261A mutant (unknown origin) expressed in human 1321N1 astrocytoma cells assessed as increase in intracellular calcium mobilization after 1 hr by Fluo-4 AM dye based fluorescence assay	2017	Journal of medicinal chemistry, 10-26, Volume: 60, Issue:20	Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y
AID278942	Ratio of Kcat to Km for HCV NS5B RNA polymerase	2007	Antimicrobial agents and chemotherapy, Feb, Volume: 51, Issue:2	Mechanism of activation of beta-D-2'-deoxy-2'-fluoro-2'-c-methylcytidine and inhibition of hepatitis C virus NS5B RNA polymerase.
AID150489	Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11)	2002	Journal of medicinal chemistry, Sep-12, Volume: 45, Issue:19	Purine and pyrimidine (P2) receptors as drug targets.
AID484781	Agonist activity at human recombinant P2Y6 receptor expressed in human 1321N1 cells assessed as [3H]inositol phosphate production up to 10 uM by scintillation proximity assay	2010	Journal of medicinal chemistry, Jun-10, Volume: 53, Issue:11	Pyrimidine ribonucleotides with enhanced selectivity as P2Y(6) receptor agonists: novel 4-alkyloxyimino, (S)-methanocarba, and 5'-triphosphate gamma-ester modifications.
AID1465377	Agonist activity at P2Y2 receptor Y268F mutant (unknown origin) expressed in human 1321N1 astrocytoma cells assessed as increase in intracellular calcium mobilization after 1 hr by Fluo-4 AM dye based fluorescence assay	2017	Journal of medicinal chemistry, 10-26, Volume: 60, Issue:20	Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y
AID1614295	Substrate activity at human POLRMT assessed as 5-radiolabled RNA/DNA incorporation levels at 100 uM after 2 hrs by PAGE analysis	2019	Journal of medicinal chemistry, 02-28, Volume: 62, Issue:4	Discovery of a Series of 2'-α-Fluoro,2'-β-bromo-ribonucleosides and Their Phosphoramidate Prodrugs as Potent Pan-Genotypic Inhibitors of Hepatitis C Virus.
AID350685	Agonist activity at N-terminal HA epitope-tagged human P2Y2 receptor Y114A mutant expressed in human 1321N1 cells assessed as increase in intracellular calcium level relative to carbachol	2009	Journal of medicinal chemistry, May-14, Volume: 52, Issue:9	Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.
AID261437	Activity against HCV 1b BK NS5B deltaC55-R158M mutant RNA polymerase	2006	Journal of medicinal chemistry, Mar-09, Volume: 49, Issue:5	2-(2-Thienyl)-5,6-dihydroxy-4-carboxypyrimidines as inhibitors of the hepatitis C virus NS5B polymerase: discovery, SAR, modeling, and mutagenesis.
AID1465373	Agonist activity at P2Y2 receptor R194A mutant (unknown origin) expressed in human 1321N1 astrocytoma cells assessed as increase in intracellular calcium mobilization after 1 hr by Fluo-4 AM dye based fluorescence assay	2017	Journal of medicinal chemistry, 10-26, Volume: 60, Issue:20	Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y
AID305248	Agonist activity at human P2Y2 receptor expressed in human 1321N1 by FLIPR assay	2007	Bioorganic & medicinal chemistry letters, Jan-15, Volume: 17, Issue:2	Novel nucleotide triphosphates as potent P2Y2 agonists with enhanced stability over UTP.
AID150636	The compound was evaluated for agonist activity against phospholipase C coupled recombinant human P2Y purinoceptor 6 (P2Y6)	2002	Journal of medicinal chemistry, Sep-12, Volume: 45, Issue:19	Purine and pyrimidine (P2) receptors as drug targets.
AID150634	The compound was evaluated for antagonist activity against phospholipase C coupled recombinant rat P2Y purinoceptor 4 (P2Y4)	2002	Journal of medicinal chemistry, Sep-12, Volume: 45, Issue:19	Purine and pyrimidine (P2) receptors as drug targets.
AID221765	Kinetic constant for galactosyltransferase inhibition was determined	1987	Journal of medicinal chemistry, Aug, Volume: 30, Issue:8	Synthesis of glycopyranosylphosphonate analogues of certain natural nucleoside diphosphate sugars as potential inhibitors of glycosyltransferases.
AID436592	Antagonist activity at mouse P2Y2 receptor expressed in NG108-15 hybrid cells assessed as inhibition of 1 uM UTP-induced intracellular calcium release preincubated 30 mins before UTP challenge by fluorescence assay	2009	Bioorganic & medicinal chemistry, Jul-15, Volume: 17, Issue:14	Synthesis of uracil nucleotide analogs with a modified, acyclic ribose moiety as P2Y(2) receptor antagonists.
AID350673	Agonist activity at N-terminal HA epitope-tagged wild type 3 human P2Y2 receptor expressed in human 1321N1 cells assessed as increase in intracellular calcium level relative to carbachol	2009	Journal of medicinal chemistry, May-14, Volume: 52, Issue:9	Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.
AID1465384	Selectivity ratio of EC50 for P2Y2 receptor R194A mutant (unknown origin) to EC50 for wild type P2Y2 receptor (unknown origin)	2017	Journal of medicinal chemistry, 10-26, Volume: 60, Issue:20	Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y
AID1465371	Agonist activity at P2Y2 receptor F111A mutant (unknown origin) expressed in human 1321N1 astrocytoma cells assessed as increase in intracellular calcium mobilization after 1 hr by Fluo-4 AM dye based fluorescence assay	2017	Journal of medicinal chemistry, 10-26, Volume: 60, Issue:20	Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y
AID1137665	Displacement of [3H]PSB-12150 from human GPR17 expressed in CHO-K1 cell membranes up to 1 mM after 60 mins by liquid scintillation counting	2014	ACS medicinal chemistry letters, Apr-10, Volume: 5, Issue:4	Development of [(3)H]2-Carboxy-4,6-dichloro-1H-indole-3-propionic Acid ([(3)H]PSB-12150): A Useful Tool for Studying GPR17.
AID460576	Agonist activity at human P2Y4 receptor expressed in human 1321N1 cells assessed as calcium elevation by fura2/AM assay	2010	Journal of medicinal chemistry, Feb-25, Volume: 53, Issue:4	5-OMe-UDP is a potent and selective P2Y(6)-receptor agonist.
AID350918	Agonist activity at N-terminal HA epitope-tagged human P2Y2 receptor Y118A mutant expressed in human 1321N1 cells assessed as increase in intracellular calcium level relative to carbachol	2009	Journal of medicinal chemistry, May-14, Volume: 52, Issue:9	Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.
AID1508630	Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay	2021	Cell reports, 04-27, Volume: 35, Issue:4	A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347154	Primary screen GU AMC qHTS for Zika virus inhibitors	2020	Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49	Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347028	Human P2Y2 receptor (P2Y receptors)	1995	British journal of pharmacology, Sep, Volume: 116, Issue:1	Pharmacological selectivity of the cloned human P2U-purinoceptor: potent activation by diadenosine tetraphosphate.
AID1346335	Human P2Y11 receptor (P2Y receptors)	2003	Molecular pharmacology, Jun, Volume: 63, Issue:6	Characterization of a Ca2+ response to both UTP and ATP at human P2Y11 receptors: evidence for agonist-specific signaling.
AID1347028	Human P2Y2 receptor (P2Y receptors)	2002	Journal of medicinal chemistry, Jan-03, Volume: 45, Issue:1	Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors.
AID1346426	Human P2Y6 receptor (P2Y receptors)	1996	Biochemical and biophysical research communications, May-15, Volume: 222, Issue:2	Cloning, functional expression and tissue distribution of the human P2Y6 receptor.
AID1346348	Human P2Y4 receptor (P2Y receptors)	2000	Molecular pharmacology, May, Volume: 57, Issue:5	ATP, an agonist at the rat P2Y(4) receptor, is an antagonist at the human P2Y(4) receptor.
AID1346293	Rat P2Y4 receptor (P2Y receptors)	1998	British journal of pharmacology, Jun, Volume: 124, Issue:3	Molecular cloning and characterization of rat P2Y4 nucleotide receptor.
AID1159607	Screen for inhibitors of RMI FANCM (MM2) intereaction	2016	Journal of biomolecular screening, Jul, Volume: 21, Issue:6	A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	421 (17.82)	18.7374
1990's	806 (34.12)	18.2507
2000's	761 (32.22)	29.6817
2010's	308 (13.04)	24.3611
2020's	66 (2.79)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Publication Type	This drug (%)	All Drugs (%)
Trials	20 (0.83%)	5.53%
Reviews	66 (2.72%)	6.00%
Case Studies	1 (0.04%)	4.05%
Observational	0 (0.00%)	0.25%
Other	2,336 (96.41%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Description	Relationhip Strength	Studies	Trials	Classes	Roles
5-bromouridine triphosphate	[no description available]	medium	53	0	organobromine compound; pyrimidine ribonucleoside 5'-triphosphate
adenosine diphosphate	[no description available]	medium	232	0	adenosine 5'-phosphate; purine ribonucleoside 5'-diphosphate	fundamental metabolite; human metabolite
uridine diphosphate	[no description available]	high	156	0	pyrimidine ribonucleoside 5'-diphosphate; uridine 5'-phosphate	Escherichia coli metabolite; mouse metabolite
2-methylthio-atp	[no description available]	medium	82	0
Reactive blue 2	[no description available]	medium	1	0	anthraquinone
inosine triphosphate	[no description available]	high	36	0	inosine phosphate; purine ribonucleoside 5'-triphosphate	Escherichia coli metabolite; human metabolite; mouse metabolite
cytidine triphosphate	[no description available]	high	283	2	cytidine 5'-phosphate; pyrimidine ribonucleoside 5'-triphosphate	Escherichia coli metabolite; mouse metabolite
cytidine triphosphate	[no description available]	high	283	0	cytidine 5'-phosphate; pyrimidine ribonucleoside 5'-triphosphate	Escherichia coli metabolite; mouse metabolite
diadenosine tetraphosphate	[no description available]	medium	1	0	organophosphate oxoanion	human metabolite; Saccharomyces cerevisiae metabolite
guanosine triphosphate	[no description available]	high	256	0	guanosine 5'-phosphate; purine ribonucleoside 5'-triphosphate	Escherichia coli metabolite; mouse metabolite; uncoupling protein inhibitor
diquafosol	[no description available]	high	9	0	pyrimidine ribonucleoside 5'-tetraphosphate; uridine 5'-phosphate	mouse metabolite; P2Y2 receptor agonist
denufosol tetrasodium	[no description available]	medium	4	0
adenosine monophosphate	[no description available]	medium	58	0	adenosine 5'-phosphate; purine ribonucleoside 5'-monophosphate	adenosine A1 receptor agonist; cofactor; EC 3.1.3.1 (alkaline phosphatase) inhibitor; EC 3.1.3.11 (fructose-bisphosphatase) inhibitor; fundamental metabolite; micronutrient; nutraceutical
pyridoxal phosphate	[no description available]	high	65	0	methylpyridines; monohydroxypyridine; pyridinecarbaldehyde; vitamin B6 phosphate	coenzyme; cofactor; EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid	[no description available]	medium	62	0	arenesulfonic acid; azobenzenes; methylpyridines; monohydroxypyridine; organic phosphate; pyridinecarbaldehyde	purinergic receptor P2X antagonist
suramin	[no description available]	medium	136	0	naphthalenesulfonic acid; phenylureas; secondary carboxamide	angiogenesis inhibitor; antinematodal drug; antineoplastic agent; apoptosis inhibitor; EC 2.7.11.13 (protein kinase C) inhibitor; GABA antagonist; GABA-gated chloride channel antagonist; purinergic receptor P2 antagonist; ryanodine receptor agonist; trypanocidal drug
trypan blue	[no description available]	medium	1	0
2'-deoxyadenosine triphosphate	[no description available]	medium	13	0	2'-deoxyadenosine 5'-phosphate; purine 2'-deoxyribonucleoside 5'-triphosphate	Escherichia coli metabolite; mouse metabolite
diadenosine tetraphosphate	[no description available]	medium	12	0	diadenosyl tetraphosphate	Escherichia coli metabolite; mouse metabolite
diadenosine tetraphosphate	[no description available]	medium	12	1	diadenosyl tetraphosphate	Escherichia coli metabolite; mouse metabolite
5'-adenylyl (beta,gamma-methylene)diphosphonate	[no description available]	medium	20	0	nucleoside triphosphate analogue
alpha,beta-methyleneadenosine 5'-triphosphate	[no description available]	medium	85	0	nucleoside triphosphate analogue
methylthio-adp	[no description available]	medium	19	0
adenosine 5'-o-(3-thiotriphosphate)	[no description available]	medium	71	0	nucleoside triphosphate analogue
mrs 2219	[no description available]	medium	1	0
ar c67085mx	[no description available]	medium	1	0
adp beta s	[no description available]	medium	18	0
kn 62	[no description available]	medium	6	0	piperazines
nf023	[no description available]	medium	1	0
cangrelor	[no description available]	medium	1	0	adenosine 5'-phosphate; aryl sulfide; nucleoside triphosphate analogue; organochlorine compound; organofluorine compound; secondary amino compound	P2Y12 receptor antagonist; platelet aggregation inhibitor
acid blue 129	[no description available]	medium	1	0
diadenosine triphosphate	[no description available]	medium	7	0	diadenosyl triphosphate	mouse metabolite
nitro-bis(2,4-pentanedionato)(pyridine)cobalt(iii)	[no description available]	medium	2	0	diadenosyl pentaphosphate	Escherichia coli metabolite; vasoconstrictor agent
uridine	[no description available]	medium	114	0	uridines	drug metabolite; fundamental metabolite; human metabolite
uridine	[no description available]	medium	114	1	uridines	drug metabolite; fundamental metabolite; human metabolite
uridine monophosphate	[no description available]	high	57	0	pyrimidine ribonucleoside 5'-monophosphate; uridine 5'-phosphate	Escherichia coli metabolite; human metabolite; mouse metabolite
cytidine monophosphate	[no description available]	high	15	3	cytidine 5'-phosphate; pyrimidine ribonucleoside 5'-monophosphate	Escherichia coli metabolite; human metabolite; mouse metabolite
cytidine monophosphate	[no description available]	high	15	0	cytidine 5'-phosphate; pyrimidine ribonucleoside 5'-monophosphate	Escherichia coli metabolite; human metabolite; mouse metabolite
cytidine diphosphate	[no description available]	high	8	0	cytidine 5'-phosphate; pyrimidine ribonucleoside 5'-diphosphate	Escherichia coli metabolite; mouse metabolite
cytidine	[no description available]	high	16	1	cytidines	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
cytidine	[no description available]	high	16	0	cytidines	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
deoxycytidine	[no description available]	high	15	1	pyrimidine 2'-deoxyribonucleoside	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
deoxycytidine	[no description available]	high	15	0	pyrimidine 2'-deoxyribonucleoside	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
deoxycytidine monophosphate	[no description available]	medium	1	0	2'-deoxycytidine phosphate; pyrimidine 2'-deoxyribonucleoside 5'-monophosphate	Escherichia coli metabolite; mouse metabolite
gemcitabine	[no description available]	medium	6	0	organofluorine compound; pyrimidine 2'-deoxyribonucleoside	antimetabolite; antineoplastic agent; antiviral drug; DNA synthesis inhibitor; EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor; environmental contaminant; immunosuppressive agent; photosensitizing agent; prodrug; radiosensitizing agent; xenobiotic
gemcitabine	[no description available]	medium	6	1	organofluorine compound; pyrimidine 2'-deoxyribonucleoside	antimetabolite; antineoplastic agent; antiviral drug; DNA synthesis inhibitor; EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor; environmental contaminant; immunosuppressive agent; photosensitizing agent; prodrug; radiosensitizing agent; xenobiotic
2'-fluoro-2'-deoxycytidine	[no description available]	medium	1	0
2'-methyl-2'-deoxycytidine	[no description available]	medium	1	0
2'-c-methylcytidine	[no description available]	medium	2	0
psi 6130	[no description available]	medium	3	0
phosphoribofuranosylbarbituric acid	[no description available]	medium	1	0
deoxyuridine triphosphate	[no description available]	medium	3	0	deoxyuridine phosphate; pyrimidine 2'-deoxyribonucleoside 5'-triphosphate	Arabidopsis thaliana metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite
TTP	[no description available]	medium	1	0	pyrimidine ribonucleoside 5'-triphosphate
3'-o-(n-methylanthraniloyl) atp	[no description available]	medium	1	0
3'-o-(n-methylanthraniloyl)adenosine 5'-diphosphate	[no description available]	medium	1	0	purine ribonucleoside 5'-diphosphate
2'(3')-o-(n-methyl)anthraniloylguanosine 5'-triphosphate	[no description available]	medium	1	0	purine ribonucleoside 5'-triphosphate	fluorescent probe
uridine 5'-tetraphosphate	[no description available]	medium	2	0
carbachol	[no description available]	medium	26	0	ammonium salt; carbamate ester	cardiotonic drug; miotic; muscarinic agonist; nicotinic acetylcholine receptor agonist; non-narcotic analgesic
5-fluorouridine 5'-triphosphate	[no description available]	medium	30	0
5-fluorouridine 5'-triphosphate	[no description available]	medium	30	2
4-thiouridine triphosphate	[no description available]	medium	12	0
denufosol tetrasodium	[no description available]	medium	2	0
4-thiouridylic acid	[no description available]	medium	2	0
ono 1078	[no description available]	medium	2	0	chromones
uridine diphosphate glucose	[no description available]	medium	35	0	UDP-D-glucose	fundamental metabolite
mdl29,951	[no description available]	medium	1	0
montelukast	[no description available]	medium	2	0	aliphatic sulfide; monocarboxylic acid; quinolines	anti-arrhythmia drug; anti-asthmatic drug; leukotriene antagonist
gavestinel	[no description available]	medium	1	0
9-beta-d-arabinofuranosylguanosine 5'-triphosphate	[no description available]	medium	2	0
1-amino-9,10-dihydro-9,10-dioxo-4-(phenylamino)-2-anthracenesulfonic acid	[no description available]	medium	1	0
mrs2500	[no description available]	medium	1	0
methylene diphosphonate	[no description available]	medium	1	0	1,1-bis(phosphonic acid)	bone density conservation agent; chelator
phosphorodithioic acid	[no description available]	medium	1	0	phosphorothioic acid
amitriptyline	[no description available]	medium	1	0	carbotricyclic compound; tertiary amine	adrenergic uptake inhibitor; antidepressant; environmental contaminant; tropomyosin-related kinase B receptor agonist; xenobiotic
diclofenac	[no description available]	medium	2	0	amino acid; aromatic amine; dichlorobenzene; monocarboxylic acid; secondary amino compound	antipyretic; drug allergen; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic
diclofenac	[no description available]	medium	2	1	amino acid; aromatic amine; dichlorobenzene; monocarboxylic acid; secondary amino compound	antipyretic; drug allergen; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic
propafenone	[no description available]	medium	1	0	aromatic ketone; secondary alcohol; secondary amino compound	anti-arrhythmia drug
zalcitabine	[no description available]	medium	3	0	pyrimidine 2',3'-dideoxyribonucleoside	antimetabolite; antiviral drug; HIV-1 reverse transcriptase inhibitor
lamivudine	[no description available]	medium	2	0	monothioacetal; nucleoside analogue; oxacycle; primary alcohol	allergen; anti-HBV agent; antiviral drug; EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor; HIV-1 reverse transcriptase inhibitor; prodrug
2',3'-dideoxyadenosine triphosphate	[no description available]	medium	1	0	purine deoxyribonucleoside triphosphate
aphidicolin	[no description available]	medium	3	0	tetracyclic diterpenoid	antimicrobial agent; antimitotic; antineoplastic agent; antiviral drug; apoptosis inducer; Aspergillus metabolite; DNA synthesis inhibitor; EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor; fungal metabolite
sofosbuvir	[no description available]	medium	3	0	isopropyl ester; L-alanyl ester; nucleotide conjugate; organofluorine compound; phosphoramidate ester	antiviral drug; hepatitis C protease inhibitor; prodrug
erythrose	[no description available]	medium	2	0	erythrose	plant metabolite
phosphotyrosine	[no description available]	medium	3	0	L-tyrosine derivative; non-proteinogenic L-alpha-amino acid; O(4)-phosphotyrosine	Escherichia coli metabolite; immunogen
phosphorus radioisotopes	[no description available]	medium	41	0
manganese	[no description available]	medium	31	0	elemental manganese; manganese group element atom	Escherichia coli metabolite; micronutrient
pyrimidine dimers	[no description available]	medium	2	0
histamine	[no description available]	medium	17	0	aralkylamino compound; imidazoles	human metabolite; mouse metabolite; neurotransmitter
glutaminase	[no description available]	medium	5	0
glutamine	[no description available]	medium	18	0	amino acid zwitterion; glutamine family amino acid; glutamine; L-alpha-amino acid; polar amino acid zwitterion; proteinogenic amino acid	EC 1.14.13.39 (nitric oxide synthase) inhibitor; Escherichia coli metabolite; human metabolite; metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite
triphosphoric acid	[no description available]	medium	11	0	acyclic phosphorus acid anhydride; phosphorus oxoacid
lacto-n-neotetraose	[no description available]	medium	1	0
uracil	[no description available]	medium	19	0	pyrimidine nucleobase; pyrimidone	allergen; Daphnia magna metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; prodrug; Saccharomyces cerevisiae metabolite
atorvastatin	[no description available]	medium	1	0	aromatic amide; dihydroxy monocarboxylic acid; monofluorobenzenes; pyrroles; statin (synthetic)	environmental contaminant; xenobiotic
pyrophosphate	[no description available]	medium	10	0	diphosphate ion
indican	[no description available]	medium	1	0	beta-D-glucoside; exopolysaccharide; indolyl carbohydrate
acetylglucosamine	[no description available]	medium	11	0	N-acetyl-D-glucosamine	epitope
guanine	[no description available]	medium	6	0	2-aminopurines; oxopurine; purine nucleobase	algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
tryptophan	[no description available]	medium	5	0	erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid zwitterion; L-alpha-amino acid; proteinogenic amino acid; tryptophan zwitterion; tryptophan	antidepressant; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite
deoxyguanosine	[no description available]	medium	1	0	purine 2'-deoxyribonucleoside; purines 2'-deoxy-D-ribonucleoside	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
guanosine	[no description available]	medium	11	0	guanosines; purines D-ribonucleoside	fundamental metabolite
8-hydroxy-2'-deoxyguanosine	[no description available]	medium	1	0	guanosines	biomarker
8-hydroxyguanosine	[no description available]	medium	1	0	purine nucleoside
pseudouridine	[no description available]	medium	3	0	pseudouridines	fundamental metabolite
valsartan	[no description available]	medium	1	0	biphenylyltetrazole; monocarboxylic acid amide; monocarboxylic acid	angiotensin receptor antagonist; antihypertensive agent; environmental contaminant; xenobiotic
glycosides	[no description available]	medium	1	0
deoxyglucose	[no description available]	medium	2	0
uric acid	[no description available]	medium	3	0	uric acid	Escherichia coli metabolite; human metabolite; mouse metabolite
interleukin-8	[no description available]	medium	10	0
angiotensin ii	[no description available]	medium	13	0	amino acid zwitterion; angiotensin II	human metabolite
avapro	[no description available]	medium	1	0	azaspiro compound; biphenylyltetrazole	angiotensin receptor antagonist; antihypertensive agent; environmental contaminant; xenobiotic
arabinose	[no description available]	medium	1	0	L-arabinose	Escherichia coli metabolite; mouse metabolite
arabinofuranose	[no description available]	medium	1	0	L-arabinose
digoxigenin	[no description available]	medium	17	0	12beta-hydroxy steroid; 14beta-hydroxy steroid; 3beta-hydroxy steroid; 3beta-sterol	hapten; plant metabolite
tetramethylrhodamine	[no description available]	medium	1	0	xanthene dye
erythrosine	[no description available]	medium	9	0
s-adenosylhomocysteine	[no description available]	medium	2	0	adenosines; amino acid zwitterion; homocysteine derivative; homocysteines; organic sulfide	cofactor; EC 2.1.1.72 [site-specific DNA-methyltransferase (adenine-specific)] inhibitor; EC 2.1.1.79 (cyclopropane-fatty-acyl-phospholipid synthase) inhibitor; epitope; fundamental metabolite
3'-deoxy-3',4'-didehydro-CTP(4-)	[no description available]	medium	2	0	organophosphate oxoanion
s-adenosylmethionine	[no description available]	medium	4	0	organic cation; sulfonium compound	coenzyme; cofactor; human metabolite; micronutrient; Mycoplasma genitalium metabolite; nutraceutical; Saccharomyces cerevisiae metabolite
5-fluorouridine	[no description available]	medium	8	0	organofluorine compound; uridines	mutagen
guanosine monophosphate	[no description available]	medium	6	0	guanosine 5'-phosphate; purine ribonucleoside 5'-monophosphate	biomarker; Escherichia coli metabolite; metabolite; mouse metabolite
alanine	[no description available]	medium	8	0	alanine zwitterion; alanine; L-alpha-amino acid; proteinogenic amino acid; pyruvate family amino acid	EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor; fundamental metabolite
ribavirin	[no description available]	medium	3	0	1-ribosyltriazole; aromatic amide; monocarboxylic acid amide; primary carboxamide	anticoronaviral agent; antiinfective agent; antimetabolite; antiviral agent; EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor
s 8932	[no description available]	medium	1	0	aromatic amine; C-nucleoside; carboxylic ester; nitrile; phosphoramidate ester; pyrrolotriazine	anticoronaviral agent; antiviral drug; prodrug
idx184	[no description available]	medium	1	0
fluorouracil	[no description available]	medium	31	3	nucleobase analogue; organofluorine compound	antimetabolite; antineoplastic agent; environmental contaminant; immunosuppressive agent; radiosensitizing agent; xenobiotic
capecitabine	[no description available]	medium	3	2	carbamate ester; cytidines; organofluorine compound	antimetabolite; antineoplastic agent; prodrug
palladium	[no description available]	medium	3	0	metal allergen; nickel group element atom; platinum group metal atom
fluorescein	[no description available]	medium	12	0	2-benzofurans; gamma-lactone; organic heteropentacyclic compound; oxaspiro compound; polyphenol; xanthene dye	fluorescent dye; radioopaque medium
piperidines	[no description available]	medium	2	0
guanosine diphosphate	[no description available]	medium	16	0	guanosine 5'-phosphate; purine ribonucleoside 5'-diphosphate	Escherichia coli metabolite; mouse metabolite; uncoupling protein inhibitor
uridine diphosphate galactose	[no description available]	medium	6	0	UDP-D-galactose	mouse metabolite
glycerate 1,3-biphosphate	[no description available]	medium	1	0	2,3-bisphosphoglyceric acid; acyl monophosphate	Escherichia coli metabolite; mouse metabolite
1-(5-isoquinolinesulfonyl)-2-methylpiperazine	[no description available]	medium	7	0	isoquinolines; N-sulfonylpiperazine	EC 2.7.11.13 (protein kinase C) inhibitor
ammonium hydroxide	[no description available]	medium	9	0	azane; gas molecular entity; mononuclear parent hydride	EC 3.5.1.4 (amidase) inhibitor; metabolite; mouse metabolite; neurotoxin; NMR chemical shift reference compound; nucleophilic reagent; refrigerant
diphosphoric acid	[no description available]	medium	1	0	acyclic phosphorus acid anhydride; phosphorus oxoacid	Escherichia coli metabolite
thiourea	[no description available]	medium	5	0	one-carbon compound; thioureas; ureas	antioxidant; chromophore
paxilline	[no description available]	medium	2	0	diterpene alkaloid; enone; organic heterohexacyclic compound; terpenoid indole alkaloid; tertiary alcohol	anticonvulsant; Aspergillus metabolite; EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor; genotoxin; geroprotector; mycotoxin; Penicillium metabolite; potassium channel blocker
bisindolylmaleimide i	[no description available]	medium	10	0
gö6983	[no description available]	medium	1	0	indoles; maleimides
thapsigargin	[no description available]	medium	63	0	butyrate ester; organic heterotricyclic compound; sesquiterpene lactone	calcium channel blocker; EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor
curdlan	[no description available]	medium	1	0	hexose
epiglucan	[no description available]	medium	2	0
mannose 1-phosphate	[no description available]	medium	1	0	mannose phosphate	fundamental metabolite; human metabolite
n-acetylglucosamine-1-phosphate	[no description available]	medium	6	0	N-acetyl-D-glucosamine 1-phosphate	Escherichia coli metabolite; human metabolite; mouse metabolite
galactose-1-phosphate	[no description available]	medium	4	0	alpha-D-hexose 1-phosphate; D-galactopyranose 1-phosphate	Escherichia coli metabolite; mouse metabolite
galactosamine	[no description available]	medium	12	0	D-galactosamine; primary amino compound	toxin
glucose-1-phosphate	[no description available]	medium	12	0	D-glucopyranose 1-phosphate
glucosamine	[no description available]	medium	12	0	D-glucosamine	Escherichia coli metabolite; geroprotector; mouse metabolite
glucosamine 1-phosphate	[no description available]	medium	3	0	glucosamine phosphate	Escherichia coli metabolite
xylose 1-phosphate	[no description available]	medium	1	0	xylose phosphate
ureidosuccinic acid	[no description available]	medium	1	0	aspartic acid derivative; C4-dicarboxylic acid; N-carbamoyl-amino acid	Escherichia coli metabolite; human metabolite; Saccharomyces cerevisiae metabolite
aspartic acid	[no description available]	medium	22	2	aspartate family amino acid; aspartic acid; L-alpha-amino acid; proteinogenic amino acid	Escherichia coli metabolite; mouse metabolite; neurotransmitter
cyclic gmp	[no description available]	medium	17	0	3',5'-cyclic purine nucleotide; guanyl ribonucleotide	Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
cellulose	[no description available]	medium	2	0	glycoside
bis(3',5')-cyclic diguanylic acid	[no description available]	medium	1	0	cyclic purine dinucleotide; guanyl ribonucleotide	immunomodulator; signalling molecule
fluorescein-5-isothiocyanate	[no description available]	medium	2	0	fluorescein isothiocyanate
fura-2	[no description available]	medium	55	0
carbon monoxide	[no description available]	medium	1	0	carbon oxide; gas molecular entity; one-carbon compound	biomarker; EC 1.9.3.1 (cytochrome c oxidase) inhibitor; human metabolite; ligand; metabolite; mitochondrial respiratory-chain inhibitor; mouse metabolite; neurotoxin; neurotransmitter; P450 inhibitor; probe; signalling molecule; vasodilator agent
inositol 1-phosphate	[no description available]	medium	2	0
u 73122	[no description available]	medium	30	0	aromatic ether; aza-steroid; maleimides	EC 3.1.4.11 (phosphoinositide phospholipase C) inhibitor
2-aminoethoxydiphenyl borate	[no description available]	medium	9	0	organoboron compound; primary amino compound	calcium channel blocker; IP3 receptor antagonist; potassium channel opener
pyrimidinones	[no description available]	medium	1	0
azides	[no description available]	medium	21	0	pseudohalide anion	mitochondrial respiratory-chain inhibitor
iodine	[no description available]	medium	3	0	diatomic iodine	nutrient
2',2'-difluorodeoxycytidine 5'-triphosphate	[no description available]	medium	2	1	pyrimidone
floxuridine	[no description available]	medium	7	1	nucleoside analogue; organofluorine compound; pyrimidine 2'-deoxyribonucleoside	antimetabolite; antineoplastic agent; antiviral drug; radiosensitizing agent
2',2'-difluoro-2'-deoxyuridine	[no description available]	medium	1	1
neuropeptide y	[no description available]	medium	3	0
urea	[no description available]	medium	3	0	isourea; monocarboxylic acid amide; one-carbon compound	Daphnia magna metabolite; Escherichia coli metabolite; fertilizer; flour treatment agent; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
lithium chloride	[no description available]	medium	4	0	inorganic chloride; lithium salt	antimanic drug; geroprotector
7-deazapurine	[no description available]	medium	1	0
y 27632	[no description available]	medium	4	0	aromatic amide
ryanodine	[no description available]	medium	13	0
nifedipine	[no description available]	medium	14	0	C-nitro compound; dihydropyridine; methyl ester	calcium channel blocker; human metabolite; tocolytic agent; vasodilator agent
bradykinin	[no description available]	medium	36	0	oligopeptide	human blood serum metabolite; vasodilator agent
valine	[no description available]	medium	1	0	L-alpha-amino acid zwitterion; L-alpha-amino acid; proteinogenic amino acid; pyruvate family amino acid; valine	algal metabolite; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite
chlorine	[no description available]	medium	64	0	halide anion; monoatomic chlorine	cofactor; Escherichia coli metabolite; human metabolite
ribose	[no description available]	medium	8	0	D-ribose; ribopyranose
orotic acid	[no description available]	medium	25	0	pyrimidinemonocarboxylic acid	Escherichia coli metabolite; metabolite; mouse metabolite
sq-23377	[no description available]	medium	31	0	cyclic ether; enol; polyunsaturated fatty acid; very long-chain fatty acid	calcium ionophore; metabolite
adenosine triphosphate uridine monophosphate	[no description available]	medium	3	0
carbocyanines	[no description available]	medium	4	0	cyanine dye; organic iodide salt	fluorochrome
nile red	[no description available]	medium	1	0	aromatic amine; cyclic ketone; organic heterotetracyclic compound; tertiary amino compound	fluorochrome; histological dye
oligonucleotides	[no description available]	medium	16	0
epidermal growth factor	[no description available]	medium	16	0
neurotensin	[no description available]	medium	2	0	peptide hormone	human metabolite; mitogen; neurotransmitter; vulnerary
adenosine	[no description available]	medium	118	1	adenosines; purines D-ribonucleoside	analgesic; anti-arrhythmia drug; fundamental metabolite; human metabolite; vasodilator agent
oxalates	[no description available]	medium	2	0
4,4'-diisothiocyanostilbene-2,2'-disulfonic acid	[no description available]	medium	25	0
2'-deoxycytidine 5'-triphosphate	[no description available]	medium	12	0	2'-deoxycytidine phosphate; pyrimidine 2'-deoxyribonucleoside 5'-triphosphate	Escherichia coli metabolite; human metabolite; mouse metabolite
pyrimidine	[no description available]	medium	5	0	diazine; pyrimidines	Daphnia magna metabolite
anticodon	[no description available]	medium	1	0
favipiravir	[no description available]	medium	1	0	hydroxypyrazine; organofluorine compound; primary carboxamide	anticoronaviral agent; antiviral drug; EC 2.7.7.48 (RNA-directed RNA polymerase) inhibitor
pyrazines	[no description available]	medium	2	0	diazine; pyrazines	Daphnia magna metabolite
xanthosine 5'-triphosphate	[no description available]	medium	2	0	purine ribonucleoside 5'-triphosphate; xanthosine 5'-phosphate	Escherichia coli metabolite; mouse metabolite
3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate	[no description available]	medium	31	0	purine ribonucleoside triphosphate
deuterium	[no description available]	medium	2	0	dihydrogen
guanidine	[no description available]	medium	2	0	carboxamidine; guanidines; one-carbon compound
orotidylic acid	[no description available]	medium	1	0	pyrimidine ribonucleoside 5'-monophosphate	Escherichia coli metabolite; human metabolite; mouse metabolite
dinoprostone	[no description available]	medium	19	0	prostaglandins E	human metabolite; mouse metabolite; oxytocic
sphingosine	[no description available]	medium	5	0	sphing-4-enine	human metabolite; mouse metabolite
sphingosine 1-phosphate	[no description available]	medium	3	0	sphingoid 1-phosphate	mouse metabolite; signalling molecule; sphingosine-1-phosphate receptor agonist; T-cell proliferation inhibitor; vasodilator agent
glutamic acid	[no description available]	medium	5	0	glutamic acid; glutamine family amino acid; L-alpha-amino acid; proteinogenic amino acid	Escherichia coli metabolite; ferroptosis inducer; micronutrient; mouse metabolite; neurotransmitter; nutraceutical
carbonyl cyanide m-chlorophenyl hydrazone	[no description available]	medium	1	0	hydrazone; monochlorobenzenes; nitrile	antibacterial agent; geroprotector; ionophore
brefeldin a	[no description available]	medium	3	0	macrolide antibiotic	Penicillium metabolite
carbenoxolone sodium	[no description available]	medium	6	0	triterpenoid
1,2-bis(2-aminophenoxy)ethane n,n,n',n'-tetraacetic acid acetoxymethyl ester	[no description available]	medium	11	0
colforsin	[no description available]	medium	28	0	acetate ester; cyclic ketone; labdane diterpenoid; organic heterotricyclic compound; tertiary alpha-hydroxy ketone; triol	adenylate cyclase agonist; anti-HIV agent; antihypertensive agent; plant metabolite; platelet aggregation inhibitor; protein kinase A agonist
amiloride	[no description available]	medium	41	2	aromatic amine; guanidines; organochlorine compound; pyrazines	diuretic; sodium channel blocker
glyburide	[no description available]	medium	13	0	monochlorobenzenes; N-sulfonylurea	anti-arrhythmia drug; EC 2.7.1.33 (pantothenate kinase) inhibitor; EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor; hypoglycemic agent
egtazic acid	[no description available]	medium	35	0	diether; tertiary amino compound; tetracarboxylic acid	chelator
genistein	[no description available]	medium	6	0	7-hydroxyisoflavones	antineoplastic agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; geroprotector; human urinary metabolite; phytoestrogen; plant metabolite; tyrosine kinase inhibitor
bumetanide	[no description available]	medium	6	0	amino acid; benzoic acids; sulfonamide	diuretic; EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor
fulvestrant	[no description available]	medium	1	0	17beta-hydroxy steroid; 3-hydroxy steroid; organofluorine compound; sulfoxide	antineoplastic agent; estrogen antagonist; estrogen receptor antagonist
1-methyl-3-isobutylxanthine	[no description available]	medium	9	0	3-isobutyl-1-methylxanthine
nad	[no description available]	medium	11	0	organophosphate oxoanion	cofactor; human metabolite; hydrogen acceptor; Saccharomyces cerevisiae metabolite
indomethacin	[no description available]	medium	27	0	aromatic ether; indole-3-acetic acids; monochlorobenzenes; N-acylindole	analgesic; drug metabolite; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; gout suppressant; non-steroidal anti-inflammatory drug; xenobiotic metabolite; xenobiotic
5-bromo-4-chloro-3-indoxyl phosphate	[no description available]	medium	1	0	aryl phosphate; indoles; organobromine compound; organochlorine compound	chromogenic compound
choline	[no description available]	medium	6	1	cholines	allergen; Daphnia magna metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; neurotransmitter; nutrient; plant metabolite; Saccharomyces cerevisiae metabolite
inosine	[no description available]	medium	7	0	inosines; purines D-ribonucleoside	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
idoxuridine	[no description available]	medium	1	0	organoiodine compound; pyrimidine 2'-deoxyribonucleoside	antiviral drug; DNA synthesis inhibitor
5-iodouridine	[no description available]	medium	1	0
fluorodeoxyuridylate	[no description available]	medium	10	0	pyrimidine 2'-deoxyribonucleoside 5'-monophosphate
triazoles	[no description available]	medium	4	0	1,2,3-triazole
zidovudine	[no description available]	medium	5	0	azide; pyrimidine 2',3'-dideoxyribonucleoside	antimetabolite; antiviral drug; HIV-1 reverse transcriptase inhibitor
valproic acid	[no description available]	medium	1	0	branched-chain fatty acid; branched-chain saturated fatty acid	anticonvulsant; antimanic drug; EC 3.5.1.98 (histone deacetylase) inhibitor; GABA agent; neuroprotective agent; psychotropic drug; teratogenic agent
ceramide 1-phosphate	[no description available]	medium	1	0	N-acylsphingosine 1-phosphate
wortmannin	[no description available]	medium	1	0	acetate ester; cyclic ketone; delta-lactone; organic heteropentacyclic compound	anticoronaviral agent; antineoplastic agent; autophagy inhibitor; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; geroprotector; Penicillium metabolite; radiosensitizing agent
rtki cpd	[no description available]	medium	2	0
quinazolines	[no description available]	medium	5	0	azaarene; mancude organic heterobicyclic parent; ortho-fused heteroarene; quinazolines
hydroxocobalamin	[no description available]	medium	3	3
kb r7943	[no description available]	medium	1	0
ouabain	[no description available]	medium	8	0	11alpha-hydroxy steroid; 14beta-hydroxy steroid; 5beta-hydroxy steroid; alpha-L-rhamnoside; cardenolide glycoside; steroid hormone	anti-arrhythmia drug; cardiotonic drug; EC 2.3.3.1 [citrate (Si)-synthase] inhibitor; EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor; EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor; EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor; ion transport inhibitor; plant metabolite
floxuridine	[no description available]	medium	1	0
deoxyuridine	[no description available]	medium	6	0	pyrimidine 2'-deoxyribonucleoside	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
cidofovir anhydrous	[no description available]	medium	1	0	phosphonic acids; pyrimidone	anti-HIV agent; antineoplastic agent; antiviral drug; photosensitizing agent
cytosine	[no description available]	medium	3	0	aminopyrimidine; pyrimidine nucleobase; pyrimidone	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
organophosphonates	[no description available]	medium	2	0	divalent inorganic anion; phosphite ion
endothelin-1	[no description available]	medium	7	0
opc 12759	[no description available]	medium	1	0	secondary carboxamide
cyclosporine	[no description available]	medium	4	0
bimatoprost	[no description available]	medium	1	0	monocarboxylic acid amide	antiglaucoma drug; antihypertensive agent
carbostyril	[no description available]	medium	1	0	monohydroxyquinoline; quinolone	bacterial xenobiotic metabolite
sodium pyrophosphate	[no description available]	medium	1	0	inorganic sodium salt	chelator; food emulsifier; food thickening agent
4-aminophenylphosphate	[no description available]	medium	1	0
acetyl phosphate	[no description available]	medium	1	0	acyl monophosphate	Escherichia coli metabolite; human metabolite; mouse metabolite
thymidine monophosphate	[no description available]	medium	3	0	thymidine 5'-monophosphate	fundamental metabolite
inositol 1,4,5-trisphosphate	[no description available]	medium	53	0	myo-inositol trisphosphate	mouse metabolite
aminoimidazole carboxamide	[no description available]	medium	4	0	aminoimidazole; monocarboxylic acid amide	mouse metabolite
aica ribonucleotide	[no description available]	medium	1	0	1-(phosphoribosyl)imidazolecarboxamide; aminoimidazole	cardiovascular drug; Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
glycerophosphoinositol 4,5-bisphosphate	[no description available]	medium	8	0
leukotriene b4	[no description available]	medium	1	0	dihydroxy monocarboxylic acid; hydroxy polyunsaturated fatty acid; leukotriene; long-chain fatty acid	human metabolite; mouse metabolite; plant metabolite; vasoconstrictor agent
rottlerin	[no description available]	medium	1	0	aromatic ketone; benzenetriol; chromenol; enone; methyl ketone	anti-allergic agent; antihypertensive agent; antineoplastic agent; apoptosis inducer; K-ATP channel agonist; metabolite
1-hexadecyl-2-acetyl-glycero-3-phosphocholine	[no description available]	medium	5	0	2-acetyl-1-alkyl-sn-glycero-3-phosphocholine	antihypertensive agent; beta-adrenergic antagonist; bronchoconstrictor agent; hematologic agent; vasodilator agent
n-formylmethionine leucyl-phenylalanine	[no description available]	medium	7	0	tripeptide
acadesine	[no description available]	medium	1	0	1-ribosylimidazolecarboxamide; aminoimidazole; nucleoside analogue	antineoplastic agent; platelet aggregation inhibitor
muromonab-cd3	[no description available]	medium	1	0	alkaloid; macrocycle; organic heteropentacyclic compound; organonitrogen heterocyclic compound; oxacycle; tertiary amino compound	antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; IP3 receptor antagonist; marine metabolite
oxazoles	[no description available]	medium	2	0	1,3-oxazoles; mancude organic heteromonocyclic parent; monocyclic heteroarene
fenamic acid	[no description available]	medium	3	0	aminobenzoic acid; secondary amino compound	membrane transport modulator
phenobarbital	[no description available]	medium	2	0	barbiturates	anticonvulsant; drug allergen; excitatory amino acid antagonist; sedative
tetracaine	[no description available]	medium	1	0	benzoate ester; tertiary amino compound	local anaesthetic
terbutaline	[no description available]	medium	5	0	phenylethanolamines; resorcinols	anti-asthmatic drug; beta-adrenergic agonist; bronchodilator agent; EC 3.1.1.7 (acetylcholinesterase) inhibitor; hypoglycemic agent; sympathomimetic agent; tocolytic agent
fructose-1,6-diphosphate	[no description available]	medium	2	0
propionic acid	[no description available]	medium	1	0	saturated fatty acid; short-chain fatty acid	antifungal drug
acetyl coenzyme a	[no description available]	medium	2	0	acyl-CoA	acyl donor; coenzyme; effector; fundamental metabolite
apyrase	[no description available]	medium	16	0
pd 98059	[no description available]	medium	9	0	aromatic amine; monomethoxyflavone	EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; geroprotector
histidine	[no description available]	medium	4	0	amino acid zwitterion; histidine; L-alpha-amino acid; polar amino acid zwitterion; proteinogenic amino acid	algal metabolite; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite
arginine	[no description available]	medium	12	0	arginine; glutamine family amino acid; L-alpha-amino acid; proteinogenic amino acid	biomarker; Escherichia coli metabolite; micronutrient; mouse metabolite; nutraceutical
guanylyl imidodiphosphate	[no description available]	medium	2	0	nucleoside triphosphate analogue
sk&f-96356	[no description available]	medium	1	0
hydrogen carbonate	[no description available]	medium	11	0	carbon oxoanion	cofactor; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
threonine	[no description available]	medium	5	0	amino acid zwitterion; aspartate family amino acid; L-alpha-amino acid; proteinogenic amino acid; threonine	algal metabolite; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite
uridine diphosphate n-acetylglucosamine	[no description available]	medium	9	0
ruberythric acid	[no description available]	medium	1	0
teriflunomide	[no description available]	medium	2	0	(trifluoromethyl)benzenes; aromatic amide; enamide; enol; nitrile; secondary carboxamide	drug metabolite; EC 1.3.98.1 [dihydroorotate oxidase (fumarate)] inhibitor; hepatotoxic agent; non-steroidal anti-inflammatory drug; tyrosine kinase inhibitor
nitrites	[no description available]	medium	2	0	monovalent inorganic anion; nitrogen oxoanion; reactive nitrogen species	human metabolite
homocysteine	[no description available]	medium	2	0	amino acid zwitterion; homocysteine; serine family amino acid	fundamental metabolite; mouse metabolite
folic acid	[no description available]	medium	3	0	folic acids; N-acyl-amino acid	human metabolite; mouse metabolite; nutrient
thymidine 5'-triphosphate	[no description available]	medium	30	0	pyrimidine 2'-deoxyribonucleoside 5'-triphosphate; thymidine phosphate	Escherichia coli metabolite; mouse metabolite
dactinomycin	[no description available]	medium	15	0	actinomycin	mutagen
alpha-amanitin	[no description available]	medium	1	0
latrunculin b	[no description available]	medium	1	0	cyclic hemiketal; macrolide; oxabicycloalkane; thiazolidinone	actin polymerisation inhibitor; metabolite; toxin
fm1 43	[no description available]	medium	1	0	organic bromide salt; pyridinium salt; quaternary ammonium salt; tertiary amine	fluorochrome
thiazolidines	[no description available]	medium	3	0	thiazolidine
latrunculin a	[no description available]	medium	2	0	cyclic hemiketal; macrolide; oxabicycloalkane; thiazolidinone	actin polymerisation inhibitor; metabolite; toxin
cytochalasin d	[no description available]	medium	4	0
iodine	[no description available]	medium	2	0	halide anion; monoatomic iodine	human metabolite
2-methylthioadenosine	[no description available]	medium	2	0
4-o-methyl-12-o-tetradecanoylphorbol 13-acetate	[no description available]	medium	1	0
tetradecanoylphorbol acetate	[no description available]	medium	48	0	acetate ester; diester; phorbol ester; tertiary alpha-hydroxy ketone; tetradecanoate ester	antineoplastic agent; apoptosis inducer; carcinogenic agent; mitogen; plant metabolite; protein kinase C agonist; reactive oxygen species generator
perylene	[no description available]	medium	1	0	ortho- and peri-fused polycyclic arene; perylenes
4-bromo-a-23187	[no description available]	medium	1	0
calcimycin	[no description available]	medium	11	0	benzoxazole
cytochrome c-t	[no description available]	medium	1	0
arginine vasopressin	[no description available]	medium	2	0	vasopressin	cardiovascular drug; hematologic agent; mitogen
deamino arginine vasopressin	[no description available]	medium	1	0	heterodetic cyclic peptide	diagnostic agent; renal agent; vasopressin receptor agonist
xanthenes	[no description available]	medium	13	0	xanthene
bromodeoxyuridine	[no description available]	medium	6	0	pyrimidine 2'-deoxyribonucleoside	antimetabolite; antineoplastic agent
triphenyltetrazolium	[no description available]	medium	1	0	organic cation
phentolamine	[no description available]	medium	4	0	imidazoles; phenols; substituted aniline; tertiary amino compound	alpha-adrenergic antagonist; vasodilator agent
atropine	[no description available]	medium	3	0
isoproterenol	[no description available]	medium	21	0	catechols; secondary alcohol; secondary amino compound	beta-adrenergic agonist; bronchodilator agent; cardiotonic drug; sympathomimetic agent
8-methoxymethyl-3-isobutyl-1-methylxanthine	[no description available]	medium	1	0	oxopurine
gamma-aminobutyric acid	[no description available]	medium	2	0	amino acid zwitterion; gamma-amino acid; monocarboxylic acid	human metabolite; neurotransmitter; Saccharomyces cerevisiae metabolite; signalling molecule
ym-254890	[no description available]	medium	2	0
aldosterone	[no description available]	medium	3	0	11beta-hydroxy steroid; 18-oxo steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; C21-steroid hormone; mineralocorticoid; primary alpha-hydroxy ketone; steroid aldehyde	human metabolite; mouse metabolite
oligomycins	[no description available]	medium	2	0
mercaptoethanol	[no description available]	medium	2	0	alkanethiol; primary alcohol	geroprotector
capsaicin	[no description available]	medium	7	0	capsaicinoid	non-narcotic analgesic; TRPV1 agonist; voltage-gated sodium channel blocker
5-bromouridine	[no description available]	medium	2	0	uridines	mutagen
bromouracil	[no description available]	medium	2	0	nucleobase analogue; pyrimidines	mutagen
sch-202676	[no description available]	medium	1	0
thiazolyl blue	[no description available]	medium	1	0	organic bromide salt	colorimetric reagent; dye
thiazoles	[no description available]	medium	3	0	1,3-thiazoles; mancude organic heteromonocyclic parent; monocyclic heteroarene
pyrene	[no description available]	medium	1	0	ortho- and peri-fused polycyclic arene	fluorescent probe; persistent organic pollutant
cyclen	[no description available]	medium	1	0	azacycloalkane; crown amine; saturated organic heteromonocyclic parent
diazoxide	[no description available]	medium	2	0	benzothiadiazine; organochlorine compound; sulfone	antihypertensive agent; beta-adrenergic agonist; bronchodilator agent; cardiotonic drug; diuretic; K-ATP channel agonist; sodium channel blocker; sympathomimetic agent; vasodilator agent
ranolazine	[no description available]	medium	1	0	aromatic amide; monocarboxylic acid amide; monomethoxybenzene; N-alkylpiperazine; secondary alcohol
clotrimazole	[no description available]	medium	4	0	conazole antifungal drug; imidazole antifungal drug; imidazoles; monochlorobenzenes	antiinfective agent; environmental contaminant; xenobiotic
charybdotoxin	[no description available]	medium	16	0
tacrolimus	[no description available]	medium	2	0	macrolide lactam	bacterial metabolite; immunosuppressive agent
thiophenes	[no description available]	medium	1	0	mancude organic heteromonocyclic parent; monocyclic heteroarene; thiophenes; volatile organic compound	non-polar solvent
benzothiophene	[no description available]	medium	1	0	1-benzothiophenes; benzothiophene
flavin-adenine dinucleotide	[no description available]	medium	1	0	flavin adenine dinucleotide; vitamin B2	cofactor; Escherichia coli metabolite; human metabolite; mouse metabolite; prosthetic group
nickel	[no description available]	medium	8	0	metal allergen; nickel group element atom	epitope; micronutrient
copper adenosine triphosphate	[no description available]	medium	1	0
iberiotoxin	[no description available]	medium	5	0
tram 34	[no description available]	medium	3	0	organochlorine compound
penfluridol	[no description available]	medium	1	0	diarylmethane
1,2-bis(2-aminophenoxy)ethane-n,n,n',n'-tetraacetic acid	[no description available]	medium	11	0	polyamino carboxylic acid; tetracarboxylic acid	chelator
adenylyl imidodiphosphate	[no description available]	medium	10	0	adenosine 5'-phosphate
thromboplastin	[no description available]	medium	2	0
sm 21	[no description available]	medium	1	0	monocarboxylic acid
bd 1047	[no description available]	medium	1	0	primary amine
sm 346	[no description available]	medium	1	0
pd 145065	[no description available]	medium	1	0
losartan	[no description available]	medium	2	0	biphenylyltetrazole; imidazoles	angiotensin receptor antagonist; anti-arrhythmia drug; antihypertensive agent; endothelin receptor antagonist
dinoprost	[no description available]	medium	8	0	monocarboxylic acid; prostaglandins Falpha	human metabolite; mouse metabolite
desoxycorticosterone	[no description available]	medium	2	0	20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; mineralocorticoid; primary alpha-hydroxy ketone	human metabolite; mouse metabolite
gold	[no description available]	medium	2	0	copper group element atom; elemental gold
phthalic acid	[no description available]	medium	1	0	benzenedicarboxylic acid	human xenobiotic metabolite
2-aminopurine	[no description available]	medium	1	0	2-aminopurines; nucleobase analogue	antimetabolite
cholestyramine resin	[no description available]	medium	1	1
lactic acid	[no description available]	medium	1	0	2-hydroxy monocarboxylic acid	algal metabolite; Daphnia magna metabolite
potassium chloride	[no description available]	medium	23	0	inorganic chloride; inorganic potassium salt; potassium salt	fertilizer
uridine diphosphate n-acetylgalactosamine	[no description available]	medium	5	0	nucleotide-sugar oxoanion	human metabolite
acetylgalactosamine	[no description available]	medium	2	0	N-acetyl-D-hexosamine; N-acetylgalactosamine	Escherichia coli metabolite; human metabolite; mouse metabolite
n-acetylgalactosamine-1-phosphate	[no description available]	medium	1	0	D-galactosamine 1-phosphate	human metabolite
gadolinium chloride	[no description available]	medium	2	0	gadolinium coordination entity	TRP channel blocker
gadolinium	[no description available]	medium	4	0	f-block element atom; lanthanoid atom
quinacrine	[no description available]	medium	3	0	acridines; aromatic ether; organochlorine compound; tertiary amino compound	antimalarial; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor
ethylmaleimide	[no description available]	medium	1	0	maleimides	anticoronaviral agent; EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor; EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor; EC 2.7.1.1 (hexokinase) inhibitor
phorbolol myristate acetate	[no description available]	medium	3	0
benzoic acid	[no description available]	medium	1	0	benzoic acids	algal metabolite; antimicrobial food preservative; drug allergen; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; EC 3.1.1.3 (triacylglycerol lipase) inhibitor; human xenobiotic metabolite; plant metabolite
phosphothreonine	[no description available]	medium	1	0	L-threonine derivative; non-proteinogenic L-alpha-amino acid; O-phosphoamino acid	Escherichia coli metabolite
coenzyme a	[no description available]	medium	2	0	adenosine 3',5'-bisphosphate	coenzyme; Escherichia coli metabolite; mouse metabolite
pantoic acid	[no description available]	medium	1	0	pantoic acid
antimony	[no description available]	medium	1	0	metalloid atom; pnictogen
pyroantimonate	[no description available]	medium	1	0
erythrosine	[no description available]	medium	1	0
vanadates	[no description available]	medium	5	0	trivalent inorganic anion; vanadium oxoanion	EC 3.1.3.1 (alkaline phosphatase) inhibitor; EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor; EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor
8-((4-chlorophenyl)thio)cyclic-3',5'-amp	[no description available]	medium	2	0	3',5'-cyclic purine nucleotide; adenyl ribonucleotide; aryl sulfide; organochlorine compound	protein kinase agonist
vasoactive intestinal peptide	[no description available]	medium	2	0
proline	[no description available]	medium	1	0	amino acid zwitterion; glutamine family amino acid; L-alpha-amino acid; proline; proteinogenic amino acid	algal metabolite; compatible osmolytes; Escherichia coli metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite
terbium	[no description available]	medium	1	0	f-block element atom; lanthanoid atom
pyrazinoate	[no description available]	medium	1	0	monocarboxylic acid anion
aluminum	[no description available]	medium	2	0	boron group element atom; elemental aluminium; metal atom
pantothenic acid	[no description available]	medium	1	0	pantothenic acid; vitamin B5	antidote to curare poisoning; geroprotector; human blood serum metabolite
phosphopantothenic acid	[no description available]	medium	1	0	amidoalkyl phosphate	Escherichia coli metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
methoxamine	[no description available]	medium	2	0	amphetamines	alpha-adrenergic agonist; antihypotensive agent
8-oxodeoxyguanosine triphosphate	[no description available]	medium	1	0	purine 2'-deoxyribonucleoside 5'-triphosphate	mutagen
1,3-dipropyl-8-cyclopentylxanthine	[no description available]	medium	9	0	oxopurine	adenosine A1 receptor antagonist; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor
dimaprit	[no description available]	medium	1	0	imidothiocarbamic ester
cordycepin	[no description available]	medium	3	0	3'-deoxyribonucleoside; adenosines	antimetabolite; nucleoside antibiotic
ng-nitroarginine methyl ester	[no description available]	medium	15	0	alpha-amino acid ester; L-arginine derivative; methyl ester; N-nitro compound	EC 1.14.13.39 (nitric oxide synthase) inhibitor
allopurinol	[no description available]	medium	2	0	nucleobase analogue; organic heterobicyclic compound	antimetabolite; EC 1.17.3.2 (xanthine oxidase) inhibitor; gout suppressant; radical scavenger
raffinose	[no description available]	medium	2	0	raffinose family oligosaccharide; trisaccharide	mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
leflunomide	[no description available]	medium	4	0	(trifluoromethyl)benzenes; isoxazoles; monocarboxylic acid amide	antineoplastic agent; antiparasitic agent; EC 1.3.98.1 [dihydroorotate oxidase (fumarate)] inhibitor; EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; hepatotoxic agent; immunosuppressive agent; non-steroidal anti-inflammatory drug; prodrug; pyrimidine synthesis inhibitor; tyrosine kinase inhibitor
isoxazoles	[no description available]	medium	6	0	isoxazoles; mancude organic heteromonocyclic parent; monocyclic heteroarene
hoe 33342	[no description available]	medium	2	0
tyrosine	[no description available]	medium	8	0	amino acid zwitterion; erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid; proteinogenic amino acid; tyrosine	EC 1.3.1.43 (arogenate dehydrogenase) inhibitor; fundamental metabolite; micronutrient; nutraceutical
cystic fibrosis transmembrane conductance regulator (505-511)	[no description available]	medium	1	0
inosinic acid	[no description available]	medium	5	0	inosine phosphate; purine ribonucleoside 5'-monophosphate	Escherichia coli metabolite; human metabolite; mouse metabolite
ornithine	[no description available]	medium	1	0	non-proteinogenic L-alpha-amino acid; ornithine	algal metabolite; hepatoprotective agent; mouse metabolite
arachidonyltrifluoromethane	[no description available]	medium	1	0	fatty acid derivative; ketone; olefinic compound; organofluorine compound	EC 3.1.1.4 (phospholipase A2) inhibitor
5,8,11,14-eicosatetraynoic acid	[no description available]	medium	1	0	long-chain fatty acid
2'-deoxyguanosine 5'-phosphate	[no description available]	medium	2	0	deoxyguanosine phosphate; guanyl deoxyribonucleotide; purine 2'-deoxyribonucleoside 5'-monophosphate	Escherichia coli metabolite; mouse metabolite
dibutyryl cyclic gmp	[no description available]	medium	2	0
bucladesine	[no description available]	medium	9	0	3',5'-cyclic purine nucleotide
prostaglandin d2	[no description available]	medium	2	0	prostaglandins D	human metabolite; mouse metabolite
okadaic acid	[no description available]	medium	7	0	ketal
nicardipine	[no description available]	medium	5	0	benzenes; C-nitro compound; diester; dihydropyridine; methyl ester; tertiary amino compound
caffeine	[no description available]	medium	13	0	purine alkaloid; trimethylxanthine	adenosine A2A receptor antagonist; adenosine receptor antagonist; adjuvant; central nervous system stimulant; diuretic; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; environmental contaminant; food additive; fungal metabolite; geroprotector; human blood serum metabolite; mouse metabolite; mutagen; plant metabolite; psychotropic drug; ryanodine receptor agonist; xenobiotic
4-aminopyridine	[no description available]	medium	5	0	aminopyridine; aromatic amine	avicide; orphan drug; potassium channel blocker
pinacidil	[no description available]	medium	3	0	pyridines
tetraethylammonium	[no description available]	medium	6	0	quaternary ammonium ion
17-octadecynoic acid	[no description available]	medium	1	0	acetylenic fatty acid; long-chain fatty acid; monounsaturated fatty acid; terminal acetylenic compound	EC 1.14.14.94 (leukotriene-B4 20-monooxygenase) inhibitor; EC 1.14.15.3 (alkane 1-monooxygenase) inhibitor; P450 inhibitor
prazosin	[no description available]	medium	3	0	aromatic ether; furans; monocarboxylic acid amide; piperazines; quinazolines	alpha-adrenergic antagonist; antihypertensive agent; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor
be 2254	[no description available]	medium	1	0	tetralins
cp 65,526	[no description available]	medium	1	0
flag peptide	[no description available]	medium	1	0	peptide
cyanine dye 3	[no description available]	medium	1	0
6-cyano-7-nitroquinoxaline-2,3-dione	[no description available]	medium	1	0	quinoxaline derivative
cytarabine	[no description available]	medium	7	0	beta-D-arabinoside; monosaccharide derivative; pyrimidine nucleoside	antimetabolite; antineoplastic agent; antiviral agent; immunosuppressive agent
293b cpd	[no description available]	medium	1	0	1-benzopyran
adenine	[no description available]	medium	8	0	6-aminopurines; purine nucleobase	Daphnia magna metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
lucifer yellow	[no description available]	medium	3	0	organic lithium salt	fluorochrome
mannitol	[no description available]	medium	2	0	mannitol	allergen; antiglaucoma drug; compatible osmolytes; Escherichia coli metabolite; food anticaking agent; food bulking agent; food humectant; food stabiliser; food thickening agent; hapten; metabolite; osmotic diuretic; sweetening agent
w 7	[no description available]	medium	1	0
berbamine	[no description available]	medium	1	0	phenylpropanoid
ml 9	[no description available]	medium	1	0
ethylene chlorohydrin	[no description available]	medium	1	0	chloroethanol	xenobiotic metabolite
2,2,2-trichloroethanol	[no description available]	medium	1	0	chloroethanol	mouse metabolite
cytidine diphosphate choline	[no description available]	medium	3	1	nucleotide-(amino alcohol)s; phosphocholines	human metabolite; mouse metabolite; neuroprotective agent; psychotropic drug; Saccharomyces cerevisiae metabolite
phosphatidylcholines	[no description available]	medium	8	0	1,2-diacyl-sn-glycero-3-phosphocholine
ammonium chloride	[no description available]	medium	3	0	ammonium salt; inorganic chloride	ferroptosis inhibitor
tretinoin	[no description available]	medium	4	0	retinoic acid; vitamin A	anti-inflammatory agent; antineoplastic agent; antioxidant; AP-1 antagonist; human metabolite; keratolytic drug; retinoic acid receptor agonist; retinoid X receptor agonist; signalling molecule
muramidase	[no description available]	medium	2	0
oxytocin	[no description available]	medium	2	0	heterodetic cyclic peptide; peptide hormone	oxytocic; vasodilator agent
serine	[no description available]	medium	6	0	L-alpha-amino acid; proteinogenic amino acid; serine family amino acid; serine zwitterion; serine	algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
adenosine-5'-(n-ethylcarboxamide)	[no description available]	medium	14	0	adenosines; monocarboxylic acid amide	adenosine A1 receptor agonist; adenosine A2A receptor agonist; antineoplastic agent; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; vasodilator agent
azobenzene	[no description available]	medium	1	0	azobenzenes
sepharose	[no description available]	medium	4	0
corticosterone	[no description available]	medium	1	0	11beta-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; C21-steroid; glucocorticoid; primary alpha-hydroxy ketone	human metabolite; mouse metabolite
cocaine	[no description available]	medium	1	0	benzoate ester; methyl ester; tertiary amino compound; tropane alkaloid	adrenergic uptake inhibitor; central nervous system stimulant; dopamine uptake inhibitor; environmental contaminant; local anaesthetic; mouse metabolite; plant metabolite; serotonin uptake inhibitor; sodium channel blocker; sympathomimetic agent; vasoconstrictor agent; xenobiotic
arl-67156	[no description available]	medium	5	0
2',3'-dideoxythymidine triphosphate	[no description available]	medium	1	0	pyrimidine 2',3'-dideoxyribonucleoside 5'-triphosphate; thymidine phosphate
lactose	[no description available]	medium	1	0	lactose
vitamin b 12	[no description available]	medium	2	0
thiamine pyrophosphate	[no description available]	medium	2	0	organic chloride salt; vitamin B1
dipyridamole	[no description available]	medium	6	1	piperidines; pyrimidopyrimidine; tertiary amino compound; tetrol	adenosine phosphodiesterase inhibitor; EC 3.5.4.4 (adenosine deaminase) inhibitor; platelet aggregation inhibitor; vasodilator agent
coformycin	[no description available]	medium	2	0	coformycins	EC 3.5.4.4 (adenosine deaminase) inhibitor
9-(2-hydroxy-3-nonyl)adenine	[no description available]	medium	1	0
platinum	[no description available]	medium	1	0	elemental platinum; nickel group element atom; platinum group metal atom
cyanides	[no description available]	medium	2	0	pseudohalide anion	EC 1.9.3.1 (cytochrome c oxidase) inhibitor
thymidine	[no description available]	medium	17	0	pyrimidine 2'-deoxyribonucleoside	Escherichia coli metabolite; human metabolite; metabolite; mouse metabolite
acid blue 80	[no description available]	medium	1	0
15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid	[no description available]	medium	5	0
phenidone	[no description available]	medium	1	0
sb 203580	[no description available]	medium	3	0	imidazoles; monofluorobenzenes; pyridines; sulfoxide	EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; geroprotector; Hsp90 inhibitor; neuroprotective agent
fibrinogen	[no description available]	medium	3	0	iditol	fungal metabolite
l 663536	[no description available]	medium	1	0	aryl sulfide; indoles; monocarboxylic acid; monochlorobenzenes	antineoplastic agent; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; leukotriene antagonist
u 0126	[no description available]	medium	2	0	aryl sulfide; dinitrile; enamine; substituted aniline	antineoplastic agent; antioxidant; apoptosis inducer; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; osteogenesis regulator; vasoconstrictor agent
phosphoribosyl pyrophosphate	[no description available]	medium	21	1	5-O-phosphono-D-ribofuranosyl diphosphate	Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite
lysine	[no description available]	medium	4	0	aspartate family amino acid; L-alpha-amino acid zwitterion; L-alpha-amino acid; lysine; organic molecular entity; proteinogenic amino acid	algal metabolite; anticonvulsant; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite
ag 1879	[no description available]	medium	2	0	aromatic amine; monochlorobenzenes; pyrazolopyrimidine	beta-adrenergic antagonist; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; geroprotector
atrial natriuretic factor	[no description available]	medium	1	0	polypeptide
anandamide	[no description available]	medium	1	0	endocannabinoid; N-acylethanolamine 20:4	human blood serum metabolite; neurotransmitter; vasodilator agent
hydroxylamine	[no description available]	medium	1	0	hydroxylamines	algal metabolite; bacterial xenobiotic metabolite; EC 1.1.3.13 (alcohol oxidase) inhibitor; EC 4.2.1.22 (cystathionine beta-synthase) inhibitor; EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor; nitric oxide donor; nucleophilic reagent
3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid	[no description available]	medium	1	0
evans blue	[no description available]	medium	2	0	organic sodium salt	fluorochrome; histological dye; sodium channel blocker; teratogenic agent
fluo-3	[no description available]	medium	7	0	xanthene dye	fluorochrome
2',3'-dialdehyde atp	[no description available]	medium	5	0
succinic acid	[no description available]	medium	3	0	alpha,omega-dicarboxylic acid; C4-dicarboxylic acid	anti-ulcer drug; fundamental metabolite; micronutrient; nutraceutical; radiation protective agent
amlodipine	[no description available]	medium	1	0	dihydropyridine; ethyl ester; methyl ester; monochlorobenzenes; primary amino compound	antihypertensive agent; calcium channel blocker; vasodilator agent
3-deazaguanine	[no description available]	medium	1	0
ucn 1028 c	[no description available]	medium	4	0
phenylephrine	[no description available]	medium	8	0	phenols; phenylethanolamines; secondary amino compound	alpha-adrenergic agonist; cardiotonic drug; mydriatic agent; nasal decongestant; protective agent; sympathomimetic agent; vasoconstrictor agent
nitroglycerin	[no description available]	medium	1	0	nitroglycerol	explosive; muscle relaxant; nitric oxide donor; prodrug; tocolytic agent; vasodilator agent; xenobiotic
5-nitro-2-(3-phenylpropylamino)benzoic acid	[no description available]	medium	6	0	nitrobenzoic acid
propranolol	[no description available]	medium	4	1	naphthalenes; propanolamine; secondary amine	anti-arrhythmia drug; antihypertensive agent; anxiolytic drug; beta-adrenergic antagonist; environmental contaminant; human blood serum metabolite; vasodilator agent; xenobiotic
1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazole	[no description available]	medium	3	0	ether; imidazoles; monomethoxybenzene	TRP channel blocker
sarcosine	[no description available]	medium	3	0	N-alkylglycine zwitterion; N-alkylglycine; N-methyl-amino acid; N-methylglycines	Escherichia coli metabolite; glycine receptor agonist; glycine transporter 1 inhibitor; human metabolite; mouse metabolite
isatin	[no description available]	medium	1	0	indoledione	EC 1.4.3.4 (monoamine oxidase) inhibitor; plant metabolite
sarkosyl	[no description available]	medium	3	0
isatin beta-thiosemicarbazone	[no description available]	medium	1	0
rubidium	[no description available]	medium	3	0	alkali metal atom
deoxyguanosine triphosphate	[no description available]	medium	5	0	deoxyguanosine phosphate; guanyl deoxyribonucleotide; purine 2'-deoxyribonucleoside 5'-triphosphate	Arabidopsis thaliana metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
6-thioguanosine	[no description available]	medium	1	0	purine nucleoside
diazomethane	[no description available]	medium	1	0	diazo compound	alkylating agent; antineoplastic agent; carcinogenic agent; poison
iodoacetic acid	[no description available]	medium	1	0	haloacetic acid; organoiodine compound	alkylating agent
fructose-6-phosphate	[no description available]	medium	1	0	D-fructose 6-phosphate
phosphocreatine	[no description available]	medium	8	0	phosphagen; phosphoamino acid	human metabolite; mouse metabolite
phosphoenolpyruvate	[no description available]	medium	2	0	carboxyalkyl phosphate; monocarboxylic acid	fundamental metabolite
cgs 15943	[no description available]	medium	2	0	aromatic amine; biaryl; furans; organochlorine compound; primary amino compound; quinazolines; triazoloquinazoline	adenosine A1 receptor antagonist; adenosine A2A receptor antagonist; antineoplastic agent; central nervous system stimulant
nicotine	[no description available]	medium	2	0	3-(1-methylpyrrolidin-2-yl)pyridine	anxiolytic drug; biomarker; immunomodulator; mitogen; neurotoxin; nicotinic acetylcholine receptor agonist; peripheral nervous system drug; phytogenic insecticide; plant metabolite; psychotropic drug; teratogenic agent; xenobiotic
phorbol 12,13-dibutyrate	[no description available]	medium	6	0	butyrate ester; phorbol ester; tertiary alpha-hydroxy ketone
chelerythrine	[no description available]	medium	3	0	benzophenanthridine alkaloid; organic cation	antibacterial agent; antineoplastic agent; EC 2.7.11.13 (protein kinase C) inhibitor
furosemide	[no description available]	medium	2	0	chlorobenzoic acid; furans; sulfonamide	environmental contaminant; loop diuretic; xenobiotic
h 89	[no description available]	medium	2	0	N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide
dantrolene	[no description available]	medium	1	0	hydrazone; imidazolidine-2,4-dione	muscle relaxant; neuroprotective agent; ryanodine receptor antagonist
osteoprotegerin	[no description available]	medium	1	0	long-chain fatty acid
lanthanum	[no description available]	medium	6	0	f-block element atom; lanthanoid atom; scandium group element atom
barium	[no description available]	medium	10	0	alkaline earth metal atom; elemental barium
arachidonic acid	[no description available]	medium	21	0	icosa-5,8,11,14-tetraenoic acid; long-chain fatty acid; omega-6 fatty acid	Daphnia galeata metabolite; EC 3.1.1.1 (carboxylesterase) inhibitor; human metabolite; mouse metabolite
sucrose	[no description available]	medium	2	0	glycosyl glycoside	algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; osmolyte; Saccharomyces cerevisiae metabolite; sweetening agent
palmitoyl trifluoromethyl ketone	[no description available]	medium	1	0
asparagine	[no description available]	medium	1	0	amino acid zwitterion; asparagine; aspartate family amino acid; L-alpha-amino acid; proteinogenic amino acid	Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite
biotin	[no description available]	medium	15	0	biotins; vitamin B7	coenzyme; cofactor; Escherichia coli metabolite; fundamental metabolite; human metabolite; mouse metabolite; nutraceutical; prosthetic group; Saccharomyces cerevisiae metabolite
chlorpromazine	[no description available]	medium	1	0	organochlorine compound; phenothiazines; tertiary amine	anticoronaviral agent; antiemetic; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; phenothiazine antipsychotic drug
carbamyl phosphate	[no description available]	medium	4	0	acyl monophosphate; one-carbon compound	Escherichia coli metabolite; mouse metabolite
phosphonoacetic acid	[no description available]	medium	15	2	monocarboxylic acid; phosphonic acids	antiviral agent; EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor
fluconazole	[no description available]	medium	1	0	conazole antifungal drug; difluorobenzene; tertiary alcohol; triazole antifungal drug	environmental contaminant; P450 inhibitor; xenobiotic
malachite green	[no description available]	medium	2	0	organic chloride salt	antibacterial agent; antifungal drug; carcinogenic agent; environmental contaminant; fluorochrome; histological dye; teratogenic agent
c.i. 42510	[no description available]	medium	3	0
mastoparan	[no description available]	medium	1	0	mastoparans; peptidyl amide	antimicrobial agent
tamoxifen	[no description available]	medium	2	0	stilbenoid; tertiary amino compound	angiogenesis inhibitor; antineoplastic agent; bone density conservation agent; EC 1.2.3.1 (aldehyde oxidase) inhibitor; EC 2.7.11.13 (protein kinase C) inhibitor; estrogen antagonist; estrogen receptor antagonist; estrogen receptor modulator
oxonic acid	[no description available]	medium	1	0	1,3,5-triazines; monocarboxylic acid
tegafur	[no description available]	medium	1	0	organohalogen compound; pyrimidines
s 1 (combination)	[no description available]	medium	1	0
spermine	[no description available]	medium	2	0	polyazaalkane; tetramine	antioxidant; fundamental metabolite; immunosuppressive agent
boron	[no description available]	medium	1	0	boron group element atom; metalloid atom; nonmetal atom	micronutrient
chlorine	[no description available]	medium	3	0	diatomic chlorine; gas molecular entity	bleaching agent
phenyl acetate	[no description available]	medium	2	0	benzenes; phenyl acetates
aminopterin	[no description available]	medium	1	0	dicarboxylic acid	EC 1.5.1.3 (dihydrofolate reductase) inhibitor; mutagen
niflumic acid	[no description available]	medium	4	0	aromatic carboxylic acid; pyridines
ribose-5-triphosphate	[no description available]	medium	1	0
4,5-diaminofluorescein	[no description available]	medium	1	0
lead	[no description available]	medium	2	0	carbon group element atom; elemental lead; metal atom	neurotoxin
lead sulfide	[no description available]	medium	1	0
trimethyloxamine	[no description available]	medium	1	0	tertiary amine oxide	Escherichia coli metabolite; metabolite; osmolyte
enprofylline	[no description available]	medium	1	0	oxopurine	anti-arrhythmia drug; anti-asthmatic drug; bronchodilator agent; non-steroidal anti-inflammatory drug
ethidium	[no description available]	medium	5	0	phenanthridines	fluorochrome; intercalator
heme	[no description available]	medium	1	0
bicuculline	[no description available]	medium	1	0	benzylisoquinoline alkaloid; isoquinoline alkaloid; isoquinolines	agrochemical; central nervous system stimulant; GABA-gated chloride channel antagonist; GABAA receptor antagonist; neurotoxin
strychnine	[no description available]	medium	1	0	monoterpenoid indole alkaloid; organic heteroheptacyclic compound	avicide; cholinergic antagonist; glycine receptor antagonist; neurotransmitter agent; rodenticide
theophylline	[no description available]	medium	10	0	dimethylxanthine	adenosine receptor antagonist; anti-asthmatic drug; anti-inflammatory agent; bronchodilator agent; drug metabolite; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; fungal metabolite; human blood serum metabolite; immunomodulator; muscle relaxant; vasodilator agent
8-(4-sulfophenyl)theophylline	[no description available]	medium	4	0
go 6976	[no description available]	medium	1	0	indolocarbazole; organic heterohexacyclic compound	EC 2.7.11.13 (protein kinase C) inhibitor
phosphatidylethanol	[no description available]	medium	2	0
inosine diphosphate	[no description available]	medium	1	0	inosine phosphate; purine ribonucleoside 5'-diphosphate	fundamental metabolite
benzamil	[no description available]	medium	2	0	guanidines; pyrazines
thrombin aptamer	[no description available]	medium	1	0
sodium bicarbonate	[no description available]	medium	2	0	one-carbon compound; organic sodium salt	antacid; food anticaking agent
ethylisopropylamiloride	[no description available]	medium	3	0	aromatic amine; guanidines; monocarboxylic acid amide; organochlorine compound; pyrazines; tertiary amino compound	anti-arrhythmia drug; neuroprotective agent; sodium channel blocker
sphingosine kinase	[no description available]	medium	1	0
cromakalim	[no description available]	medium	2	0
sdz pco 400	[no description available]	medium	1	0	1-benzopyran
cyclopentane	[no description available]	medium	1	0	cycloalkane; cyclopentanes; volatile organic compound	non-polar solvent
kn 93	[no description available]	medium	2	0	monochlorobenzenes; monomethoxybenzene; primary alcohol; sulfonamide; tertiary amino compound	EC 2.7.11.17 (Ca(2+)/calmodulin-dependent protein kinase) inhibitor; geroprotector
lysophosphatidic acid	[no description available]	medium	3	0	1-acyl-sn-glycerol 3-phosphate
6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2h-pyran-2-one	[no description available]	medium	2	0	naphthalenes
betadex	[no description available]	medium	1	0	cyclodextrin
guanosine 5'-o-(3-thiotriphosphate)	[no description available]	medium	6	0	nucleoside triphosphate analogue
thymidine 5'-4-nitrophenyl phosphate	[no description available]	medium	1	0	aryl phosphate; C-nitro compound; pyrimidine 2'-deoxyribonucleoside 5'-monophosphate
2,4-dinitrophenol	[no description available]	medium	1	0	dinitrophenol	allergen; antiseptic drug; bacterial xenobiotic metabolite; geroprotector; oxidative phosphorylation inhibitor
rotenone	[no description available]	medium	1	0	organic heteropentacyclic compound; rotenones	antineoplastic agent; metabolite; mitochondrial NADH:ubiquinone reductase inhibitor; phytogenic insecticide; piscicide; toxin
ribose 1-phosphate	[no description available]	medium	2	0	D-ribose 1-phosphate	Escherichia coli metabolite
xe 991, anthracenone	[no description available]	medium	1	0	anthracenes
pyrimidin-2-one beta-ribofuranoside	[no description available]	medium	1	0	pyrimidine ribonucleosides
n-methylaspartate	[no description available]	medium	1	0	amino dicarboxylic acid; D-alpha-amino acid; D-aspartic acid derivative; secondary amino compound	neurotransmitter agent
3-nitrobenzeneboronic acid	[no description available]	medium	1	0
3-aminobenzeneboronic acid	[no description available]	medium	1	0
glucosamine 6-phosphate	[no description available]	medium	1	0	2-amino-2-deoxy-D-glucopyranose 6-phosphate	human metabolite; Saccharomyces cerevisiae metabolite
uridine diphosphate n-acetyl-d-mannosaminuronic acid	[no description available]	medium	1	0
losartan potassium	[no description available]	medium	3	0
betaine	[no description available]	medium	1	0	amino-acid betaine; glycine derivative	fundamental metabolite
neurokinin a	[no description available]	medium	1	0
tetrodotoxin	[no description available]	medium	6	0	azatetracycloalkane; oxatetracycloalkane; quinazoline alkaloid	animal metabolite; bacterial metabolite; marine metabolite; neurotoxin; voltage-gated sodium channel blocker
phenolsulfonphthalein	[no description available]	medium	1	0	2,1-benzoxathiole; arenesulfonate ester; phenols; sultone	acid-base indicator; diagnostic agent; two-colour indicator
acetazolamide	[no description available]	medium	1	0	monocarboxylic acid amide; sulfonamide; thiadiazoles	anticonvulsant; diuretic; EC 4.2.1.1 (carbonic anhydrase) inhibitor
galactose	[no description available]	medium	6	0	D-galactose; galactopyranose	Escherichia coli metabolite; mouse metabolite
cycloheximide	[no description available]	medium	15	0	antibiotic fungicide; cyclic ketone; dicarboximide; piperidine antibiotic; piperidones; secondary alcohol	anticoronaviral agent; bacterial metabolite; ferroptosis inhibitor; neuroprotective agent; protein synthesis inhibitor
azauridine	[no description available]	medium	5	0	N-glycosyl-1,2,4-triazine	antimetabolite; antineoplastic agent; drug metabolite
dihydrotestosterone	[no description available]	medium	1	0	17beta-hydroxy steroid; 17beta-hydroxyandrostan-3-one; 3-oxo-5alpha-steroid	androgen; Daphnia magna metabolite; human metabolite; mouse metabolite
rifampin	[no description available]	medium	11	0	cyclic ketal; hydrazone; N-iminopiperazine; N-methylpiperazine; rifamycins; semisynthetic derivative; zwitterion	angiogenesis inhibitor; antiamoebic agent; antineoplastic agent; antitubercular agent; DNA synthesis inhibitor; EC 2.7.7.6 (RNA polymerase) inhibitor; Escherichia coli metabolite; geroprotector; leprostatic drug; neuroprotective agent; pregnane X receptor agonist; protein synthesis inhibitor
dichlororibofuranosylbenzimidazole	[no description available]	medium	1	0
mercaptopurine	[no description available]	medium	1	0	aryl thiol; purines; thiocarbonyl compound	anticoronaviral agent; antimetabolite; antineoplastic agent
thioguanine anhydrous	[no description available]	medium	1	0	2-aminopurines	anticoronaviral agent; antimetabolite; antineoplastic agent
metrizamide	[no description available]	medium	1	0	amino sugar
mercury	[no description available]	medium	3	0	elemental mercury; zinc group element atom	neurotoxin
captan	[no description available]	medium	3	0	isoindoles; organochlorine compound; organosulfur compound; phthalimide fungicide	antifungal agrochemical
arabinofuranosyluracil	[no description available]	medium	1	0
5-fluoropyrimidine	[no description available]	medium	1	0
5-fluorouridine 5'-phosphate	[no description available]	medium	3	0	organofluorine compound; pyrimidine ribonucleoside 5'-monophosphate	drug metabolite
amanitins	[no description available]	medium	16	0
pentostatin	[no description available]	medium	1	0	coformycins	antimetabolite; antineoplastic agent; Aspergillus metabolite; bacterial metabolite; EC 3.5.4.4 (adenosine deaminase) inhibitor
glycogen	[no description available]	medium	7	0
thyroxine	[no description available]	medium	3	0	2-halophenol; iodophenol; L-phenylalanine derivative; non-proteinogenic L-alpha-amino acid; thyroxine zwitterion; thyroxine	antithyroid drug; human metabolite; mouse metabolite; thyroid hormone
concanavalin a	[no description available]	medium	1	0
uridine diphosphate glucuronic acid	[no description available]	medium	9	0	UDP-D-glucuronic acid	Escherichia coli metabolite; human metabolite; mouse metabolite
azaguanine	[no description available]	medium	1	0	nucleobase analogue; triazolopyrimidines	antimetabolite; antineoplastic agent; EC 2.4.2.1 (purine-nucleoside phosphorylase) inhibitor
toyocamycin	[no description available]	medium	1	0	antibiotic antifungal agent; N-glycosylpyrrolopyrimidine; nitrile; ribonucleoside	antimetabolite; antineoplastic agent; apoptosis inducer; bacterial metabolite
1-o-indol-3-ylacetylglucose	[no description available]	medium	1	0	indoleacetic acid ester conjugate; indolyl carbohydrate
indol-3-ylacetylinositol	[no description available]	medium	1	0
triiodothyronine	[no description available]	medium	3	0	2-halophenol; amino acid zwitterion; iodophenol; iodothyronine	human metabolite; mouse metabolite; thyroid hormone
udp-glucosamine	[no description available]	medium	3	0	UDP-amino sugar
galactose	[no description available]	medium	1	0
thymidine 5'-diphosphate	[no description available]	medium	1	0	pyrimidine 2'-deoxyribonucleoside 5'-diphosphate; thymidine phosphate	Escherichia coli metabolite; mouse metabolite
1,7-phenanthroline	[no description available]	medium	3	0	phenanthroline
molybdenum	[no description available]	medium	1	0	chromium group element atom	micronutrient
brij-58	[no description available]	medium	1	0
demecolcine	[no description available]	medium	1	0	alkaloid; secondary amino compound	antineoplastic agent; microtubule-destabilising agent
acetaminophen	[no description available]	medium	1	0	acetamides; phenols	antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; cyclooxygenase 3 inhibitor; environmental contaminant; ferroptosis inducer; geroprotector; hepatotoxic agent; human blood serum metabolite; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic
guanosine tetraphosphate	[no description available]	medium	4	0	guanosine bisphosphate	Escherichia coli metabolite; mouse metabolite
flucytosine	[no description available]	medium	2	0	aminopyrimidine; nucleoside analogue; organofluorine compound; pyrimidine antifungal drug; pyrimidone	prodrug
4-nitroquinoline-1-oxide	[no description available]	medium	1	0	C-nitro compound; quinoline N-oxide	carcinogenic agent
methylnitronitrosoguanidine	[no description available]	medium	1	0	nitroso compound	alkylating agent
aminacrine	[no description available]	medium	1	0	aminoacridines; primary amino compound	acid-base indicator; antiinfective agent; antiseptic drug; fluorescent dye; MALDI matrix material; mutagen
mitomycin	[no description available]	medium	1	0	mitomycin	alkylating agent; antineoplastic agent
halothane	[no description available]	medium	1	0	haloalkane; organobromine compound; organochlorine compound; organofluorine compound	inhalation anaesthetic
laminaran	[no description available]	medium	1	0
cobalt	[no description available]	medium	3	0	cobalt group element atom; metal allergen	micronutrient
alpha-chymotrypsin	[no description available]	medium	3	0
af 013	[no description available]	medium	1	0
rifamycins	[no description available]	medium	2	0
beta-escin	[no description available]	medium	2	0
colchicine	[no description available]	medium	1	0	alkaloid; colchicine	anti-inflammatory agent; gout suppressant; mutagen
ammonium bicarbonate	[no description available]	medium	1	0	organooxygen compound
mycophenolic acid	[no description available]	medium	4	0	2-benzofurans; gamma-lactone; monocarboxylic acid; phenols	anticoronaviral agent; antimicrobial agent; antineoplastic agent; EC 1.1.1.205 (IMP dehydrogenase) inhibitor; environmental contaminant; immunosuppressive agent; mycotoxin; Penicillium metabolite; xenobiotic
pyrazofurin	[no description available]	medium	1	0	C-glycosyl compound; pyrazoles	antimetabolite; antimicrobial agent; antineoplastic agent; EC 4.1.1.23 (orotidine-5'-phosphate decarboxylase) inhibitor
ara-utp	[no description available]	medium	5	0
quinone	[no description available]	medium	1	0	1,4-benzoquinones	cofactor; human xenobiotic metabolite; mouse metabolite
catechol	[no description available]	medium	1	0	catechols	allelochemical; genotoxin; plant metabolite
hydroquinone	[no description available]	medium	1	0	benzenediol; hydroquinones	antioxidant; carcinogenic agent; cofactor; Escherichia coli metabolite; human xenobiotic metabolite; mouse metabolite; skin lightening agent
hydroxyhydroquinone	[no description available]	medium	1	0	benzenetriol	mouse metabolite
muscarine	[no description available]	medium	4	0	monosaccharide
3-deazauridine	[no description available]	medium	2	0	N-glycosyl compound
arabinofuranosylcytosine triphosphate	[no description available]	medium	5	0
2'-5'-oligoadenylate trimer	[no description available]	medium	1	0
gtp gamma-4-azidoanilide	[no description available]	medium	1	0
atp gamma-p-azidoanilide	[no description available]	medium	1	0
phosphorus	[no description available]	medium	7	0	monoatomic phosphorus; nonmetal atom; pnictogen	macronutrient
ammonium sulfate	[no description available]	medium	3	0	ammonium salt; inorganic sulfate salt	fertilizer
glucosone	[no description available]	medium	1	0	ketoaldohexose
1-hexanol	[no description available]	medium	1	0	hexanol; primary alcohol	alarm pheromone; antibacterial agent; fragrance; plant metabolite
phenylhydrazine	[no description available]	medium	1	0	phenylhydrazines	xenobiotic
uric acid riboside	[no description available]	medium	1	0	(beta-D-ribofuranosyl)uric acid
citric acid, anhydrous	[no description available]	medium	1	0	tricarboxylic acid	antimicrobial agent; chelator; food acidity regulator; fundamental metabolite
nsc 65346	[no description available]	medium	1	0	nucleoside analogue	protein kinase inhibitor
nsc 105827	[no description available]	medium	1	0
deoxycholic acid	[no description available]	medium	1	0	bile acid; C24-steroid; dihydroxy-5beta-cholanic acid	human blood serum metabolite
diltiazem	[no description available]	medium	5	0	5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate	antihypertensive agent; calcium channel blocker; vasodilator agent
8-bromocyclic gmp	[no description available]	medium	2	0	3',5'-cyclic purine nucleotide; organobromine compound	muscle relaxant; protein kinase G agonist
aurintricarboxylic acid	[no description available]	medium	2	0	monohydroxybenzoic acid; quinomethanes; tricarboxylic acid	fluorochrome; histological dye; insulin-like growth factor receptor 1 antagonist
glycochenodeoxycholic acid	[no description available]	medium	1	0	bile acid glycine conjugate	human metabolite
framycetin	[no description available]	medium	2	0	aminoglycoside	allergen; antibacterial drug; Escherichia coli metabolite
phosphoramidon	[no description available]	medium	1	0	deoxyaldohexose phosphate; dipeptide	bacterial metabolite; EC 3.4.24.11 (neprilysin) inhibitor; EC 3.4.24.71 (endothelin-converting enzyme 1) inhibitor
bq 123	[no description available]	medium	2	0	cyclic peptide
antimycin a	[no description available]	medium	2	0	amidobenzoic acid
8-bromo cyclic adenosine monophosphate	[no description available]	medium	6	0	3',5'-cyclic purine nucleotide; adenyl ribonucleotide; organobromine compound	antidepressant; protein kinase agonist
chromomycin a3	[no description available]	medium	1	0
dimethyl sulfate	[no description available]	medium	1	0	alkyl sulfate	alkylating agent; immunosuppressive agent
1,10-phenanthroline	[no description available]	medium	1	0	phenanthroline	EC 2.7.1.1 (hexokinase) inhibitor; EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitor
5-iodoacetamido-1,10-phenanthroline	[no description available]	medium	1	0
methylene blue	[no description available]	medium	2	0	organic chloride salt	acid-base indicator; antidepressant; antimalarial; antimicrobial agent; antioxidant; cardioprotective agent; EC 1.4.3.4 (monoamine oxidase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; EC 4.6.1.2 (guanylate cyclase) inhibitor; fluorochrome; histological dye; neuroprotective agent; physical tracer
Brilliant Blue	[no description available]	medium	1	0	organic molecular entity
uniblue a	[no description available]	medium	1	0
phosphorylcholine	[no description available]	medium	1	0	phosphocholines	allergen; epitope; hapten; human metabolite; mouse metabolite
psychosine	[no description available]	medium	1	0	glycosylsphingoid	human metabolite
sphingosine phosphorylcholine	[no description available]	medium	1	0
thioinosine	[no description available]	medium	4	0
4-nitrobenzylthioinosine	[no description available]	medium	4	0	purine nucleoside
papaverine	[no description available]	medium	3	0	benzylisoquinoline alkaloid; dimethoxybenzene; isoquinolines	antispasmodic drug; vasodilator agent
staurosporine	[no description available]	medium	8	0	ammonium ion derivative
cumene hydroperoxide	[no description available]	medium	2	0	peroxol	environmental contaminant; Mycoplasma genitalium metabolite; oxidising agent
2,2'-azobis(2,4-dimethylvaleronitrile)	[no description available]	medium	1	0
(4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride	[no description available]	medium	1	0
pirenzepine	[no description available]	medium	1	0	pyridobenzodiazepine	anti-ulcer drug; antispasmodic drug; muscarinic antagonist
methoctramine	[no description available]	medium	1	0	hydrochloride	muscarinic antagonist
2-(guanylformylmethoxy)-3-(triphospho)propanal	[no description available]	medium	1	0
pyridoxine	[no description available]	medium	1	0	hydroxymethylpyridine; methylpyridines; monohydroxypyridine; vitamin B6	cofactor; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
thiamine	[no description available]	medium	1	0	primary alcohol; vitamin B1	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
guanosine 5'-o-(2-thiodiphosphate)	[no description available]	medium	4	0	nucleoside diphosphate analogue
diadenosine 5',5''''-p1,p6-hexaphosphate	[no description available]	medium	3	0	diadenosyl hexaphosphate	vasoconstrictor agent
p(1),p(5)-di(adenosine-5'-)pentaphosphate	[no description available]	medium	6	0	organophosphate oxoanion
cobaltous chloride	[no description available]	medium	1	0	cobalt salt; inorganic chloride	allergen; calcium channel blocker; sensitiser; two-colour indicator
nickel chloride	[no description available]	medium	1	0	nickel coordination entity	calcium channel blocker; hapten
bimakalim	[no description available]	medium	1	0
pyrroles	[no description available]	medium	1	0	pyrrole; secondary amine
dihydropyridines	[no description available]	medium	2	0
n(6)-cyclohexyladenosine	[no description available]	medium	1	0
cytidine monophosphate n-acetylneuraminic acid	[no description available]	medium	1	0	CMP-N-acyl-beta-neuraminic acid	mouse metabolite
n-acetylmannosamine	[no description available]	medium	1	0
mannose	[no description available]	medium	2	0	D-aldohexose; D-mannose; mannopyranose	metabolite
fucose	[no description available]	medium	5	0	fucopyranose; L-fucose	Escherichia coli metabolite; mouse metabolite
inositol-1,3,4,5-tetrakisphosphate	[no description available]	medium	1	0	inositol phosphate
dihydroneopterin triphosphate	[no description available]	medium	1	0	dihydropterin; neopterins; pterin phosphate	Escherichia coli metabolite; mouse metabolite
dihydrofolate	[no description available]	medium	1	0	dihydrofolic acids	Escherichia coli metabolite; mouse metabolite
neopterin	[no description available]	medium	1	0
pteridines	[no description available]	medium	1	0	azaarene; mancude organic heterobicyclic parent; ortho-fused heteroarene; pteridines
dimethylphenylpiperazinium iodide	[no description available]	medium	3	0	N-arylpiperazine; organic iodide salt; piperazinium salt; quaternary ammonium salt	nicotinic acetylcholine receptor agonist
quinine	[no description available]	medium	1	0	cinchona alkaloid	antimalarial; muscle relaxant; non-narcotic analgesic
meglumine	[no description available]	medium	1	0	hexosamine; secondary amino compound
tagetitoxin	[no description available]	medium	2	0
verapamil	[no description available]	medium	6	0	aromatic ether; nitrile; polyether; tertiary amino compound
ro 31-8220	[no description available]	medium	6	0	imidothiocarbamic ester; indoles; maleimides	EC 2.7.11.13 (protein kinase C) inhibitor
8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine	[no description available]	medium	1	0
distearoyl phosphatidylglycerol	[no description available]	medium	1	0	phosphatidylglycerol
tobramycin	[no description available]	medium	2	0	amino cyclitol glycoside	antibacterial agent; antimicrobial agent; toxin
fludarabine	[no description available]	medium	1	0	purine nucleoside
cladribine	[no description available]	medium	2	0	organochlorine compound; purine 2'-deoxyribonucleoside	antineoplastic agent; immunosuppressive agent
vidarabine	[no description available]	medium	2	0	beta-D-arabinoside; purine nucleoside	antineoplastic agent; bacterial metabolite; nucleoside antibiotic
puromycin	[no description available]	medium	1	0	puromycins	antiinfective agent; antimicrobial agent; antineoplastic agent; EC 3.4.11.14 (cytosol alanyl aminopeptidase) inhibitor; EC 3.4.14.2 (dipeptidyl-peptidase II) inhibitor; nucleoside antibiotic; protein synthesis inhibitor
thromboxanes	[no description available]	medium	1	0
pentetic acid	[no description available]	medium	1	0	pentacarboxylic acid	copper chelator
cromolyn sodium	[no description available]	medium	1	0	organic sodium salt	anti-asthmatic drug; drug allergen
ascorbic acid	[no description available]	medium	3	0	ascorbic acid; vitamin C	coenzyme; cofactor; flour treatment agent; food antioxidant; food colour retention agent; geroprotector; plant metabolite; skin lightening agent
fluorine	[no description available]	medium	3	0	diatomic fluorine; gas molecular entity	NMR chemical shift reference compound
fura-2-am	[no description available]	medium	2	0
nystatin a1	[no description available]	medium	1	0	nystatins
leucine	[no description available]	medium	3	0	amino acid zwitterion; L-alpha-amino acid; leucine; proteinogenic amino acid; pyruvate family amino acid	algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
cytidylyl-3',5'-adenosine	[no description available]	medium	2	0	nucleoside analogue; purines
glycine	[no description available]	medium	2	0	alpha-amino acid; amino acid zwitterion; proteinogenic amino acid; serine family amino acid	EC 2.1.2.1 (glycine hydroxymethyltransferase) inhibitor; fundamental metabolite; hepatoprotective agent; micronutrient; neurotransmitter; NMDA receptor agonist; nutraceutical
hypoxanthine	[no description available]	medium	6	0	nucleobase analogue; oxopurine; purine nucleobase	fundamental metabolite
methacholine chloride	[no description available]	medium	4	0	quaternary ammonium salt
4-acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic acid	[no description available]	medium	2	0	stilbenoid
8-phenyltheophylline	[no description available]	medium	1	0
edetic acid	[no description available]	medium	6	0	ethylenediamine derivative; polyamino carboxylic acid; tetracarboxylic acid	anticoagulant; antidote; chelator; copper chelator; geroprotector
mk 473	[no description available]	medium	1	0
adenosine 2',5'-diphosphate	[no description available]	medium	1	0
deferoxamine	[no description available]	medium	1	0	acyclic desferrioxamine	bacterial metabolite; ferroptosis inhibitor; iron chelator; siderophore
glucagon	[no description available]	medium	2	0	peptide hormone
camptothecin	[no description available]	medium	1	0	delta-lactone; pyranoindolizinoquinoline; quinoline alkaloid; tertiary alcohol	antineoplastic agent; EC 5.99.1.2 (DNA topoisomerase) inhibitor; genotoxin; plant metabolite
2-chloroadenosine	[no description available]	medium	2	0	purine nucleoside
n(6)-cyclopentyladenosine	[no description available]	medium	1	0
citrulline	[no description available]	medium	1	0	amino acid zwitterion; citrulline	Daphnia magna metabolite; EC 1.14.13.39 (nitric oxide synthase) inhibitor; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; protective agent; Saccharomyces cerevisiae metabolite
inositol	[no description available]	medium	3	0	cyclitol; hexol
nikkomycin	[no description available]	medium	1	0
5-aminoimidazole-4-carboxamide-1-ribofuranosyl triphosphate	[no description available]	medium	1	0
8-azidoadenosine 5'-triphosphate	[no description available]	medium	3	0
thiazole orange	[no description available]	medium	1	0	cyanine dye	fluorochrome
2,5-hexanedione	[no description available]	medium	1	0	diketone; methyl ketone	human xenobiotic metabolite; neurotoxin
6-ketoprostaglandin f1 alpha	[no description available]	medium	1	0	prostaglandins Falpha	human metabolite; mouse metabolite
cyclic adp-ribose	[no description available]	medium	1	0	cyclic purine nucleotide; nucleotide-sugar	metabolite; ryanodine receptor agonist
adenosine diphosphate ribose	[no description available]	medium	1	0	ADP-sugar	Escherichia coli metabolite; mouse metabolite
nadp	[no description available]	medium	3	0
ribulose 5-phosphate	[no description available]	medium	1	0	ribulose 5-phosphate	mouse metabolite
bim 23056	[no description available]	medium	2	0
gramicidin a	[no description available]	medium	2	0
nitroarginine	[no description available]	medium	5	0	guanidines; L-arginine derivative; N-nitro compound; non-proteinogenic L-alpha-amino acid
thromboxane a2	[no description available]	medium	4	0	epoxy monocarboxylic acid; thromboxanes A	mouse metabolite
ovalbumin	[no description available]	medium	2	0
alendronate	[no description available]	medium	1	0	1,1-bis(phosphonic acid); primary amino compound	bone density conservation agent; EC 2.5.1.1 (dimethylallyltranstransferase) inhibitor
clodronic acid	[no description available]	medium	1	0	1,1-bis(phosphonic acid); one-carbon compound; organochlorine compound	antineoplastic agent; bone density conservation agent
ibotenic acid	[no description available]	medium	1	0	non-proteinogenic alpha-amino acid	neurotoxin
2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein	[no description available]	medium	1	0
2,5-di-tert-butylbenzoquinone	[no description available]	medium	1	0	benzoquinones; p-quinones
bathocuproine	[no description available]	medium	1	0
d-alpha tocopherol	[no description available]	medium	2	0	alpha-tocopherol	algal metabolite; antiatherogenic agent; anticoagulant; antioxidant; antiviral agent; EC 2.7.11.13 (protein kinase C) inhibitor; immunomodulator; micronutrient; nutraceutical; plant metabolite
penicillamine	[no description available]	medium	1	0	non-proteinogenic alpha-amino acid; penicillamine	antirheumatic drug; chelator; copper chelator; drug allergen
s-nitroso-n-acetylpenicillamine	[no description available]	medium	1	0	nitroso compound; nitrosothio compound	nitric oxide donor; vasodilator agent
linsidomine	[no description available]	medium	3	0	morpholines
molsidomine	[no description available]	medium	3	0	ethyl ester; morpholines; oxadiazole; zwitterion	antioxidant; apoptosis inhibitor; cardioprotective agent; nitric oxide donor; vasodilator agent
barium chloride	[no description available]	medium	6	0	barium salt; inorganic chloride	potassium channel blocker
1,2-dioleoyloxy-3-(trimethylammonium)propane	[no description available]	medium	1	0
trimethoprim	[no description available]	medium	1	0	aminopyrimidine; methoxybenzenes	antibacterial drug; diuretic; drug allergen; EC 1.5.1.3 (dihydrofolate reductase) inhibitor; environmental contaminant; xenobiotic
ampicillin	[no description available]	medium	1	0	beta-lactam antibiotic; penicillin allergen; penicillin	antibacterial drug
omega-n-methylarginine	[no description available]	medium	1	0	amino acid zwitterion; arginine derivative; guanidines; L-arginine derivative; non-proteinogenic L-alpha-amino acid
aminopyrine	[no description available]	medium	1	0	pyrazolone; tertiary amino compound	antipyretic; environmental contaminant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic
1,9-dideoxyforskolin	[no description available]	medium	1	0	acetate ester; labdane diterpenoid; organic heterotricyclic compound	plant metabolite
reserpine	[no description available]	medium	2	0	alkaloid ester; methyl ester; yohimban alkaloid	adrenergic uptake inhibitor; antihypertensive agent; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; environmental contaminant; first generation antipsychotic; plant metabolite; xenobiotic
guanethidine	[no description available]	medium	1	0	azocanes; guanidines	adrenergic antagonist; antihypertensive agent; sympatholytic agent
8-bromoadenosine-3',5'-cyclic monophosphorothioate	[no description available]	medium	1	0
benzofurans	[no description available]	medium	4	0
fura red	[no description available]	medium	2	0
acetylcysteine	[no description available]	medium	1	0	acetylcysteine; L-cysteine derivative; N-acetyl-L-amino acid	antidote to paracetamol poisoning; antiinfective agent; antioxidant; antiviral drug; ferroptosis inhibitor; geroprotector; human metabolite; mucolytic; radical scavenger; vulnerary
somatostatin, trp(8)-cys(14)-	[no description available]	medium	1	0
bim 23027	[no description available]	medium	1	0
6-thioguanosine 5'-triphosphate	[no description available]	medium	1	0
levoleucovorin	[no description available]	medium	3	1	5-formyltetrahydrofolic acid	antineoplastic agent; metabolite
atovaquone	[no description available]	medium	1	0	hydroxy-1,2-naphthoquinone
dapsone	[no description available]	medium	1	0	substituted aniline; sulfone	anti-inflammatory drug; antiinfective agent; antimalarial; leprostatic drug
naphthoquinones	[no description available]	medium	2	0
flufenamic acid	[no description available]	medium	2	0	aromatic amino acid; organofluorine compound	antipyretic; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug
adenosine 5'-o-(1-thiodiphosphate)	[no description available]	medium	2	0
sodium cyanide	[no description available]	medium	1	0	cyanide salt; one-carbon compound; sodium salt	EC 1.15.1.1 (superoxide dismutase) inhibitor
calyculin a	[no description available]	medium	1	0
alprostadil	[no description available]	medium	2	0	prostaglandins E	anticoagulant; human metabolite; platelet aggregation inhibitor; vasodilator agent
transforming growth factor beta	[no description available]	medium	1	0
cadmium chloride	[no description available]	medium	1	0	cadmium coordination entity
monoisoamyl-2,3-dimercaptosuccinate	[no description available]	medium	1	0
succimer	[no description available]	medium	1	0	dicarboxylic acid; dithiol; sulfur-containing carboxylic acid	chelator
brequinar	[no description available]	medium	4	0	biphenyls; monocarboxylic acid; monofluorobenzenes; quinolinemonocarboxylic acid	anticoronaviral agent; antimetabolite; antineoplastic agent; antiviral agent; EC 1.3.5.2 [dihydroorotate dehydrogenase (quinone)] inhibitor; immunosuppressive agent; pyrimidine synthesis inhibitor
u 73343	[no description available]	medium	4	0
phalloidine	[no description available]	medium	1	0	homodetic cyclic peptide
thallium	[no description available]	medium	1	0	boron group element atom
amphotericin b	[no description available]	medium	1	0	antibiotic antifungal drug; macrolide antibiotic; polyene antibiotic	antiamoebic agent; antiprotozoal drug; bacterial metabolite
uridine diphosphopyridoxal	[no description available]	medium	2	0
masoprocol	[no description available]	medium	1	0	nordihydroguaiaretic acid	antineoplastic agent; hypoglycemic agent; lipoxygenase inhibitor; metabolite
cesium	[no description available]	medium	1	0	alkali metal atom
hydrazine	[no description available]	medium	1	0	azane; hydrazines	EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor
1,1-diethyl-2-hydroxy-2-nitrosohydrazine	[no description available]	medium	1	0	organic anion
oxadiazoles	[no description available]	medium	2	0
quinoxalines	[no description available]	medium	2	0	mancude organic heterobicyclic parent; naphthyridine; ortho-fused heteroarene
1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one	[no description available]	medium	2	0	oxadiazoloquinoxaline	EC 4.6.1.2 (guanylate cyclase) inhibitor
glucose, (beta-d)-isomer	[no description available]	medium	1	0	D-glucopyranose	epitope; mouse metabolite
prodan	[no description available]	medium	1	0	2-acyl-6-dimethylaminonaphthalene
2-naphthylamine	[no description available]	medium	1	0	naphthylamine	carcinogenic agent
creatine	[no description available]	medium	2	0	glycine derivative; guanidines; zwitterion	geroprotector; human metabolite; mouse metabolite; neuroprotective agent; nutraceutical
titanium	[no description available]	medium	1	0	titanium group element atom
methyl methanesulfonate	[no description available]	medium	1	0	methanesulfonate ester	alkylating agent; apoptosis inducer; carcinogenic agent; genotoxin; mutagen
lanthanum chloride	[no description available]	medium	1	0
mechlorethamine	[no description available]	medium	1	0	nitrogen mustard; organochlorine compound	alkylating agent
4-nitro-2-(3-phenylpropylamino)benzoate	[no description available]	medium	1	0
5'-(4-fluorosulfonylbenzoyl)adenosine	[no description available]	medium	2	0
phorbol	[no description available]	medium	1	0	cyclic ketone; enone; tertiary alcohol; tertiary alpha-hydroxy ketone; tetracyclic diterpenoid
phorbols	[no description available]	medium	2	0	diterpene; terpenoid fundamental parent
diethylamine	[no description available]	medium	1	0	secondary aliphatic amine
diethylenetriamine	[no description available]	medium	1	0	polyazaalkane; triamine
7-nitroindazole	[no description available]	medium	2	0
ici 192605	[no description available]	medium	2	0
indazoles	[no description available]	medium	2	0	indazole
leucine methyl ester	[no description available]	medium	1	0	alpha-amino acid ester; L-leucine derivative; methyl ester
2-(4-amylcinnamoyl)amino-4-chlorobenzoic acid	[no description available]	medium	1	0
fura-pe3	[no description available]	medium	2	0
erythromycin	[no description available]	medium	2	0	cyclic ketone; erythromycin
oxidopamine	[no description available]	medium	1	0	benzenetriol; catecholamine; primary amino compound	drug metabolite; human metabolite; neurotoxin
adenosine 5'-tetraphosphate	[no description available]	medium	1	0	adenosine 5'-phosphate; purine ribonucleoside 5'-tetraphosphate
gallic acid	[no description available]	medium	2	0	trihydroxybenzoic acid	antineoplastic agent; antioxidant; apoptosis inducer; astringent; cyclooxygenase 2 inhibitor; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; geroprotector; human xenobiotic metabolite; plant metabolite
8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate	[no description available]	medium	2	0	trihydroxybenzoic acid
p-methoxy-n-methylphenethylamine	[no description available]	medium	1	0	aromatic ether; secondary amino compound	metabolite
spermidine	[no description available]	medium	1	0	polyazaalkane; triamine	autophagy inducer; fundamental metabolite; geroprotector
2',3'-o-(2,4,6-trinitrophenyl)adenosine 5'-triphosphate	[no description available]	medium	1	0	C-nitro compound; spiroketal	antagonist
cyclopentenyl cytosine	[no description available]	medium	1	0
clopidogrel	[no description available]	medium	1	0	methyl ester; monochlorobenzenes; thienopyridine	anticoagulant; P2Y12 receptor antagonist; platelet aggregation inhibitor
ticlopidine	[no description available]	medium	1	0	monochlorobenzenes; thienopyridine	anticoagulant; fibrin modulating drug; hematologic agent; P2Y12 receptor antagonist; platelet aggregation inhibitor
phenylalanine	[no description available]	medium	3	0	amino acid zwitterion; erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid; phenylalanine; proteinogenic amino acid	algal metabolite; EC 3.1.3.1 (alkaline phosphatase) inhibitor; Escherichia coli metabolite; human xenobiotic metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite
buserelin	[no description available]	medium	1	0	oligopeptide
linopirdine	[no description available]	medium	1	0	indoles
verlukast	[no description available]	medium	1	0
leukotriene d4	[no description available]	medium	1	0	dipeptide; leukotriene; organic sulfide	bronchoconstrictor agent; human metabolite; mouse metabolite
1,2-dioctanoylglycerol	[no description available]	medium	1	0
copper gluconate	[no description available]	medium	2	0	organic molecular entity
gluconic acid	[no description available]	medium	2	0	gluconic acid	chelator; Penicillium metabolite
tolbutamide	[no description available]	medium	3	0	N-sulfonylurea	human metabolite; hypoglycemic agent; insulin secretagogue; potassium channel blocker
permethrin	[no description available]	medium	1	0	cyclopropanecarboxylate ester; cyclopropanes	agrochemical; ectoparasiticide; pyrethroid ester acaricide; pyrethroid ester insecticide; scabicide
pyrethrins	[no description available]	medium	1	0
decamethrin	[no description available]	medium	1	0	aromatic ether; cyclopropanecarboxylate ester; nitrile; organobromine compound	agrochemical; antifeedant; calcium channel agonist; EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; pyrethroid ester insecticide
ecdysterone	[no description available]	medium	1	0	14alpha-hydroxy steroid; 20-hydroxy steroid; 22-hydroxy steroid; 25-hydroxy steroid; 2beta-hydroxy steroid; 3beta-sterol; ecdysteroid; phytoecdysteroid	animal metabolite; plant metabolite
muristerone a	[no description available]	medium	1	0
7-methyl-diguanosine triphosphate	[no description available]	medium	1	0
s-(2,4-dinitrophenyl)glutathione	[no description available]	medium	1	0	glutathione conjugate
melitten	[no description available]	medium	1	0
heptanol	[no description available]	medium	1	0	heptanol; primary alcohol	flavouring agent; fragrance; gap junctional intercellular communication inhibitor; plant metabolite
loperamide	[no description available]	medium	1	0	monocarboxylic acid amide; monochlorobenzenes; piperidines; tertiary alcohol	anticoronaviral agent; antidiarrhoeal drug; mu-opioid receptor agonist
oxotremorine	[no description available]	medium	2	0	N-alkylpyrrolidine
fluorides	[no description available]	medium	2	0	halide anion; monoatomic fluorine
dithionite	[no description available]	medium	1	0	sulfur oxide; sulfur oxoanion
tetrafluoroaluminate	[no description available]	medium	1	0
nitrogenase	[no description available]	medium	1	0
aspirin	[no description available]	medium	1	0	benzoic acids; phenyl acetates; salicylates	anticoagulant; antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; drug allergen; EC 1.1.1.188 (prostaglandin-F synthase) inhibitor; geroprotector; non-narcotic analgesic; non-steroidal anti-inflammatory drug; plant activator; platelet aggregation inhibitor; prostaglandin antagonist; teratogenic agent
bay-k-8644	[no description available]	medium	2	0	(trifluoromethyl)benzenes; C-nitro compound; dihydropyridine; methyl ester
1,4-dihydropyridine	[no description available]	medium	1	0
transferrin	[no description available]	medium	3	0
inositol 1,3,4-trisphosphate	[no description available]	medium	1	0	inositol phosphate oxoanion	human metabolite
pyrrolidine dithiocarbamate	[no description available]	medium	1	0	dithiocarbamic acids; pyrrolidines	anticonvulsant; antineoplastic agent; geroprotector; neuroprotective agent; NF-kappaB inhibitor; radical scavenger
5-(4-nitrophenyl)-2,4-pentadienal	[no description available]	medium	1	0
kt 5823	[no description available]	medium	1	0	gamma-lactam; hemiaminal; indolocarbazole; methyl ester; organic heterooctacyclic compound	EC 2.7.11.12 (cGMP-dependent protein kinase) inhibitor
inositol 4,5-bisphosphate	[no description available]	medium	1	0	myo-inositol bisphosphate
bromine	[no description available]	medium	1	0	diatomic bromine
calixarenes	[no description available]	medium	1	0
calix(4)arene	[no description available]	medium	1	0
zaprinast	[no description available]	medium	3	0	triazolopyrimidines
adenosine 3'-phosphate-5'-phosphate	[no description available]	medium	1	0	adenosine bisphosphate	Escherichia coli metabolite; mouse metabolite
cadmium	[no description available]	medium	3	0	cadmium molecular entity; zinc group element atom
europium cryptate	[no description available]	medium	1	0
uridine diphosphate galactosamine	[no description available]	medium	1	0	UDP-amino sugar
geldanamycin	[no description available]	medium	1	0
ecdysone	[no description available]	medium	1	0	14alpha-hydroxy steroid; 22-hydroxy steroid; 25-hydroxy steroid; 2beta-hydroxy steroid; 3beta-sterol; 6-oxo steroid; ecdysteroid	prohormone
zm 241385	[no description available]	medium	1	0	diamino-1,3,5-triazine
8-cyclopentyl-1,3-dimethylxanthine	[no description available]	medium	1	0	oxopurine
lidocaine	[no description available]	medium	1	0	benzenes; monocarboxylic acid amide; tertiary amino compound	anti-arrhythmia drug; drug allergen; environmental contaminant; local anaesthetic; xenobiotic
inositol-3,4,5,6-tetrakisphosphate	[no description available]	medium	2	0	myo-inositol tetrakisphosphate	mouse metabolite
1-palmitoyl-2-oleoylphosphatidylcholine	[no description available]	medium	1	0
1-palmitoyl-2-oleoylphosphatidylethanolamine	[no description available]	medium	1	0	(18R,21S)-24-amino-21-hydroxy-21-oxido-15-oxo-16,20,22-trioxa-21lambdalambda(5)-phosphatetracosan-18-yl icosanoate; phosphatidylethanolamine
mifepristone	[no description available]	medium	1	0	3-oxo-Delta(4) steroid; acetylenic compound; tertiary amino compound	abortifacient; contraceptive drug; hormone antagonist; synthetic oral contraceptive
daunorubicin	[no description available]	medium	1	0	aminoglycoside antibiotic; anthracycline; p-quinones; tetracenequinones	antineoplastic agent; bacterial metabolite
arginine	[no description available]	medium	1	0
diazooxonorleucine	[no description available]	medium	1	0	amino acid zwitterion; diazo compound; ketone; non-proteinogenic L-alpha-amino acid	analgesic; antibacterial agent; antimetabolite; antineoplastic agent; antiviral agent; apoptosis inducer; bacterial metabolite; EC 2.4.2.14 (amidophosphoribosyltransferase) inhibitor; EC 3.5.1.2 (glutaminase) inhibitor; EC 6.3.4.2 [CTP synthase (glutamine hydrolyzing)] inhibitor; EC 6.3.5.1 [NAD(+) synthase (glutamine-hydrolysing)] inhibitor; EC 6.3.5.2 [GMP synthase (glutamine-hydrolysing)] inhibitor; EC 6.3.5.3 (phosphoribosylformylglycinamidine synthase) inhibitor; EC 6.3.5.4 [asparagine synthase (glutamine-hydrolysing)] inhibitor; EC 6.3.5.5 [carbamoyl-phosphate synthase (glutamine-hydrolysing)] inhibitor; glutamine antagonist
acivicin	[no description available]	medium	1	0	isoxazoles; non-proteinogenic L-alpha-amino acid; organochlorine compound	antileishmanial agent; antimetabolite; antimicrobial agent; antineoplastic agent; EC 2.3.2.2 (gamma-glutamyltransferase) inhibitor; glutamine antagonist; metabolite
nisoldipine	[no description available]	medium	1	0	C-nitro compound; dicarboxylic acids and O-substituted derivatives; diester; dihydropyridine; methyl ester
cgp 12177	[no description available]	medium	1	0	aromatic ether; benzimidazoles; secondary alcohol; secondary amino compound	beta-adrenergic antagonist
methyl orange	[no description available]	medium	1	0
dehydroepiandrosterone sulfate	[no description available]	medium	1	0	17-oxo steroid; steroid sulfate	EC 2.7.1.33 (pantothenate kinase) inhibitor; human metabolite; mouse metabolite
imidazole	[no description available]	medium	1	0	imidazole
ursodeoxycholic acid	[no description available]	medium	1	0	bile acid; C24-steroid; dihydroxy-5beta-cholanic acid	human metabolite; mouse metabolite
taurochenodeoxycholic acid	[no description available]	medium	1	0	bile acid taurine conjugate	human metabolite; mouse metabolite
ursodoxicoltaurine	[no description available]	medium	1	0	bile acid taurine conjugate	anti-inflammatory agent; apoptosis inhibitor; bone density conservation agent; cardioprotective agent; human metabolite; neuroprotective agent
2,5-di-tert-butylhydroquinone	[no description available]	medium	1	0	hydroquinones
dapi	[no description available]	medium	1	0	indoles	fluorochrome
3,3'-dihexyl-2,2'-oxacarbocyanine	[no description available]	medium	1	0
rolipram	[no description available]	medium	2	0	pyrrolidin-2-ones	antidepressant; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor
meclofenamic acid	[no description available]	medium	2	0	aminobenzoic acid; organochlorine compound; secondary amino compound	analgesic; anticonvulsant; antineoplastic agent; antipyretic; antirheumatic drug; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-steroidal anti-inflammatory drug
20-hydroxy-5,8,11,14-eicosatetraenoic acid	[no description available]	medium	1	0	HETE; hydroxy monocarboxylic acid	human metabolite; mouse metabolite
ddms	[no description available]	medium	1	0	chlorophenylethane; monochlorobenzenes
glycyl-arginyl-glycyl-aspartyl-serine	[no description available]	medium	1	0
d 609	[no description available]	medium	1	0
spironolactone	[no description available]	medium	1	0	3-oxo-Delta(4) steroid; oxaspiro compound; steroid lactone; thioester	aldosterone antagonist; antihypertensive agent; diuretic; environmental contaminant; xenobiotic
phloretin	[no description available]	medium	1	0	dihydrochalcones	antineoplastic agent; plant metabolite
pd 123319	[no description available]	medium	1	0	imidazopyridine	angiotensin receptor antagonist; endothelin receptor antagonist; vasoconstrictor agent
sodium dodecyl sulfate	[no description available]	medium	1	0	organic sodium salt	detergent; protein denaturant
pituitrin	[no description available]	medium	3	0
ro 31-8425	[no description available]	medium	1	0
pyranine	[no description available]	medium	1	0	organic sodium salt	fluorochrome
firefly luciferin	[no description available]	medium	2	0	1,3-thiazolemonocarboxylic acid; benzothiazoles; imidothioate	luciferin
acridine orange	[no description available]	medium	1	0	aminoacridines; aromatic amine; tertiary amino compound	fluorochrome; histological dye
glycylphenylalanine 2-naphthylamide	[no description available]	medium	1	0	dipeptide; N-(2-naphthyl)carboxamide	chromogenic compound
11-cis-retinal	[no description available]	medium	1	0	retinal	chromophore; human metabolite; mouse metabolite
methionine	[no description available]	medium	4	0	aspartate family amino acid; L-alpha-amino acid; methionine zwitterion; methionine; proteinogenic amino acid	antidote to paracetamol poisoning; human metabolite; micronutrient; mouse metabolite; nutraceutical
podophyllotoxin	[no description available]	medium	1	0	furonaphthodioxole; lignan; organic heterotetracyclic compound	antimitotic; antineoplastic agent; keratolytic drug; microtubule-destabilising agent; plant metabolite; tubulin modulator
4-epianhydrotetracycline	[no description available]	medium	1	0
thiamine pyrophosphate	[no description available]	medium	2	0	organophosphate oxoanion; vitamin B1	human metabolite; Saccharomyces cerevisiae metabolite
olivomycins	[no description available]	medium	1	0
phenoxybenzamine	[no description available]	medium	1	0	aromatic amine
methysergide	[no description available]	medium	2	0	ergoline alkaloid
morphine	[no description available]	medium	2	0	morphinane alkaloid; organic heteropentacyclic compound; tertiary amino compound	anaesthetic; drug allergen; environmental contaminant; geroprotector; mu-opioid receptor agonist; opioid analgesic; plant metabolite; vasodilator agent; xenobiotic
hexestrol	[no description available]	medium	1	0	stilbenoid
trifluoperazine	[no description available]	medium	1	0	N-alkylpiperazine; N-methylpiperazine; organofluorine compound; phenothiazines	antiemetic; calmodulin antagonist; dopaminergic antagonist; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor; EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor; phenothiazine antipsychotic drug
mizoribine	[no description available]	medium	1	0	imidazoles	anticoronaviral agent
tetrakis(acetoxymercuri)methane	[no description available]	medium	1	0
2'-deoxyuridylic acid	[no description available]	medium	1	0	deoxyuridine phosphate; pyrimidine 2'-deoxyribonucleoside 5'-monophosphate	Escherichia coli metabolite; metabolite; mouse metabolite
methotrexate	[no description available]	medium	1	1	dicarboxylic acid; monocarboxylic acid amide; pteridines	abortifacient; antimetabolite; antineoplastic agent; antirheumatic drug; dermatologic drug; DNA synthesis inhibitor; EC 1.5.1.3 (dihydrofolate reductase) inhibitor; immunosuppressive agent
sapropterin	[no description available]	medium	1	0	5,6,7,8-tetrahydrobiopterin	coenzyme; cofactor; diagnostic agent; human metabolite
coomassie brilliant blue	[no description available]	medium	1	0
phosphatidylbutanol	[no description available]	medium	1	0
bilirubin	[no description available]	medium	1	0	biladienes; dicarboxylic acid	antioxidant; human metabolite; mouse metabolite
cysteine	[no description available]	medium	1	0	cysteinium	fundamental metabolite
dithiothreitol	[no description available]	medium	1	0	1,4-dimercaptobutane-2,3-diol; butanediols; dithiol; glycol; thiol	chelator; human metabolite; reducing agent
potassium phosphate	[no description available]	medium	1	0	inorganic phosphate salt; inorganic potassium salt
lometrexol	[no description available]	medium	1	0
gallopamil	[no description available]	medium	1	0	benzenes; organic amino compound
acetic anhydride	[no description available]	medium	1	0	acyclic carboxylic anhydride	metabolite; reagent
cholecystokinin	[no description available]	medium	1	0
2-deoxyribose 1-phosphate, (alpha-d-erythro)-isomer	[no description available]	medium	1	0	2-deoxy-D-ribofuranose 1-phosphate
alpha-fluoro-beta-alanine	[no description available]	medium	1	0	organonitrogen compound; organooxygen compound
beta-alanine	[no description available]	medium	2	0	amino acid zwitterion; beta-amino acid	agonist; fundamental metabolite; human metabolite; inhibitor; neurotransmitter
cimetidine	[no description available]	medium	1	0	aliphatic sulfide; guanidines; imidazoles; nitrile	adjuvant; analgesic; anti-ulcer drug; H2-receptor antagonist; P450 inhibitor
12-hydroxy-5,8,10,14-eicosatetraenoic acid	[no description available]	medium	1	0
chloroquine	[no description available]	medium	1	0	aminoquinoline; organochlorine compound; secondary amino compound; tertiary amino compound	anticoronaviral agent; antimalarial; antirheumatic drug; autophagy inhibitor; dermatologic drug
metoprolol	[no description available]	medium	1	1	aromatic ether; propanolamine; secondary alcohol; secondary amino compound	antihypertensive agent; beta-adrenergic antagonist; environmental contaminant; geroprotector; xenobiotic
glycerol	[no description available]	medium	1	0	alditol; triol	algal metabolite; detergent; Escherichia coli metabolite; geroprotector; human metabolite; mouse metabolite; osmolyte; Saccharomyces cerevisiae metabolite; solvent
5-(n,n-hexamethylene)amiloride	[no description available]	medium	1	0	aromatic amine; azepanes; guanidines; monocarboxylic acid amide; organochlorine compound; pyrazines	antineoplastic agent; apoptosis inducer; odorant receptor antagonist; sodium channel blocker
phenytoin	[no description available]	medium	2	0	imidazolidine-2,4-dione	anticonvulsant; drug allergen; sodium channel blocker; teratogenic agent
hydrogen	[no description available]	medium	1	0	elemental hydrogen; elemental molecule; gas molecular entity	antioxidant; electron donor; food packaging gas; fuel; human metabolite
2-deoxy-2-fluorogalactose	[no description available]	medium	1	0
dihydrouracil	[no description available]	medium	1	0	pyrimidone	Escherichia coli metabolite; human metabolite; metabolite; mouse metabolite
n-carbamoyl-beta-alanine	[no description available]	medium	1	0	beta-alanine derivative	metabolite; mouse metabolite
toluene	[no description available]	medium	1	0	methylbenzene; toluenes; volatile organic compound	cholinergic antagonist; fuel additive; neurotoxin; non-polar solvent
allopurinol riboside	[no description available]	medium	1	0	nucleoside analogue	metabolite
tisopurine	[no description available]	medium	1	0	pyrazolopyrimidine
4-aminopyrazolo(3,4-d)pyrimidine	[no description available]	medium	1	0
thiopurinol ribonucleoside	[no description available]	medium	1	0
methylmercuric chloride	[no description available]	medium	1	0	chlorine molecular entity; mercury coordination entity; one-carbon compound
phosphoglyceroyl-atp	[no description available]	medium	1	0
1-naphthylamine-5-sulfonic acid	[no description available]	medium	1	0	naphthalenesulfonic acid
thiamphenicol	[no description available]	medium	1	0	monocarboxylic acid amide; sulfone	antimicrobial agent; immunosuppressive agent
antipyrylazo iii	[no description available]	medium	1	0
helium	[no description available]	medium	1	0	monoatomic helium; noble gas atom; s-block element atom	food packaging gas
neon	[no description available]	medium	1	0	monoatomic neon; noble gas atom; p-block element atom
magnesium gtp	[no description available]	medium	1	0
chlortetracycline	[no description available]	medium	1	0
allylamine	[no description available]	medium	1	0	alkylamine
trichloroacetic acid	[no description available]	medium	1	0	monocarboxylic acid; organochlorine compound	carcinogenic agent; metabolite; mouse metabolite
8-hydroxyguanosine triphosphate	[no description available]	medium	2	0
ly 171883	[no description available]	medium	1	0	acetophenones; aromatic ether; phenols; tetrazoles	anti-asthmatic drug; leukotriene antagonist
thromboxane b2	[no description available]	medium	1	0	thromboxanes B	human metabolite; mouse metabolite
dicyclohexylcarbodiimide	[no description available]	medium	2	0	carbodiimide	ATP synthase inhibitor; cross-linking reagent; peptide coupling reagent
calpain	[no description available]	medium	1	0
dolichols	[no description available]	medium	1	0	polyterpene
ethyldimethylaminopropyl carbodiimide	[no description available]	medium	1	0
carbodiimides	[no description available]	medium	1	0	carbodiimide
diethylcarbamazine	[no description available]	medium	1	0	N-carbamoylpiperazine; N-methylpiperazine
trifluoroacetic acid	[no description available]	medium	1	0	fluoroalkanoic acid	human xenobiotic metabolite; NMR chemical shift reference compound; reagent
lysophosphatidylcholines	[no description available]	medium	1	0	1-O-acyl-sn-glycero-3-phosphocholine
digitonin	[no description available]	medium	1	0
3-methylcholanthrene	[no description available]	medium	1	0	ortho- and peri-fused polycyclic arene	aryl hydrocarbon receptor agonist; carcinogenic agent
diphenhydramine	[no description available]	medium	1	0	ether; tertiary amino compound	anti-allergic agent; antidyskinesia agent; antiemetic; antiparkinson drug; antipruritic drug; antitussive; H1-receptor antagonist; local anaesthetic; muscarinic antagonist; oneirogen; sedative
cobamamide	[no description available]	medium	1	0
adenylosuccinate	[no description available]	medium	1	0
8-azidoguanosine triphosphate	[no description available]	medium	1	0
pulmicort	[no description available]	medium	1	0	11beta-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(1),Delta(4)-steroid; cyclic acetal; glucocorticoid; primary alpha-hydroxy ketone	anti-inflammatory drug; bronchodilator agent; drug allergen
bw 58c	[no description available]	medium	1	0
glucose-1,6-bisphosphate	[no description available]	medium	1	0	D-glucose 1,6-bisphosphate	Escherichia coli metabolite; human metabolite
5'-methylthioadenosine	[no description available]	medium	1	0	thioadenosine	algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
adenosine kinase	[no description available]	medium	1	0
glycolipids	[no description available]	medium	1	0
sulfoquinovosyl diglyceride	[no description available]	medium	1	0
quin2	[no description available]	medium	1	0
naloxone	[no description available]	medium	1	0	morphinane alkaloid; organic heteropentacyclic compound; tertiary alcohol	antidote to opioid poisoning; central nervous system depressant; mu-opioid receptor antagonist
isomethyleugenol	[no description available]	medium	6	0	isomethyleugenol
vendex	[no description available]	medium	1	0	organotin acaricide
fomesafen	[no description available]	medium	1	0	aromatic ether; C-nitro compound; monochlorobenzenes; N-sulfonylcarboxamide; organofluorine compound; phenols	agrochemical; EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide
eye	[no description available]	medium	1	0
trazodone hydrochloride	[no description available]	medium	5	0	hydrochloride	adrenergic antagonist; antidepressant; H1-receptor antagonist; sedative; serotonin uptake inhibitor
1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone	[no description available]	medium	3	0	dichlorobenzene; differentiation-inducing factor; monomethoxybenzene; resorcinols	eukaryotic metabolite; signalling molecule
guaifenesin	[no description available]	medium	5	0	methoxybenzenes
monoisopropanolamine	[no description available]	low	0	0	amino alcohol; secondary alcohol	Escherichia coli metabolite
dihydro-3-coumaric acid	[no description available]	low	0	0	monocarboxylic acid	Escherichia coli metabolite; human xenobiotic metabolite
3-mercaptopyruvic acid	[no description available]	low	0	0	2-oxo monocarboxylic acid; thiol	antidote to cyanide poisoning; Escherichia coli metabolite; human metabolite; mouse metabolite
4-aminobutyraldehyde	[no description available]	low	0	0	aminobutanal; omega-aminoaldehyde	Escherichia coli metabolite; mouse metabolite
aminolevulinic acid	[no description available]	low	0	0	4-oxo monocarboxylic acid; amino acid zwitterion; delta-amino acid	antineoplastic agent; dermatologic drug; Escherichia coli metabolite; human metabolite; mouse metabolite; photosensitizing agent; plant metabolite; prodrug; Saccharomyces cerevisiae metabolite
5,6,7,8-tetrahydropteridine	[no description available]	low	0	0	pteridines	cofactor; Escherichia coli metabolite
acetaldehyde	[no description available]	low	0	0	aldehyde	carcinogenic agent; EC 3.5.1.4 (amidase) inhibitor; electron acceptor; Escherichia coli metabolite; human metabolite; mouse metabolite; mutagen; oxidising agent; Saccharomyces cerevisiae metabolite; teratogenic agent
agmatine	[no description available]	low	0	0	guanidines; primary amino compound	Escherichia coli metabolite; mouse metabolite
allantoin	[no description available]	low	0	0	imidazolidine-2,4-dione; ureas	Escherichia coli metabolite; human metabolite; Saccharomyces cerevisiae metabolite; vulnerary
aminoacetone	[no description available]	low	0	0	methyl ketone; propanones	Escherichia coli metabolite; mouse metabolite
arsenic acid	[no description available]	low	0	0	arsenic oxoacid	Escherichia coli metabolite
betaine aldehyde	[no description available]	low	0	0	quaternary ammonium ion	Aspergillus metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite
butyraldehyde	[no description available]	low	0	0	butanals	biomarker; Escherichia coli metabolite; mouse metabolite
cadaverine	[no description available]	low	0	0	alkane-alpha,omega-diamine	Daphnia magna metabolite; Escherichia coli metabolite; mouse metabolite; plant metabolite
carbamic acid	[no description available]	low	0	0	carbon oxoacid; one-carbon compound; organonitrogen compound	Escherichia coli metabolite
coproporphyrinogen iii	[no description available]	low	0	0	coproporphyrinogen	Escherichia coli metabolite; mouse metabolite
2-aminoacetaldehyde	[no description available]	low	0	0	amino aldehyde; omega-aminoaldehyde	Escherichia coli metabolite
2,3-diaminopropionic acid	[no description available]	low	0	0	alanine derivative; amino acid zwitterion; beta-amino acid; diamino acid; non-proteinogenic alpha-amino acid	Escherichia coli metabolite
octanoic acid	[no description available]	low	0	0	medium-chain fatty acid; straight-chain saturated fatty acid	antibacterial agent; Escherichia coli metabolite; human metabolite
hydrogen sulfide	[no description available]	low	0	0	gas molecular entity; hydracid; mononuclear parent hydride; sulfur hydride	Escherichia coli metabolite; genotoxin; metabolite; signalling molecule; toxin; vasodilator agent
oxaluric acid	[no description available]	low	0	0	2-oxo monocarboxylic acid; ureas	Escherichia coli metabolite
n(1)-acetylspermidine	[no description available]	low	0	0	acetylspermidine	Escherichia coli metabolite; metabolite
propionaldehyde	[no description available]	low	0	0	alpha-CH2-containing aldehyde; propanals	Escherichia coli metabolite
phosphoglycolate	[no description available]	low	0	0	carboxyalkyl phosphate	Escherichia coli metabolite; mouse metabolite
hydrogen selenide	[no description available]	low	0	0	mononuclear parent hydride; selenium hydride	Escherichia coli metabolite; mouse metabolite
3,3-dimethylallyl pyrophosphate	[no description available]	low	0	0	prenol phosphate	epitope; Escherichia coli metabolite; mouse metabolite; phosphoantigen
diacetyl	[no description available]	low	0	0	alpha-diketone	Escherichia coli metabolite; Saccharomyces cerevisiae metabolite
dihydroxyacetone phosphate	[no description available]	low	0	0	glycerone phosphates; primary alpha-hydroxy ketone	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
dihydroxyacetone	[no description available]	low	0	0	ketotriose; primary alpha-hydroxy ketone	antifungal agent; Escherichia coli metabolite; human metabolite; metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
1,4-dihydroxy-2-naphthoic acid	[no description available]	low	0	0	dihydroxy monocarboxylic acid; naphthalenediols; naphthohydroquinone; naphthoic acid	Escherichia coli metabolite
5,6-dimethylbenzimidazole	[no description available]	low	0	0	dimethylbenzimidazole	Escherichia coli metabolite; human metabolite
dimethyl sulfoxide	[no description available]	low	0	0	sulfoxide; volatile organic compound	alkylating agent; antidote; Escherichia coli metabolite; geroprotector; MRI contrast agent; non-narcotic analgesic; polar aprotic solvent; radical scavenger
ethanolamine	[no description available]	low	0	0	ethanolamines; primary alcohol; primary amine	Escherichia coli metabolite; human metabolite; mouse metabolite
formaldehyde	[no description available]	low	0	0	aldehyde; one-carbon compound	allergen; carcinogenic agent; disinfectant; EC 3.5.1.4 (amidase) inhibitor; environmental contaminant; Escherichia coli metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
gamma-butyrobetaine	[no description available]	low	0	0	amino-acid betaine	Escherichia coli metabolite; human metabolite
glyoxylic acid	[no description available]	low	0	0	2-oxo monocarboxylic acid; aldehydic acid	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
hydrogen cyanide	[no description available]	low	0	0	hydracid; one-carbon compound	Escherichia coli metabolite; human metabolite; poison
toxopyrimidine	[no description available]	low	0	0	aminopyrimidine; aromatic primary alcohol	Escherichia coli metabolite; Saccharomyces cerevisiae metabolite
thiocyanic acid	[no description available]	low	0	0	hydracid; one-carbon compound; organosulfur compound	Escherichia coli metabolite
hydroxymethylbilane	[no description available]	low	0	0	bilanes	Escherichia coli metabolite; mouse metabolite
iminoaspartic acid	[no description available]	low	0	0	aspartic acid derivative; C4-dicarboxylic acid; ketimine	Escherichia coli metabolite
indole	[no description available]	low	0	0	indole; polycyclic heteroarene	Escherichia coli metabolite
lipoamide	[no description available]	low	0	0	dithiolanes; monocarboxylic acid amide	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
racemethionine	[no description available]	low	0	0	alpha-amino acid; amino acid zwitterion; sulfur-containing amino acid	algal metabolite; Daphnia magna metabolite; Escherichia coli metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
pyruvaldehyde	[no description available]	low	0	0	2-oxo aldehyde; propanals	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
methanol	[no description available]	low	0	0	alkyl alcohol; one-carbon compound; primary alcohol; volatile organic compound	amphiprotic solvent; Escherichia coli metabolite; fuel; human metabolite; mouse metabolite; Mycoplasma genitalium metabolite
niacinamide	[no description available]	low	0	0	pyridine alkaloid; pyridinecarboxamide; vitamin B3	anti-inflammatory agent; antioxidant; cofactor; EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor; EC 3.5.1.98 (histone deacetylase) inhibitor; Escherichia coli metabolite; geroprotector; human urinary metabolite; metabolite; mouse metabolite; neuroprotective agent; Saccharomyces cerevisiae metabolite; Sir2 inhibitor
niacin	[no description available]	low	0	0	pyridine alkaloid; pyridinemonocarboxylic acid; vitamin B3	antidote; antilipemic drug; EC 3.5.1.19 (nicotinamidase) inhibitor; Escherichia coli metabolite; human urinary metabolite; metabolite; mouse metabolite; plant metabolite; vasodilator agent
hydroxypyruvic acid	[no description available]	low	0	0	2-oxo monocarboxylic acid; 3-hydroxy monocarboxylic acid; primary alpha-hydroxy ketone	Escherichia coli metabolite; human metabolite
oxamic acid	[no description available]	low	0	0	dicarboxylic acid monoamide	Escherichia coli metabolite
4-aminobenzoic acid	[no description available]	low	0	0	aminobenzoic acid; aromatic amino-acid zwitterion	allergen; Escherichia coli metabolite; plant metabolite
phenylacetaldehyde	[no description available]	low	0	0	alpha-CH2-containing aldehyde; phenylacetaldehydes	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
phenylacetic acid	[no description available]	low	0	0	benzenes; monocarboxylic acid; phenylacetic acids	allergen; Aspergillus metabolite; auxin; EC 6.4.1.1 (pyruvate carboxylase) inhibitor; Escherichia coli metabolite; human metabolite; plant growth retardant; plant metabolite; Saccharomyces cerevisiae metabolite; toxin
phenethylamine	[no description available]	low	0	0	alkaloid; aralkylamine; phenylethylamine	Escherichia coli metabolite; human metabolite; mouse metabolite
porphobilinogen	[no description available]	low	0	0	aralkylamino compound; dicarboxylic acid; pyrroles	Escherichia coli metabolite; metabolite; mouse metabolite
prephenic acid	[no description available]	low	0	0	oxo dicarboxylic acid	Escherichia coli metabolite; plant metabolite
pyridoxal	[no description available]	low	0	0	hydroxymethylpyridine; methylpyridines; monohydroxypyridine; pyridinecarbaldehyde; vitamin B6	cofactor; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
pyridoxamine	[no description available]	low	0	0	aminoalkylpyridine; hydroxymethylpyridine; monohydroxypyridine; vitamin B6	Escherichia coli metabolite; human metabolite; iron chelator; mouse metabolite; nephroprotective agent; plant metabolite; Saccharomyces cerevisiae metabolite
pyridoxamine phosphate	[no description available]	low	0	0	aminoalkylpyridine; methylpyridines; monohydroxypyridine; vitamin B6 phosphate	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
pyridoxine 5-phosphate	[no description available]	low	0	0	vitamin B6 phosphate	Escherichia coli metabolite; mouse metabolite
quinolinic acid	[no description available]	low	0	0	pyridinedicarboxylic acid	Escherichia coli metabolite; human metabolite; mouse metabolite; NMDA receptor agonist
dimethyl sulfide	[no description available]	low	0	0	aliphatic sulfide	algal metabolite; bacterial xenobiotic metabolite; EC 3.5.1.4 (amidase) inhibitor; Escherichia coli metabolite; marine metabolite
succinic semialdehyde	[no description available]	low	0	0	aldehydic acid	Escherichia coli metabolite; mouse metabolite
sulfur dioxide	[no description available]	low	0	0	sulfur oxide	Escherichia coli metabolite; food bleaching agent; refrigerant
tartronate semialdehyde	[no description available]	low	0	0	2-hydroxy monocarboxylic acid; 3-oxo monocarboxylic acid; aldehyde	Escherichia coli metabolite; mouse metabolite
taurine	[no description available]	low	0	0	amino sulfonic acid; zwitterion	antioxidant; Escherichia coli metabolite; glycine receptor agonist; human metabolite; mouse metabolite; nutrient; radical scavenger; Saccharomyces cerevisiae metabolite
thymine	[no description available]	low	0	0	pyrimidine nucleobase; pyrimidone	Escherichia coli metabolite; human metabolite; mouse metabolite
2-(4-methyl-1,3-thiazol-5-yl)ethanol	[no description available]	low	0	0	1,3-thiazoles; primary alcohol	Escherichia coli metabolite; human metabolite; Saccharomyces cerevisiae metabolite
trimethylamine	[no description available]	low	0	0	methylamines; tertiary amine	Escherichia coli metabolite; human xenobiotic metabolite
uroporphyrinogen iii	[no description available]	low	0	0	uroporphyrinogen	Escherichia coli metabolite; mouse metabolite
isopentenyl pyrophosphate	[no description available]	low	0	0	prenol phosphate	antigen; antioxidant; epitope; Escherichia coli metabolite; mouse metabolite; phosphoantigen
beta-glycerophosphoric acid	[no description available]	low	0	0	glycerol monophosphate	Escherichia coli metabolite; plant metabolite
4-cresol	[no description available]	low	0	0	cresol	Escherichia coli metabolite; human metabolite; uremic toxin
4-aminobenzoic acid	[no description available]	low	0	0	aminobenzoate; aromatic amino-acid anion	Escherichia coli metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
tyramine	[no description available]	low	0	0	monoamine molecular messenger; primary amino compound; tyramines	EC 3.1.1.8 (cholinesterase) inhibitor; Escherichia coli metabolite; human metabolite; mouse metabolite; neurotransmitter
sorbitol	[no description available]	low	0	0	glucitol	cathartic; Escherichia coli metabolite; food humectant; human metabolite; laxative; metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite; sweetening agent
chloramphenicol	[no description available]	low	0	0	C-nitro compound; carboxamide; diol; organochlorine compound	antibacterial drug; antimicrobial agent; Escherichia coli metabolite; geroprotector; Mycoplasma genitalium metabolite; protein synthesis inhibitor
isoleucine	[no description available]	low	0	0	aspartate family amino acid; isoleucine; L-alpha-amino acid zwitterion; L-alpha-amino acid; proteinogenic amino acid	algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
methanesulfonic acid	[no description available]	low	0	0	alkanesulfonic acid; one-carbon compound	Escherichia coli metabolite
trehalose	[no description available]	low	0	0	trehalose	Escherichia coli metabolite; geroprotector; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
acetol	[no description available]	low	0	0	methyl ketone; primary alcohol; primary alpha-hydroxy ketone; propanones	Escherichia coli metabolite; human metabolite; mouse metabolite
shikimic acid	[no description available]	low	0	0	alpha,beta-unsaturated monocarboxylic acid; cyclohexenecarboxylic acid; hydroxy monocarboxylic acid	Escherichia coli metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
phosphoadenosine phosphosulfate	[no description available]	low	0	0	acyl sulfate; adenosine bisphosphate; purine ribonucleoside bisphosphate	Escherichia coli metabolite; mouse metabolite
adenosine phosphosulfate	[no description available]	low	0	0	acyl monophosphate; acyl sulfate; adenosine 5'-phosphate	Escherichia coli metabolite; mouse metabolite
pyridoxamine dihydrochloride	[no description available]	low	0	0	hydrochloride; vitamin B6	Escherichia coli metabolite; human metabolite; iron chelator; mouse metabolite; nephroprotective agent; plant metabolite; Saccharomyces cerevisiae metabolite
galactitol	[no description available]	low	0	0	hexitol	Escherichia coli metabolite; human metabolite; metabolite; mouse metabolite
chorismic acid	[no description available]	low	0	0	5-[(1-carboxyethenyl)oxy]-6-hydroxycyclohexa-1,3-diene-1-carboxylic acid	Escherichia coli metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
homoserine	[no description available]	low	0	0	amino acid zwitterion; homoserine	algal metabolite; Escherichia coli metabolite; human metabolite; Saccharomyces cerevisiae metabolite
2'-deoxyadenosine	[no description available]	low	0	0	purine 2'-deoxyribonucleoside; purines 2'-deoxy-D-ribonucleoside	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
nicotinamide mononucleotide	[no description available]	low	0	0	nicotinamide mononucleotide	Escherichia coli metabolite; mouse metabolite
1,3,4-butanetriol	[no description available]	low	0	0	triol	bacterial xenobiotic metabolite; Escherichia coli metabolite
d-glutamate	[no description available]	low	0	0	D-alpha-amino acid; glutamic acid	Escherichia coli metabolite; mouse metabolite
silver	[no description available]	low	0	0	copper group element atom; elemental silver	Escherichia coli metabolite
molybdate ion	[no description available]	low	0	0	divalent inorganic anion; molybdenum oxoanion	Escherichia coli metabolite
myrmicacin	[no description available]	low	0	0	3-hydroxy fatty acid; medium-chain fatty acid	antimitotic; Escherichia coli metabolite
d-lactic acid	[no description available]	low	0	0	2-hydroxypropanoic acid	Escherichia coli metabolite; human metabolite
xanthosine	[no description available]	low	0	0	purines D-ribonucleoside; xanthosines	Escherichia coli metabolite; human metabolite; mouse metabolite
glutathione disulfide	[no description available]	low	0	0	glutathione derivative; organic disulfide	Escherichia coli metabolite; mouse metabolite
n-(3-aminopropyl)cadaverine	[no description available]	low	0	0	polyazaalkane; triamine	Escherichia coli metabolite
3'-cmp	[no description available]	low	0	0	cytidine 3'-phosphate; pyrimidine ribonucleoside 3'-monophosphate	Escherichia coli metabolite; metabolite; mouse metabolite
hydracrylic acid	[no description available]	low	0	0	3-hydroxy monocarboxylic acid; omega-hydroxy-short-chain fatty acid	Escherichia coli metabolite; human metabolite
plasmenylserine	[no description available]	low	0	0	O-phosphoserine	EC 1.4.7.1 [glutamate synthase (ferredoxin)] inhibitor; EC 2.5.1.49 (O-acetylhomoserine aminocarboxypropyltransferase) inhibitor; EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
cifostodine	[no description available]	low	0	0	2',3'-cyclic pyrimidine nucleotide	Escherichia coli metabolite; mouse metabolite; Mycoplasma genitalium metabolite
ubiquinone-o	[no description available]	low	0	0	ubiquinones	Escherichia coli metabolite; human metabolite
D-serine	[no description available]	low	0	0	D-alpha-amino acid; serine zwitterion; serine	Escherichia coli metabolite; human metabolite; NMDA receptor agonist
D-alanine	[no description available]	low	0	0	alanine zwitterion; alanine; D-alpha-amino acid	EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor; Escherichia coli metabolite; human metabolite
D-tyrosine	[no description available]	low	0	0	D-alpha-amino acid zwitterion; D-alpha-amino acid; tyrosine	Escherichia coli metabolite
xanthosine 5'-triphosphate	[no description available]	low	0	0	purine ribonucleoside 5'-monophosphate; xanthosine 5'-phosphate	Escherichia coli metabolite; metabolite; mouse metabolite
succinyl-coenzyme a	[no description available]	low	0	0	omega-carboxyacyl-CoA	Escherichia coli metabolite; inhibitor; mouse metabolite
L-2-aminoadipic acid	[no description available]	low	0	0	2-aminoadipic acid	Escherichia coli metabolite; human metabolite
acetoacetyl coa	[no description available]	low	0	0	3-oxo-fatty acyl-CoA	Escherichia coli metabolite; mouse metabolite
propionyl-coenzyme a	[no description available]	low	0	0	acyl-CoA	Escherichia coli metabolite; metabolite; mouse metabolite
stearoyl-coenzyme a	[no description available]	low	0	0	11,12-saturated fatty acyl-CoA; long-chain fatty acyl-CoA	Escherichia coli metabolite; mouse metabolite
3'-uridylic acid	[no description available]	low	0	0	pyrimidine ribonucleoside 3'-monophosphate; uridine phosphate	Escherichia coli metabolite
2',3'-cyclic amp	[no description available]	low	0	0	2',3'-cyclic purine nucleotide	Escherichia coli metabolite
2,5-diketogluconic acid	[no description available]	low	0	0	diketoaldonic acid	Escherichia coli metabolite
l-lactic acid	[no description available]	low	0	0	(2S)-2-hydroxy monocarboxylic acid; 2-hydroxypropanoic acid	Escherichia coli metabolite; human metabolite
selenodiglutathione	[no description available]	low	0	0	glutathione derivative; thioselenide	Escherichia coli metabolite; metabolite
2-deoxyglucose-6-phosphate	[no description available]	low	0	0	deoxyaldohexose phosphate	Escherichia coli metabolite; Mycoplasma genitalium metabolite
3,4-dihydroxyphenylacetaldehyde	[no description available]	low	0	0	alpha-CH2-containing aldehyde; catechols; phenylacetaldehydes	Escherichia coli metabolite; human metabolite; mouse metabolite
protoporphyrinogen	[no description available]	low	0	0	porphyrinogens	Escherichia coli metabolite; mouse metabolite
thymidine diphosphate-l-rhamnose	[no description available]	low	0	0	dTDP-L-rhamnose	Escherichia coli metabolite
butyryl-coenzyme a	[no description available]	low	0	0	butanoyl-CoAs	Escherichia coli metabolite; mouse metabolite
trehalose-6-phosphate	[no description available]	low	0	0	trehalose phosphate	Escherichia coli metabolite
erythrose 4-phosphate	[no description available]	low	0	0	erythrose phosphate	Escherichia coli metabolite; human metabolite; mouse metabolite
ribulose-1,5 diphosphate	[no description available]	low	0	0	ribulose phosphate	Escherichia coli metabolite; plant metabolite
n(8)-acetylspermidine	[no description available]	low	0	0	acetylspermidine	Escherichia coli metabolite; human metabolite
aerobactin	[no description available]	low	0	0	L-lysine derivative	Escherichia coli metabolite; siderophore; virulence factor
lipid x	[no description available]	low	0	0	N-acyl-D-glucosamine 1-phosphate	Escherichia coli metabolite
gamma-glutamylcysteine	[no description available]	low	0	0	gamma-glutamylcysteine	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
glutamate-1-semialdehyde	[no description available]	low	0	0	5-oxo monocarboxylic acid; amino acid zwitterion; gamma-amino acid; glutamic semialdehyde	Escherichia coli metabolite
mannitol-1-phosphate	[no description available]	low	0	0	alditol 1-phosphate; hexitol phosphate	Escherichia coli metabolite; human metabolite
2'-deoxycytidine diphosphate	[no description available]	low	0	0	2'-deoxycytidine phosphate; pyrimidine 2'-deoxyribonucleoside 5'-diphosphate	Escherichia coli metabolite; human metabolite; mouse metabolite; Mycoplasma genitalium metabolite
o-phosphohomoserine	[no description available]	low	0	0	O-phosphorylhomoserine	Escherichia coli metabolite
ribulose	[no description available]	low	0	0	ribulose	Escherichia coli metabolite; human metabolite
2,3-dihydroxybenzoylserine	[no description available]	low	0	0	L-serine derivative	Escherichia coli metabolite
sorbitol 6-phosphate	[no description available]	low	0	0	alditol 6-phosphate; glucitol phosphate	Escherichia coli metabolite; mouse metabolite
beta-aspartyl phosphate	[no description available]	low	0	0	aminoacyl phosphate; L-aspartic acid derivative; non-proteinogenic L-alpha-amino acid	Escherichia coli metabolite
alpha-ribazole	[no description available]	low	0	0	1-ribosylbenzimidazole; dimethylbenzimidazole	Escherichia coli metabolite; mouse metabolite
abrine	[no description available]	low	0	0	L-tryptophan derivative; N-methyl-L-alpha-amino acid zwitterion; N-methyl-L-alpha-amino acid	Escherichia coli metabolite
3-deoxy-d-arabino-heptulosonate-7-phosphate	[no description available]	low	0	0	ketoaldonic acid phosphate	Escherichia coli metabolite
saicar	[no description available]	low	0	0	1-(phosphoribosyl)imidazolecarboxamide	Escherichia coli metabolite; mouse metabolite
n(6)-(n-threonylcarbonyl)adenosine	[no description available]	low	0	0	L-threonine derivative; N-(adenosin-N(6)-ylcarbonyl)threonine	Escherichia coli metabolite; human metabolite
sedoheptulose 1,7-bisphosphate	[no description available]	low	0	0	ketoheptose phosphate; sedoheptulose derivative	Escherichia coli metabolite; mouse metabolite
sedoheptulose 7-phosphate	[no description available]	low	0	0	ketoheptose phosphate; sedoheptulose derivative	Escherichia coli metabolite; human metabolite; mouse metabolite
histidinol	[no description available]	low	0	0	amino alcohol; imidazoles	EC 2.3.1.97 (glycylpeptide N-tetradecanoyltransferase) inhibitor; Escherichia coli metabolite; human metabolite; Saccharomyces cerevisiae metabolite
carboxyaminoimidazole ribotide	[no description available]	low	0	0	1-(phosphoribosyl)imidazole; aminoimidazole; imidazole-4-carboxylic acid	Escherichia coli metabolite; mouse metabolite
lauroyl-coenzyme a	[no description available]	low	0	0	medium-chain fatty acyl-CoA	Escherichia coli metabolite; mouse metabolite
nicotinic acid adenine dinucleotide	[no description available]	low	0	0	nicotinic acid dinucleotide	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
phenylacetyl-coenzyme a	[no description available]	low	0	0	acyl-CoA	Escherichia coli metabolite; metabolite; mouse metabolite
5-formamidoimidazole-4-carboxamide ribotide	[no description available]	low	0	0	1-(phosphoribosyl)imidazolecarboxamide	Escherichia coli metabolite; mouse metabolite
6,7-dimethyl-8-ribityllumazine, (d)-isomer	[no description available]	low	0	0	pteridines	cofactor; Escherichia coli metabolite
2'-deoxyadenosine triphosphate	[no description available]	low	0	0	2'-deoxyadenosine 5'-phosphate; purine 2'-deoxyribonucleoside 5'-diphosphate	Escherichia coli metabolite; human metabolite; mouse metabolite
9-mercaptodethiobiotin	[no description available]	low	0	0	imidazolidinone; monocarboxylic acid; thiol; ureas	Escherichia coli metabolite
idonic acid	[no description available]	low	0	0	idonic acid	Escherichia coli metabolite
gamma-glutamyl phosphate	[no description available]	low	0	0	gamma-glutamyl phosphate	Escherichia coli metabolite; mouse metabolite
5-amino-6-ribitylamino-2,4-(1h,3h)pyrimidinedione	[no description available]	low	0	0	aminouracil; hydroxypyrimidine	Escherichia coli metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
hydroxythreonine	[no description available]	low	0	0	amino acid zwitterion; hydroxy-amino acid; L-threonine derivative; non-proteinogenic L-alpha-amino acid	Escherichia coli metabolite; Saccharomyces cerevisiae metabolite
n(1)-((5'-phosphoribulosyl)formimino)-5-aminoimidazo-4-carboxamide ribonucleotide	[no description available]	low	0	0	1-(phosphoribosyl)imidazolecarboxamide	Escherichia coli metabolite
2-oxo-3-deoxygalactonic acid	[no description available]	low	0	0	hexonic acid; ketoaldonic acid	Escherichia coli metabolite
5'-deoxyadenosine	[no description available]	low	0	0	5'-deoxyribonucleoside; adenosines	Escherichia coli metabolite; human metabolite; mouse metabolite
xylulose-5-phosphate, (d)-isomer	[no description available]	low	0	0	xylulose 5-phosphate	Escherichia coli metabolite; mouse metabolite
diaminopimelic acid	[no description available]	low	0	0	2,6-diaminopimelic acid; amino acid zwitterion	Escherichia coli metabolite
3-dehydroquinic acid	[no description available]	low	0	0	2-hydroxy monocarboxylic acid; 4-hydroxy monocarboxylic acid; 4-oxo monocarboxylic acid; 5-hydroxy monocarboxylic acid; secondary alpha-hydroxy ketone	Escherichia coli metabolite
o-succinylhomoserine	[no description available]	low	0	0	hemisuccinate; o-succinylhomoserine	Escherichia coli metabolite; Saccharomyces cerevisiae metabolite
s-adenosyl-3-methylthiopropylamine	[no description available]	low	0	0	adenosines; sulfonium compound	Escherichia coli metabolite; human urinary metabolite; mouse metabolite; rat metabolite
6-phosphonoglucono-delta-lactone	[no description available]	low	0	0	aldonolactone phosphate	Escherichia coli metabolite; mouse metabolite
cysteinylglycine	[no description available]	low	0	0	dipeptide zwitterion; dipeptide	Escherichia coli metabolite; human metabolite; Saccharomyces cerevisiae metabolite
tartaric acid	[no description available]	low	0	0	tartaric acid	Escherichia coli metabolite
s-ribosyl-l-homocysteine	[no description available]	low	0	0	S-(5-deoxy-D-ribos-5-yl)-L-homocysteine	Escherichia coli metabolite
4-hydroxyphenylacetaldehyde	[no description available]	low	0	0	alpha-CH2-containing aldehyde; phenylacetaldehydes	Escherichia coli metabolite; human metabolite; mouse metabolite
pantothenylcysteine 4'-phosphate	[no description available]	low	0	0	L-cysteine derivative	Escherichia coli metabolite; mouse metabolite
glutathionylspermidine	[no description available]	low	0	0	glutathione derivative	Escherichia coli metabolite
arbutin	[no description available]	low	0	0	beta-D-glucoside; monosaccharide derivative	Escherichia coli metabolite; plant metabolite
2-c-methylerythritol 4-phosphate	[no description available]	low	0	0	tetritol phosphate	Escherichia coli metabolite
1-deoxy-d-xylulose 5-phosphate	[no description available]	low	0	0	xylulose phosphate	Escherichia coli metabolite
c(alpha)-formylglycine	[no description available]	low	0	0	3-oxoalanine; amino acid zwitterion; L-alanine derivative; non-proteinogenic L-alpha-amino acid	Escherichia coli metabolite
dephosphocoenzyme a	[no description available]	low	0	0	adenosine 5'-phosphate	Escherichia coli metabolite; human metabolite; mouse metabolite
n(1)-(5-phosphoribosyl)-5,6-dimethylbenzimidazole	[no description available]	low	0	0	1-ribosylbenzimidazole; dimethylbenzimidazole; ribose monophosphate	Escherichia coli metabolite; mouse metabolite
ribothymidine	[no description available]	low	0	0	methyluridine	antigen; Escherichia coli metabolite; human metabolite
palmitoleic acid	[no description available]	low	0	0	hexadec-9-enoic acid	algal metabolite; Daphnia galeata metabolite; EC 3.1.1.1 (carboxylesterase) inhibitor; Escherichia coli metabolite; human blood serum metabolite
oleic acid	[no description available]	low	0	0	octadec-9-enoic acid	antioxidant; Daphnia galeata metabolite; EC 3.1.1.1 (carboxylesterase) inhibitor; Escherichia coli metabolite; mouse metabolite; plant metabolite; solvent
farnesyl pyrophosphate	[no description available]	low	0	0	farnesyl diphosphate	Escherichia coli metabolite; mouse metabolite
geranyl pyrophosphate	[no description available]	low	0	0	polyprenyl diphosphate	Escherichia coli metabolite; mouse metabolite
1,5-dihydro-fad	[no description available]	low	0	0	flavin adenine dinucleotide	Escherichia coli metabolite; mouse metabolite
s-hydroxymethylglutathione	[no description available]	low	0	0	S-substituted glutathione	Escherichia coli metabolite; mouse metabolite
hexanoyl-coenzyme a	[no description available]	low	0	0	medium-chain fatty acyl-CoA	Escherichia coli metabolite; human metabolite; mouse metabolite
4-phosphoerythronate	[no description available]	low	0	0	4-phosphoerythronic acid	Escherichia coli metabolite; mouse metabolite
riboflavin	[no description available]	low	0	0	flavin; vitamin B2	anti-inflammatory agent; antioxidant; cofactor; Escherichia coli metabolite; food colouring; fundamental metabolite; human urinary metabolite; mouse metabolite; photosensitizing agent; plant metabolite
malonyl coenzyme a	[no description available]	low	0	0	malonyl-CoAs	EC 2.3.1.21 (carnitine O-palmitoyltransferase) inhibitor; Escherichia coli metabolite; metabolite; mouse metabolite
sucrose-6-phosphate	[no description available]	low	0	0	disaccharide phosphate	Escherichia coli metabolite
palmitoyl coenzyme a	[no description available]	low	0	0	11,12-saturated fatty acyl-CoA; 3-substituted propionyl-CoA; long-chain fatty acyl-CoA; palmitoyl bioconjugate	Escherichia coli metabolite; mouse metabolite
glycerylphosphorylcholine	[no description available]	low	0	0	phosphocholines; sn-glycerol 3-phosphates	Escherichia coli metabolite; human metabolite; mouse metabolite; neuroprotective agent; parasympatholytic; Saccharomyces cerevisiae metabolite
cysteine sulfinic acid	[no description available]	low	0	0	organosulfinic acid; S-substituted L-cysteine	Escherichia coli metabolite; human metabolite; metabotropic glutamate receptor agonist; mouse metabolite
fusidic acid	[no description available]	low	0	0	11alpha-hydroxy steroid; 3alpha-hydroxy steroid; alpha,beta-unsaturated monocarboxylic acid; steroid acid; steroid antibiotic; sterol ester	EC 2.7.1.33 (pantothenate kinase) inhibitor; Escherichia coli metabolite; protein synthesis inhibitor
iminoglycine	[no description available]	low	0	0	dehydroamino acid; imine; zwitterion	Escherichia coli metabolite
2-keto-3-deoxy-6-phosphogluconate	[no description available]	low	0	0	ketoaldonic acid phosphate	Escherichia coli metabolite
formyl-coenzyme a	[no description available]	low	0	0	acyl-CoA	Escherichia coli metabolite
3-deoxy-2-octulosonic acid(2)-lipid iv(a)	[no description available]	low	0	0	lipid As	Escherichia coli metabolite
maleamic acid	[no description available]	low	0	0	alpha,beta-unsaturated monocarboxylic acid; dicarboxylic acid monoamide	bacterial xenobiotic metabolite; Escherichia coli metabolite
retinol palmitate	[no description available]	low	0	0	all-trans-retinyl ester; retinyl palmitate	antioxidant; Escherichia coli metabolite; human xenobiotic metabolite
canthaxanthin	[no description available]	low	0	0	carotenone	biological pigment; Escherichia coli metabolite; food colouring; fungal metabolite
(e)-4-hydroxy-3-methylbut-2-enyl diphosphate	[no description available]	low	0	0	prenol phosphate	epitope; Escherichia coli metabolite; phosphoantigen
menaquinone 7	[no description available]	low	0	0	menaquinone	bone density conservation agent; cofactor; Escherichia coli metabolite; human blood serum metabolite; Mycoplasma genitalium metabolite
xylulose	[no description available]	low	0	0	xylulose	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
vitamin mk 8	[no description available]	low	0	0	menaquinone	Escherichia coli metabolite; human metabolite
5-ketogluconic acid	[no description available]	low	0	0	hexonic acid; ketoaldonic acid	Escherichia coli metabolite
oleoyl-coenzyme a	[no description available]	low	0	0	octadecenoyl-CoA	Escherichia coli metabolite; mouse metabolite
menaquinone 9	[no description available]	low	0	0	menaquinone	Escherichia coli metabolite
allolactose	[no description available]	low	0	0	glycosylglucose	Escherichia coli metabolite
fuculose	[no description available]	low	0	0	deoxyketohexose	Escherichia coli metabolite; human metabolite
1-deoxy-2-pentulose	[no description available]	low	0	0	deoxypentose	Escherichia coli metabolite
fructosyl-lysine	[no description available]	low	0	0	fructosamine; glyco-amino acid	Escherichia coli metabolite
lipid a	[no description available]	low	0	0	dodecanoate ester; lipid A; tetradecanoate ester	Escherichia coli metabolite
methionine sulfoxide	[no description available]	low	0	0	amino acid zwitterion; L-methionine S-oxide	Escherichia coli metabolite
(S)-4,5-dihydroxypentane-2,3-dione	[no description available]	low	0	0	alpha-diketone; secondary alpha-hydroxy ketone	Escherichia coli metabolite
kdo2-lipid a	[no description available]	low	0	0	dodecanoate ester; lipid As; tetradecanoate ester	Escherichia coli metabolite
oxalyl-coenzyme a	[no description available]	low	0	0	omega-carboxyacyl-CoA	Escherichia coli metabolite
s-tetradecanoyl-coenzyme a	[no description available]	low	0	0	11,12-saturated fatty acyl-CoA; long-chain fatty acyl-CoA	Escherichia coli metabolite; mouse metabolite
novobiocin	[no description available]	low	0	0	carbamate ester; ether; hexoside; hydroxycoumarin; monocarboxylic acid amide; monosaccharide derivative; phenols	antibacterial agent; antimicrobial agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; Escherichia coli metabolite; hepatoprotective agent
diguanosine tetraphosphate	[no description available]	low	0	0	guanosine 5'-phosphate; purine ribonucleoside 5'-tetraphosphate	Escherichia coli metabolite; mouse metabolite
deoxyinosine	[no description available]	low	0	0	purine 2'-deoxyribonucleoside; purines 2'-deoxy-D-ribonucleoside	Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
7,8-dihydroneopterin	[no description available]	low	0	0	dihydropterin; neopterins	Escherichia coli metabolite; human metabolite; metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
deoxyinosine monophosphate	[no description available]	low	0	0	deoxyinosine phosphate; purine 2'-deoxyribonucleoside 5'-monophosphate	Escherichia coli metabolite; human metabolite; mouse metabolite; Mycoplasma genitalium metabolite
2'-deoxyinosine triphosphate	[no description available]	low	0	0	deoxyinosine phosphate; purine 2'-deoxyribonucleoside 5'-triphosphate	Escherichia coli metabolite; mouse metabolite
gdp-4-keto-6-deoxymannose	[no description available]	low	0	0	GDP-sugar	Escherichia coli metabolite; mouse metabolite
guanosine diphosphate mannose	[no description available]	low	0	0	GDP-D-mannose	Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite
guanosine pentaphosphate	[no description available]	low	0	0	guanosine 5'-phosphate; guanosine bisphosphate	Escherichia coli metabolite; mouse metabolite
queuine	[no description available]	low	0	0	pyrrolopyrimidine	Escherichia coli metabolite
3'-guanylic acid	[no description available]	low	0	0	guanosine 3'-phosphate; purine ribonucleoside 3'-monophosphate	Escherichia coli metabolite
2',3'-cyclic gmp	[no description available]	low	0	0	2',3'-cyclic purine nucleotide	Escherichia coli metabolite
leucovorin	[no description available]	low	0	0	formyltetrahydrofolic acid	Escherichia coli metabolite; mouse metabolite
5,10-methenyltetrahydrofolate	[no description available]	low	0	0	methylenetetrahydrofolic acid	Escherichia coli metabolite; mouse metabolite
10-formyltetrahydrofolate	[no description available]	low	0	0	formyltetrahydrofolic acid	Escherichia coli metabolite; mouse metabolite
colibactin	[no description available]	low	0	0	1,3-thiazoles; azaspiro compound; polyketide; pyrroline; secondary carboxamide	alkylating agent; carcinogenic agent; Escherichia coli metabolite; genotoxin
alpha-hydroxyglutarate	[no description available]	low	0	0	2-hydroxydicarboxylic acid; dicarboxylic fatty acid	metabolite; mouse metabolite
alpha-ketoadipic acid	[no description available]	low	0	0	oxo dicarboxylic acid	human urinary metabolite; mouse metabolite
3-hydroxyanthranilic acid	[no description available]	low	0	0	aminobenzoic acid; monohydroxybenzoic acid	human metabolite; mouse metabolite
4-hydroxybenzaldehyde	[no description available]	low	0	0	hydroxybenzaldehyde	EC 1.14.17.1 (dopamine beta-monooxygenase) inhibitor; mouse metabolite; plant metabolite
4-hydroxyphenylacetic acid	[no description available]	low	0	0	monocarboxylic acid; phenols	fungal metabolite; human metabolite; mouse metabolite; plant metabolite
isocaproaldehyde	[no description available]	low	0	0	alpha-CH2-containing aldehyde	human metabolite; mouse metabolite
ethylene glycol	[no description available]	low	0	0	ethanediol; glycol	metabolite; mouse metabolite; solvent; toxin
allantoic acid	[no description available]	low	0	0	ureas	mouse metabolite; plant metabolite
anthranilic acid	[no description available]	low	0	0	aminobenzoic acid	human metabolite; mouse metabolite
hydrobromic acid	[no description available]	low	0	0	gas molecular entity; hydrogen halide; mononuclear parent hydride	mouse metabolite
1-butanol	[no description available]	low	0	0	alkyl alcohol; primary alcohol; short-chain primary fatty alcohol	human metabolite; mouse metabolite; protic solvent
carnitine	[no description available]	low	0	0	amino-acid betaine	human metabolite; mouse metabolite
hydrochloric acid	[no description available]	low	0	0	chlorine molecular entity; gas molecular entity; hydrogen halide; mononuclear parent hydride	mouse metabolite
aminoethylphosphonic acid	[no description available]	low	0	0	phosphonic acids; primary amino compound; zwitterion	human metabolite; metabolite; mouse metabolite
1,2-dihydroxy-1,2-dihydronaphthalene	[no description available]	low	0	0	dihydronaphthalenes; naphthalenediols	bacterial xenobiotic metabolite; mouse metabolite
4-nitrophenylphosphate	[no description available]	low	0	0	aryl phosphate	mouse metabolite
trimethylenediamine	[no description available]	low	0	0	alkane-alpha,omega-diamine	human metabolite; mouse metabolite; reagent
n(1)-methylnicotinamide	[no description available]	low	0	0	pyridinium ion	algal metabolite; anti-inflammatory agent; human urinary metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
phosphonoacetaldehyde	[no description available]	low	0	0	phosphonic acids	mouse metabolite
gamma-guanidinobutyric acid	[no description available]	low	0	0	guanidines; monocarboxylic acid; zwitterion	fungal metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
alpha-keto-delta-guanidinovaleric acid	[no description available]	low	0	0	2-oxo monocarboxylic acid; zwitterion	human metabolite; mouse metabolite
diethyl phosphate	[no description available]	low	0	0	dialkyl phosphate	human xenobiotic metabolite; mouse metabolite
o,o-diethyl phosphorothionate	[no description available]	low	0	0	organic thiophosphate	human xenobiotic metabolite; mouse metabolite
dihydrolipoamide	[no description available]	low	0	0	dithiol; monocarboxylic acid amide	cofactor; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
dimethylglycine	[no description available]	low	0	0	amino acid zwitterion; N-methyl-amino acid; N-methylglycines	Daphnia magna metabolite; human metabolite; mouse metabolite
glycocyamine	[no description available]	low	0	0	guanidinoacetic acids; zwitterion	bacterial metabolite; human metabolite; mouse metabolite; nutraceutical; rat metabolite
carbonic acid	[no description available]	low	0	0	carbon oxoacid; chalcocarbonic acid	mouse metabolite
hydantoin-5-propionic acid	[no description available]	low	0	0	imidazolidine-2,4-dione; monocarboxylic acid	metabolite; mouse metabolite
indole-3-acetaldehyde	[no description available]	low	0	0	indoleacetaldehyde	bacterial metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
indoleacetic acid	[no description available]	low	0	0	indole-3-acetic acids; monocarboxylic acid	auxin; human metabolite; mouse metabolite; plant hormone; plant metabolite
lactaldehyde	[no description available]	low	0	0	hydroxyaldehyde; propanals	mouse metabolite
melatonin	[no description available]	low	0	0	acetamides; tryptamines	anticonvulsant; central nervous system depressant; geroprotector; hormone; human metabolite; immunological adjuvant; mouse metabolite; radical scavenger
n-acetylserotonin	[no description available]	low	0	0	acetamides; N-acylserotonin; phenols	antioxidant; human metabolite; mouse metabolite; tropomyosin-related kinase B receptor agonist
naphthalene	[no description available]	low	0	0	naphthalenes; ortho-fused bicyclic arene	apoptosis inhibitor; carcinogenic agent; environmental contaminant; mouse metabolite; plant metabolite; volatile oil component
hydroxide ion	[no description available]	low	0	0	oxygen hydride	mouse metabolite
4-nitrophenol	[no description available]	low	0	0	4-nitrophenols	human xenobiotic metabolite; mouse metabolite
hexadecanal	[no description available]	low	0	0	2,3-saturated fatty aldehyde; long-chain fatty aldehyde	human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
parathion	[no description available]	low	0	0	C-nitro compound; organic thiophosphate; organothiophosphate insecticide	acaricide; agrochemical; avicide; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; mouse metabolite
phenanthrene	[no description available]	low	0	0	ortho-fused polycyclic arene; ortho-fused tricyclic hydrocarbon; phenanthrenes	environmental contaminant; mouse metabolite
phenol	[no description available]	low	0	0	phenols	antiseptic drug; disinfectant; human xenobiotic metabolite; mouse metabolite
phosphorylethanolamine	[no description available]	low	0	0	phosphoethanolamine; primary amino compound	algal metabolite; human metabolite; mouse metabolite
propylene glycol	[no description available]	low	0	0	glycol; propane-1,2-diols	allergen; human xenobiotic metabolite; mouse metabolite; protic solvent
tryptamine	[no description available]	low	0	0	aminoalkylindole; aralkylamino compound; indole alkaloid; tryptamines	human metabolite; mouse metabolite; plant metabolite
perillic acid	[no description available]	low	0	0	alpha,beta-unsaturated monocarboxylic acid; cyclohexenecarboxylic acid	antineoplastic agent; human metabolite; mouse metabolite
homovanillic acid	[no description available]	low	0	0	guaiacols; monocarboxylic acid	human metabolite; mouse metabolite
hydroxyindoleacetic acid	[no description available]	low	0	0	indole-3-acetic acids	drug metabolite; human metabolite; mouse metabolite
5-methoxytryptamine	[no description available]	low	0	0	aromatic ether; primary amino compound; tryptamines	5-hydroxytryptamine 2A receptor agonist; 5-hydroxytryptamine 2B receptor agonist; 5-hydroxytryptamine 2C receptor agonist; antioxidant; cardioprotective agent; human metabolite; mouse metabolite; neuroprotective agent; radiation protective agent; serotonergic agonist
6-hydroxymelatonin	[no description available]	low	0	0	acetamides; tryptamines	metabolite; mouse metabolite
adrenic acid	[no description available]	low	0	0	docosatetraenoic acid	mouse metabolite
benzo(a)pyrene	[no description available]	low	0	0	ortho- and peri-fused polycyclic arene	carcinogenic agent; mouse metabolite
chloral hydrate	[no description available]	low	0	0	aldehyde hydrate; ethanediol; organochlorine compound	general anaesthetic; mouse metabolite; sedative; xenobiotic
2,5-dihydroxybenzoic acid	[no description available]	low	0	0	dihydroxybenzoic acid	EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; fungal metabolite; human metabolite; MALDI matrix material; mouse metabolite
tele-methylhistamine	[no description available]	low	0	0	imidazoles; primary amino compound	human metabolite; mouse metabolite
1,7-dimethylxanthine	[no description available]	low	0	0	dimethylxanthine	central nervous system stimulant; human blood serum metabolite; human xenobiotic metabolite; mouse metabolite
theobromine	[no description available]	low	0	0	dimethylxanthine	adenosine receptor antagonist; bronchodilator agent; food component; human blood serum metabolite; mouse metabolite; plant metabolite; vasodilator agent
estriol	[no description available]	low	0	0	16alpha-hydroxy steroid; 17beta-hydroxy steroid; 3-hydroxy steroid	estrogen; human metabolite; human xenobiotic metabolite; mouse metabolite
hydroxyproline	[no description available]	low	0	0	4-hydroxyproline; L-alpha-amino acid zwitterion	human metabolite; mouse metabolite; plant metabolite
estrone	[no description available]	low	0	0	17-oxo steroid; 3-hydroxy steroid; phenolic steroid; phenols	antineoplastic agent; bone density conservation agent; estrogen; human metabolite; mouse metabolite
androsterone	[no description available]	low	0	0	17-oxo steroid; 3alpha-hydroxy steroid; androstanoid; C19-steroid	androgen; anticonvulsant; human blood serum metabolite; human metabolite; human urinary metabolite; mouse metabolite; pheromone
etiocholanolone	[no description available]	low	0	0	17-oxo steroid; 3alpha-hydroxy steroid; androstanoid	human metabolite; mouse metabolite
dehydroepiandrosterone	[no description available]	low	0	0	17-oxo steroid; 3beta-hydroxy-Delta(5)-steroid; androstanoid	androgen; human metabolite; mouse metabolite
levodopa	[no description available]	low	0	0	amino acid zwitterion; dopa; L-tyrosine derivative; non-proteinogenic L-alpha-amino acid	allelochemical; antidyskinesia agent; antiparkinson drug; dopaminergic agent; hapten; human metabolite; mouse metabolite; neurotoxin; plant growth retardant; plant metabolite; prodrug
cysteamine	[no description available]	low	0	0	amine; thiol	geroprotector; human metabolite; mouse metabolite; radiation protective agent
androstenedione	[no description available]	low	0	0	17-oxo steroid; 3-oxo-Delta(4) steroid; androstanoid	androgen; Daphnia magna metabolite; human metabolite; mouse metabolite
1-naphthaldehyde	[no description available]	low	0	0	naphthaldehyde	mouse metabolite
2-naphthaldehyde	[no description available]	low	0	0	naphthaldehyde	mouse metabolite
17-alpha-hydroxyprogesterone	[no description available]	low	0	0	17alpha-hydroxy-C21-steroid; 17alpha-hydroxy steroid; tertiary alpha-hydroxy ketone	human metabolite; metabolite; mouse metabolite; progestin
methylamine	[no description available]	low	0	0	methylamines; one-carbon compound; primary aliphatic amine	mouse metabolite
ethylene oxide	[no description available]	low	0	0	gas molecular entity; oxacycle; saturated organic heteromonocyclic parent	allergen; mouse metabolite; mutagen
vinylidene chloride	[no description available]	low	0	0	chloroethenes	carcinogenic agent; mouse metabolite; mutagen
trichloroacetaldehyde	[no description available]	low	0	0	aldehyde; organochlorine compound	mouse metabolite
gibberellic acid	[no description available]	low	0	0	C19-gibberellin; gibberellin monocarboxylic acid; lactone; organic heteropentacyclic compound	mouse metabolite; plant metabolite
trichloroethylene	[no description available]	low	0	0	chloroethenes	inhalation anaesthetic; mouse metabolite
pyridoxic acid	[no description available]	low	0	0	hydroxymethylpyridine; methylpyridines; monohydroxypyridine; vitamin B6	human urinary metabolite; mouse metabolite
1-nitronaphthalene	[no description available]	low	0	0	mononitronaphthalene	environmental contaminant; mouse metabolite
beta-glucono-1,5-lactone	[no description available]	low	0	0	aldono-1,5-lactone; gluconolactone	animal metabolite; mouse metabolite
2-naphthoic acid	[no description available]	low	0	0	naphthoic acid	mouse metabolite; xenobiotic metabolite
methylphenyl carbinol	[no description available]	low	0	0	aromatic alcohol	mouse metabolite
4-hydroxyacetophenone	[no description available]	low	0	0	monohydroxyacetophenone	fungal metabolite; mouse metabolite; plant metabolite
styrene	[no description available]	low	0	0	styrenes; vinylarene; volatile organic compound	mouse metabolite; mutagen; plant metabolite
2-phenylacetamide	[no description available]	low	0	0	monocarboxylic acid amide	mouse metabolite
4-bromophenol	[no description available]	low	0	0	bromophenol	human urinary metabolite; human xenobiotic metabolite; marine metabolite; mouse metabolite; persistent organic pollutant; rat metabolite
ethylene dibromide	[no description available]	low	0	0	bromoalkane; bromohydrocarbon	algal metabolite; carcinogenic agent; fumigant; marine metabolite; mouse metabolite; mutagen
bromobenzene	[no description available]	low	0	0	bromoarene; bromobenzenes; volatile organic compound	hepatotoxic agent; mouse metabolite; non-polar solvent
2-heptanone	[no description available]	low	0	0	dialkyl ketone; methyl ketone	mouse metabolite; pheromone
2-naphthol	[no description available]	low	0	0	naphthol	antinematodal drug; genotoxin; human urinary metabolite; human xenobiotic metabolite; mouse metabolite; radical scavenger
pregnenolone	[no description available]	low	0	0	20-oxo steroid; 3beta-hydroxy-Delta(5)-steroid; C21-steroid	human metabolite; mouse metabolite
20-alpha-dihydroprogesterone	[no description available]	low	0	0	20-hydroxypregn-4-en-3-one	human metabolite; mouse metabolite
D-proline	[no description available]	low	0	0	D-alpha-amino acid zwitterion; D-alpha-amino acid; proline	mouse metabolite
diiodotyrosine	[no description available]	low	0	0	diiodotyrosine; L-tyrosine derivative; non-proteinogenic L-alpha-amino acid	human metabolite; mouse metabolite
paraoxon	[no description available]	low	0	0	aryl dialkyl phosphate; organophosphate insecticide	EC 3.1.1.7 (acetylcholinesterase) inhibitor; mouse metabolite
methyl-4-tyramine	[no description available]	low	0	0	tyramines	mouse metabolite
lithocholic acid	[no description available]	low	0	0	bile acid; C24-steroid; monohydroxy-5beta-cholanic acid	geroprotector; human metabolite; mouse metabolite
chenodeoxycholic acid	[no description available]	low	0	0	bile acid; C24-steroid; dihydroxy-5beta-cholanic acid	human metabolite; mouse metabolite
fructose-1,6-diphosphate	[no description available]	low	0	0	D-fructofuranose 1,6-bisphosphate	mouse metabolite
androstenediol	[no description available]	low	0	0	17beta-hydroxy steroid; 3beta-hydroxy-Delta(5)-steroid	androgen; human metabolite; mouse metabolite; radiation protective agent
18-hydroxycorticosterone	[no description available]	low	0	0	11beta-hydroxy steroid; 18-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo steroid; primary alpha-hydroxy ketone	human metabolite; mouse metabolite
1,2-dihydroxynaphthalene	[no description available]	low	0	0	naphthalenediol	mouse metabolite
2-hydroxyphenylacetic acid	[no description available]	low	0	0	hydroxy monocarboxylic acid; phenols	human metabolite; mouse metabolite
propiolaldehyde	[no description available]	low	0	0	terminal acetylenic compound; ynal	mouse metabolite
phenylphosphate	[no description available]	low	0	0	aryl phosphate	mouse metabolite
n-cyclohexylformamide	[no description available]	low	0	0	alicyclic compound; formamides	mouse metabolite
dihydroferulic acid	[no description available]	low	0	0	guaiacols; monocarboxylic acid; phenylpropanoid	antioxidant; human xenobiotic metabolite; mouse metabolite; plant metabolite
perillaldehyde	[no description available]	low	0	0	aldehyde; olefinic compound	human metabolite; mouse metabolite; volatile oil component
1-naphthalenemethanol	[no description available]	low	0	0	naphthylmethanol	mouse metabolite
hydroiodic acid	[no description available]	low	0	0	gas molecular entity; hydrogen halide; mononuclear parent hydride	mouse metabolite
iron	[no description available]	low	0	0	divalent metal cation; iron cation; monoatomic dication	cofactor; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
trichloroepoxyethane	[no description available]	low	0	0	epoxide	mouse metabolite
cyromazine	[no description available]	low	0	0	triamino-1,3,5-triazine	mouse metabolite; triazine insecticide
n-acetylaspartic acid	[no description available]	low	0	0	N-acetyl-L-amino acid; N-acyl-L-aspartic acid	antioxidant; human metabolite; mouse metabolite; nutraceutical; rat metabolite
homocitrulline	[no description available]	low	0	0	amino acid zwitterion; L-lysine derivative; non-proteinogenic L-alpha-amino acid; ureas	human metabolite; mouse metabolite
obtusifoliol	[no description available]	low	0	0	14alpha-methyl steroid; 3beta-sterol	mouse metabolite; plant metabolite
lathosterol	[no description available]	low	0	0	3beta-sterol; C27-steroid; cholestanoid; Delta(7)-sterol	human metabolite; mouse metabolite
2-methoxyestradiol	[no description available]	low	0	0	17beta-hydroxy steroid; 3-hydroxy steroid	angiogenesis modulating agent; antimitotic; antineoplastic agent; human metabolite; metabolite; mouse metabolite
cystine	[no description available]	low	0	0	cystine zwitterion; cystine; L-cysteine derivative; non-proteinogenic L-alpha-amino acid	EC 1.2.1.11 (aspartate-semialdehyde dehydrogenase) inhibitor; flour treatment agent; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
phenylacetylglycine	[no description available]	low	0	0	monocarboxylic acid amide; monocarboxylic acid; N-acylglycine	human metabolite; mouse metabolite
hordenine	[no description available]	low	0	0	phenethylamine alkaloid	human metabolite; mouse metabolite
7-methylxanthine	[no description available]	low	0	0	oxopurine; purine alkaloid	human xenobiotic metabolite; mouse metabolite; plant metabolite
glutaurine	[no description available]	low	0	0	dipeptide zwitterion; dipeptide; L-glutamine derivative; sulfonic acid	anticonvulsant; anxiolytic drug; hormone; human metabolite; mammalian metabolite; mouse metabolite
n'-methyl-2-pyridone-5-carboxamide	[no description available]	low	0	0	methylpyridines; pyridinecarboxamide; pyridone	metabolite; mouse metabolite
1-methyluric acid	[no description available]	low	0	0	oxopurine	human xenobiotic metabolite; mouse metabolite
cyclopropylamine	[no description available]	low	0	0	primary aliphatic amine	mouse metabolite
5-hydroxymethylcytosine	[no description available]	low	0	0	aminopyrimidine; aromatic primary alcohol; nucleobase analogue; pyrimidone	human metabolite; mouse metabolite
2,5-dihydroxybenzaldehyde	[no description available]	low	0	0	dihydroxybenzaldehyde	human metabolite; mouse metabolite; Penicillium metabolite
6-hydroxynicotinic acid	[no description available]	low	0	0	monohydroxypyridine	Arabidopsis thaliana metabolite; human urinary metabolite; mouse metabolite
2-naphthalenemethanol	[no description available]	low	0	0	naphthylmethanol	mouse metabolite; xenobiotic metabolite
hydroxyindoleacetaldehyde	[no description available]	low	0	0	hydroxyindoles; indoleacetaldehyde	human metabolite; mouse metabolite
xanthurenic acid 8-methyl ether	[no description available]	low	0	0	aromatic ether; monohydroxyquinoline; quinolinemonocarboxylic acid	carcinogenic agent; metabolite; mouse metabolite
glucose	[no description available]	low	0	0	D-glucopyranose	mouse metabolite
1,3,7-trimethylurate	[no description available]	low	0	0	oxopurine	human blood serum metabolite; human urinary metabolite; human xenobiotic metabolite; mouse metabolite
1-methylxanthine	[no description available]	low	0	0	1-methylxanthine	mouse metabolite
3,7-dimethyluric acid	[no description available]	low	0	0	oxopurine	metabolite; mouse metabolite
biocytin	[no description available]	low	0	0	azabicycloalkane; L-alpha-amino acid zwitterion; L-lysine derivative; monocarboxylic acid amide; non-proteinogenic L-alpha-amino acid; thiabicycloalkane; ureas	mouse metabolite
d-aspartic acid	[no description available]	low	0	0	aspartic acid; D-alpha-amino acid	mouse metabolite
3,4-dihydroxymandelic acid	[no description available]	low	0	0	2-hydroxy monocarboxylic acid; catechols	antioxidant; drug metabolite; human metabolite; mouse metabolite
17-alpha-hydroxypregnenolone	[no description available]	low	0	0	17alpha-hydroxy-C21-steroid; 17alpha-hydroxy steroid; 3beta-hydroxy-Delta(5)-steroid; hydroxypregnenolone; tertiary alpha-hydroxy ketone	human metabolite; mouse metabolite
mephentermine	[no description available]	low	0	0	2-aminooctadecane-1,3-diol	EC 2.7.11.13 (protein kinase C) inhibitor; human metabolite; mouse metabolite
3,4-dihydroxyphenylglycol	[no description available]	low	0	0	catechols; tetrol	metabolite; mouse metabolite
1,7-dimethyluric acid	[no description available]	low	0	0	oxopurine	human xenobiotic metabolite; mouse metabolite
24-methylenecholesterol	[no description available]	low	0	0	3beta-hydroxy-Delta(5)-steroid; 3beta-sterol	mouse metabolite
2,8-dihydroxyadenine	[no description available]	low	0	0	6-aminopurines; diol; heteroaryl hydroxy compound; oxopurine	human urinary metabolite; mammalian metabolite; mouse metabolite; nephrotoxic agent
5beta-pregnane-3,20-dione	[no description available]	low	0	0	20-oxo steroid; 3-oxo-5beta-steroid; C21-steroid	human metabolite; mouse metabolite
zymosterol	[no description available]	low	0	0	3beta-sterol; cholestanoid	human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
21-deoxycortisol	[no description available]	low	0	0	11beta-hydroxy steroid; 17alpha-hydroxy-C21-steroid; deoxycortisol; tertiary alpha-hydroxy ketone	human blood serum metabolite; mouse metabolite
5,6-dihydrothymine	[no description available]	low	0	0	pyrimidone	human metabolite; metabolite; mouse metabolite
imidazoleacetic acid	[no description available]	low	0	0	imidazoles; monocarboxylic acid	metabolite; mouse metabolite
1-hydroxyphenanthrene	[no description available]	low	0	0	phenanthrol	mouse metabolite
2,5-dihydroxypyridine	[no description available]	low	0	0	dihydroxypyridine	mouse metabolite
cerium	[no description available]	low	0	0	cholesteryl ester	mouse metabolite
zymostenol	[no description available]	low	0	0	3beta-sterol; cholestanoid	human metabolite; mouse metabolite
16-hydroxydehydroepiandrosterone	[no description available]	low	0	0	16alpha-hydroxy steroid; 17-oxo steroid; 3beta-hydroxy-Delta(5)-steroid; androstanoid; secondary alpha-hydroxy ketone	human metabolite; mouse metabolite
6,6-dimethyl-2-methylenebicyclo(3.1.1)heptan-3-ol	[no description available]	low	0	0	carbobicyclic compound; pinane monoterpenoid; secondary alcohol	GABA modulator; mouse metabolite; plant metabolite; volatile oil component
hydrogen sulfite	[no description available]	low	0	0	sulfur oxoanion	human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
ecgonine methyl ester	[no description available]	low	0	0	methyl ester; tertiary amino compound; tropane alkaloid	analgesic; central nervous system depressant; metabolite; mouse metabolite; opioid analgesic; peripheral nervous system drug
2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine	[no description available]	low	0	0	hydroxylamine; imidazopyridine	carcinogenic agent; genotoxin; human xenobiotic metabolite; mouse metabolite; mutagen; neurotoxin; rat metabolite
fructose 2,6-diphosphate	[no description available]	low	0	0	D-fructofuranose 2,6-bisphosphate	human metabolite; mouse metabolite
cholest-5-en-3 beta,7 alpha-diol	[no description available]	low	0	0	3beta-hydroxy-Delta(5)-steroid; 7alpha-hydroxy steroid; oxysterol	mouse metabolite
hypotaurine	[no description available]	low	0	0	aminosulfinic acid; zwitterion	human metabolite; metabolite; mouse metabolite
s-chloromethylglutathione	[no description available]	low	0	0	organochlorine compound; S-substituted glutathione	alkylating agent; bacterial xenobiotic metabolite; mouse metabolite
5-acetylamino-6-formylamino-3-methyluracil	[no description available]	low	0	0	formamidopyrimidine	mouse metabolite
anserine	[no description available]	low	0	0	beta-alanine derivative; dipeptide; zwitterion	animal metabolite; mouse metabolite
5,6-dihydroxyindole	[no description available]	low	0	0	dihydroxyindole	mouse metabolite
androsterone glucuronide	[no description available]	low	0	0	beta-D-glucosiduronic acid; steroid glucosiduronic acid	human metabolite; metabolite; mouse metabolite
estrone-3-glucuronide	[no description available]	low	0	0	17-oxo steroid; beta-D-glucosiduronic acid; steroid glucosiduronic acid	human metabolite; mouse metabolite
5,6-dihydroxy-2-indolylcarboxylic acid	[no description available]	low	0	0	dihydroxyindole	mouse metabolite
(20s)-20-hydroxycholesterol	[no description available]	low	0	0	20-hydroxy steroid; 3beta-hydroxy-Delta(5)-steroid; oxysterol	human metabolite; mouse metabolite
24-hydroxycholesterol	[no description available]	low	0	0	24-hydroxycholesterol	biomarker; human blood serum metabolite; mouse metabolite
phytosphingosine	[no description available]	low	0	0	amino alcohol; sphingoid; triol	mouse metabolite; Saccharomyces cerevisiae metabolite
n-acetylputrescine	[no description available]	low	0	0	N-monoacetylalkane-alpha,omega-diamine; N-substituted putrescine	metabolite; mouse metabolite
cdp ethanolamine	[no description available]	low	0	0	nucleotide-(amino alcohol)s; phosphoethanolamine	mouse metabolite
7 alpha-hydroxy-4-cholesten-3-one	[no description available]	low	0	0	3-oxo-Delta(4) steroid; 7alpha-hydroxy steroid; cholestanoid	human metabolite; mouse metabolite
27-hydroxycholesterol	[no description available]	low	0	0	26-hydroxycholesterol	apoptosis inducer; human metabolite; mouse metabolite; neuroprotective agent
dehydroalanine	[no description available]	low	0	0	2,3-dehydroamino acid; alpha,beta-unsaturated monocarboxylic acid; amino acid zwitterion; enamine; non-proteinogenic alpha-amino acid	alkylating agent; human metabolite; mouse metabolite
1-myristoyl-2-palmitoyl-sn-glycero-3-phosphocholine	[no description available]	low	0	0	1-acyl-2-hexadecanoyl-sn-glycero-3-phosphocholine; phosphatidylcholine 30:0; tetradecanoate ester	mouse metabolite
d-glutamine	[no description available]	low	0	0	amino acid zwitterion; D-alpha-amino acid; glutamine	mouse metabolite
19-hydroxytestosterone	[no description available]	low	0	0	17beta-hydroxy steroid; 19-hydroxy steroid; 3-oxo-Delta(4) steroid	mouse metabolite
2-hydroxy-1,4-benzoquinone	[no description available]	low	0	0	monohydroxy-1,4-benzoquinones	mouse metabolite
3,4-dihydroxyphenylglycolaldehyde	[no description available]	low	0	0	catechols; hydroxyaldehyde	human metabolite; mouse metabolite; neurotoxin
androsterone sulfate	[no description available]	low	0	0	17-oxo steroid; androstanoid; steroid sulfate	human metabolite; mouse metabolite
3,7,12-trihydroxycoprostane	[no description available]	low	0	0	12alpha-hydroxy steroid; 3alpha-hydroxy steroid; 7alpha-hydroxy steroid	human metabolite; mouse metabolite
saccharopine	[no description available]	low	0	0	amino acid opine; L-lysine derivative	human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
allysine	[no description available]	low	0	0	allysine; amino acid zwitterion; aminoadipate semialdehyde; non-proteinogenic L-alpha-amino acid	human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
beta-ureidoisobutyric acid	[no description available]	low	0	0	ureidocarboxylic acid	human metabolite; mouse metabolite
kynurenine	[no description available]	low	0	0	amino acid zwitterion; kynurenine; non-proteinogenic L-alpha-amino acid	human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
hydromethylthionine	[no description available]	low	0	0	aromatic amine; phenothiazines; tertiary amino compound	bacterial xenobiotic metabolite; fluorochrome; mouse metabolite; rat metabolite
5-hydroxykynuramine	[no description available]	low	0	0	hydroxykynurenamine; primary amino compound	mouse metabolite
thiocysteine	[no description available]	low	0	0	amino acid zwitterion; S-substituted L-cysteine	human metabolite; mouse metabolite
isovaleryl-coenzyme a	[no description available]	low	0	0	methylbutanoyl-CoA; short-chain fatty acyl-CoA	mouse metabolite
4,4-dimethyl-5-alpha-cholesta-(8,24)-dien-3-beta-ol	[no description available]	low	0	0	3beta-sterol	human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
campesterol	[no description available]	low	0	0	3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; C28-steroid; phytosterols	mouse metabolite
cholestane-3,7,12,26-tetrol	[no description available]	low	0	0	12alpha-hydroxy steroid; 26-hydroxy steroid; 3alpha-hydroxy steroid; 7alpha-hydroxy steroid	human metabolite; mouse metabolite
cholic acid	[no description available]	low	0	0	12alpha-hydroxy steroid; 3alpha-hydroxy steroid; 7alpha-hydroxy steroid; bile acid; C24-steroid; trihydroxy-5beta-cholanic acid	human metabolite; mouse metabolite
sitosterol, (3beta)-isomer	[no description available]	low	0	0	3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; C29-steroid; phytosterols; stigmastane sterol	anticholesteremic drug; antioxidant; mouse metabolite; plant metabolite; sterol methyltransferase inhibitor
cortisone	[no description available]	low	0	0	11-oxo steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; C21-steroid; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone	human metabolite; mouse metabolite
androstane-3,17-dione, (5alpha)-isomer	[no description available]	low	0	0	3-oxo-5alpha-steroid; androstane-3,17-dione	mouse metabolite
cholesteryl palmitate	[no description available]	low	0	0	cholesteryl ester	human metabolite; mouse metabolite
lanosterol	[no description available]	low	0	0	14alpha-methyl steroid; 3beta-sterol; tetracyclic triterpenoid	bacterial metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
21-hydroxypregnenolone	[no description available]	low	0	0	21-hydroxy steroid; hydroxypregnenolone; primary alpha-hydroxy ketone	mouse metabolite
2-hydroxyestradiol	[no description available]	low	0	0	17beta-hydroxy steroid; 2-hydroxy steroid	carcinogenic agent; human metabolite; metabolite; mouse metabolite; prodrug
epietiocholanolone	[no description available]	low	0	0	17-oxo steroid; 3beta-hydroxy steroid; androstanoid	androgen; animal metabolite; human blood serum metabolite; mouse metabolite; rat metabolite
5-hydroxyisourate	[no description available]	low	0	0	oxopurine	human metabolite; mouse metabolite
19-hydroxy-4-androstene-3,17-dione	[no description available]	low	0	0	17-oxo steroid; 19-hydroxy steroid; 3-oxo steroid; androstanoid	mouse metabolite
glyceraldehyde 3-phosphate	[no description available]	low	0	0	glyceraldehyde 3-phosphate	mouse metabolite
isomaltose	[no description available]	low	0	0	glycosylglucose	human metabolite; metabolite; mouse metabolite
n-acetylneuraminic acid	[no description available]	low	0	0	N-acetylneuraminic acids	antioxidant; bacterial metabolite; EC 3.2.1.18 (exo-alpha-sialidase) inhibitor; human metabolite; mouse metabolite
carnosine	[no description available]	low	0	0	amino acid zwitterion; dipeptide	anticonvulsant; antineoplastic agent; antioxidant; Daphnia magna metabolite; geroprotector; human metabolite; mouse metabolite; neuroprotective agent
5-hydroxytryptophan	[no description available]	low	0	0	5-hydroxytryptophan; amino acid zwitterion; hydroxy-L-tryptophan; non-proteinogenic L-alpha-amino acid	human metabolite; mouse metabolite; plant metabolite
dopaquinone	[no description available]	low	0	0	1,2-benzoquinones; amino acid zwitterion; L-phenylalanine derivative	human metabolite; mouse metabolite
pantetheine	[no description available]	low	0	0	pantetheines; thiol	human metabolite; metabolite; mouse metabolite
galactose	[no description available]	low	0	0	D-galactopyranose	epitope; mouse metabolite
galactose	[no description available]	low	0	0	D-galactopyranose	mouse metabolite
5-diphosphomevalonic acid	[no description available]	low	0	0	carboxyalkyl phosphate	human metabolite; mouse metabolite
7-dehydrocholesterol	[no description available]	low	0	0	3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; cholestanoid; Delta(5),Delta(7)-sterol	human metabolite; mouse metabolite
stachyose	[no description available]	low	0	0	raffinose family oligosaccharide; tetrasaccharide	mouse metabolite; plant metabolite
desmosterol	[no description available]	low	0	0	3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; C27-steroid; cholestanoid	human metabolite; mouse metabolite
monoiodotyrosine	[no description available]	low	0	0	amino acid zwitterion; L-tyrosine derivative; monoiodotyrosine; non-proteinogenic L-alpha-amino acid	EC 1.14.16.2 (tyrosine 3-monooxygenase) inhibitor; human metabolite; mouse metabolite
n'-formylkynurenine	[no description available]	low	0	0	amino acid zwitterion; N-formylkynurenine; non-proteinogenic amino acid derivative; non-proteinogenic L-alpha-amino acid	human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
ketodihydrosphingosine	[no description available]	low	0	0	2-amino-1-hydroxyoctadecan-3-one	mouse metabolite
nicotinamide-beta-riboside	[no description available]	low	0	0	N-glycosylnicotinamide; pyridine nucleoside	geroprotector; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
androstane-3,17-dione, (5beta)-isomer	[no description available]	low	0	0	3-oxo-5beta-steroid; androstane-3,17-dione	mouse metabolite
trimethyllysine	[no description available]	low	0	0	alpha-amino-acid cation	human metabolite; mouse metabolite
inositol 3,4-bisphosphate	[no description available]	low	0	0	myo-inositol bisphosphate	human metabolite; mouse metabolite
24,25-dihydrolanosterol	[no description available]	low	0	0	3beta-sterol; tetracyclic triterpenoid	human metabolite; mouse metabolite
2-methoxyestrone	[no description available]	low	0	0	17-oxo steroid; 3-hydroxy steroid; alicyclic ketone; aromatic ether; phenolic steroid; phenols	human metabolite; mouse metabolite
dehydroascorbic acid	[no description available]	low	0	0	dehydroascorbic acid; vitamin C	coenzyme; mouse metabolite
cortodoxone	[no description available]	low	0	0	deoxycortisol; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone	human metabolite; mouse metabolite
estradiol-3-glucuronide	[no description available]	low	0	0	17beta-hydroxy steroid; beta-D-glucosiduronic acid; steroid glucosiduronic acid	human metabolite; mouse metabolite
beta-sulfopyruvic acid	[no description available]	low	0	0	carboxyalkanesulfonic acid	mouse metabolite
acetyl adenylate	[no description available]	low	0	0	5'-acylphosphoadenosin	human metabolite; mouse metabolite
2-hydroxypropylphosphonic acid	[no description available]	low	0	0	phosphonic acids; secondary alcohol	mouse metabolite
4,4-dimethylcholesta-8,14,24-trienol	[no description available]	low	0	0	3beta-sterol; Delta(14) steroid	human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
inositol-1,4,5,6-tetrakisphosphate	[no description available]	low	0	0	myo-inositol tetrakisphosphate	mouse metabolite
maleic acid	[no description available]	low	0	0	butenedioic acid	algal metabolite; mouse metabolite; plant metabolite
prostaglandin h2	[no description available]	low	0	0	olefinic compound; oxylipin; prostaglandins H; secondary alcohol	mouse metabolite
3-hydroxy-3-methylglutaryl-coenzyme a	[no description available]	low	0	0	3-hydroxy-3-methylglutaryl-CoA; 3-hydroxy fatty acyl-CoA	human metabolite; mouse metabolite
retinol	[no description available]	low	0	0	retinol; vitamin A	human metabolite; mouse metabolite; plant metabolite
docosahexaenoate	[no description available]	low	0	0	docosahexaenoic acid; omega-3 fatty acid	algal metabolite; antineoplastic agent; Daphnia tenebrosa metabolite; human metabolite; mouse metabolite; nutraceutical
eicosapentaenoic acid	[no description available]	low	0	0	icosapentaenoic acid; omega-3 fatty acid	anticholesteremic drug; antidepressant; antineoplastic agent; Daphnia galeata metabolite; fungal metabolite; micronutrient; mouse metabolite; nutraceutical
geranylgeranyl pyrophosphate	[no description available]	low	0	0	geranylgeranyl diphosphate	mouse metabolite
colfosceril palmitate	[no description available]	low	0	0	1-acyl-2-hexadecanoyl-sn-glycero-3-phosphocholine; phosphatidylcholine 32:0	mouse metabolite; surfactant
lyso-pc	[no description available]	low	0	0	1-O-acyl-sn-glycero-3-phosphocholine; lysophosphatidylcholine 16:0	mouse metabolite
trans-4-coumaric acid	[no description available]	low	0	0	4-coumaric acid	food component; mouse metabolite; plant metabolite
retinaldehyde	[no description available]	low	0	0	retinal; vitamin A	gap junctional intercellular communication inhibitor; human metabolite; mouse metabolite
squalene	[no description available]	low	0	0	triterpene	human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
flavin mononucleotide	[no description available]	low	0	0	flavin mononucleotide; vitamin B2	bacterial metabolite; coenzyme; cofactor; human metabolite; mouse metabolite
3-hydroxybutyryl-coenzyme a	[no description available]	low	0	0	3-hydroxyacyl-CoA; hydroxybutanoyl-CoA	mouse metabolite
dihydrosphingosine 1-phosphate	[no description available]	low	0	0	sphingoid 1-phosphate	mouse metabolite
caffeic acid	[no description available]	low	0	0	caffeic acid	geroprotector; mouse metabolite
coniferyl alcohol	[no description available]	low	0	0	guaiacols; phenylpropanoid	animal metabolite; monolignol; mouse metabolite; pheromone; plant metabolite; volatile oil component
estrone sulfate	[no description available]	low	0	0	17-oxo steroid; steroid sulfate	human metabolite; mouse metabolite
raphanusamic acid	[no description available]	low	0	0	thiazolidinemonocarboxylic acid	Arabidopsis thaliana metabolite; mouse metabolite; xenobiotic metabolite
isobutyryl-coenzyme a	[no description available]	low	0	0	methyl-branched fatty acyl-CoA; short-chain fatty acyl-CoA	human metabolite; mouse metabolite
dihydroxycoprostane	[no description available]	low	0	0	3alpha-hydroxy steroid; 7alpha-hydroxy steroid	human metabolite; mouse metabolite
glutaryl-coenzyme a	[no description available]	low	0	0	glutaryl-CoAs	mouse metabolite
leukotriene a4	[no description available]	low	0	0	epoxy fatty acid; leukotriene; long-chain fatty acid; oxylipin; polyunsaturated fatty acid	human metabolite; mouse metabolite; plant metabolite
calcitriol	[no description available]	low	0	0	D3 vitamins; hydroxycalciol; triol	antineoplastic agent; antipsoriatic; bone density conservation agent; calcium channel agonist; calcium channel modulator; hormone; human metabolite; immunomodulator; metabolite; mouse metabolite; nutraceutical
beta carotene	[no description available]	low	0	0	carotenoid beta-end derivative; cyclic carotene	antioxidant; biological pigment; cofactor; ferroptosis inhibitor; human metabolite; mouse metabolite; plant metabolite; provitamin A
leukotriene c4	[no description available]	low	0	0	leukotriene	bronchoconstrictor agent; human metabolite; mouse metabolite
15-hydroxy-5,8,11,13-eicosatetraenoic acid	[no description available]	low	0	0	(5Z,8Z,11Z,13E)-15-HETE	human metabolite; mouse metabolite
5-hydroxy-6,8,11,14-eicosatetraenoic acid	[no description available]	low	0	0	HETE	human metabolite; mouse metabolite
arachidonic acid 5-hydroperoxide	[no description available]	low	0	0	5-HPETE	mouse metabolite
prostaglandin g2	[no description available]	low	0	0	prostaglandins G	human metabolite; mouse metabolite
arachidonic acid omega-9 hydroperoxide	[no description available]	low	0	0	HPETE	mouse metabolite
15-hydroperoxy-5,8,11,13-eicosatetraenoic acid, (s)-(e,z,z,z)-isomer	[no description available]	low	0	0	15-HPETE	mouse metabolite
gamma-linolenic acid	[no description available]	low	0	0	linolenic acid; omega-6 fatty acid	human metabolite; mouse metabolite; plant metabolite
alpha-linolenic acid	[no description available]	low	0	0	linolenic acid; omega-3 fatty acid	micronutrient; mouse metabolite; nutraceutical
1-palmitoyl-2-oleoyl-sn-glycerol	[no description available]	low	0	0	1,2-diacyl-sn-glycerol; 1-palmitoyl-2-oleoylglycerol	mouse metabolite
epoprostenol	[no description available]	low	0	0	prostaglandins I	mouse metabolite
9-hydroxy-10,12-octadecadienoic acid	[no description available]	low	0	0	HODE; octadecadienoic acid	human metabolite; metabolite; mouse metabolite; plant metabolite
thromboxane b3	[no description available]	low	0	0	thromboxanes B	human metabolite; mouse metabolite
11,12-dihydroxyeicosatrienoic acid	[no description available]	low	0	0	DHET	mouse metabolite
14,15-dihydroxyeicosatrienoic acid	[no description available]	low	0	0	DHET; diol; secondary allylic alcohol	mouse metabolite
5-oxo-6,8,11,14-eicosatetraenoic acid	[no description available]	low	0	0	oxoicosatetraenoic acid	human metabolite; immunomodulator; mouse metabolite
5,6-epoxy-8,11,14-eicosatrienoic acid	[no description available]	low	0	0	EET	mouse metabolite
8,9-epoxyeicosatrienoic acid	[no description available]	low	0	0	EET	mouse metabolite
1-palmitoyl-2-oleoylphosphatidylethanolamine, (z & r)-isomer	[no description available]	low	0	0	1,2-diacyl-sn-glycero-3-phosphoethanolamine; phosphatidylethanolamine 34:1 zwitterion; phosphatidylethanolamine	mouse metabolite
cholesteryl oleate	[no description available]	low	0	0	CE(18:1); cholesteryl octadec-9-enoate	mouse metabolite
calcifediol	[no description available]	low	0	0	D3 vitamins; diol; hydroxycalciol	bone density conservation agent; human metabolite; metabolite; mouse metabolite; nutraceutical
hyodeoxycholic acid	[no description available]	low	0	0	5beta-cholanic acids; 6alpha,20xi-murideoxycholic acid; bile acid; C24-steroid	human metabolite; mouse metabolite
cerium	[no description available]	low	0	0	CE(18:2); cholesteryl octadeca-9,12-dienoate	human metabolite; mouse metabolite
11-dehydrocorticosterone	[no description available]	low	0	0	11-oxo steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; corticosteroid; primary alpha-hydroxy ketone	human metabolite; mouse metabolite
stearidonic acid	[no description available]	low	0	0	long-chain fatty acid; octadecatetraenoic acid; omega-3 fatty acid	Daphnia galeata metabolite; mouse metabolite; plant metabolite
trilinolein	[no description available]	low	0	0	1,2-diacyl-3-linoleoylglycerol; 1,3-diacyl-2-linoleoylglycerol; linoleoyl containing 1,2,3-triacyl-sn-glycerol; TG(18:2/18:2/18:2); triglyceride	mouse metabolite
dimyristoylphosphatidylcholine	[no description available]	low	0	0	1,2-diacyl-sn-glycero-3-phosphocholine; phosphatidylcholine 28:0; tetradecanoate ester	antigen; mouse metabolite
2,3-oxidosqualene	[no description available]	low	0	0	2,3-epoxysqualene	human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
deoxyribose	[no description available]	low	0	0	deoxypentose	human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
monodehydroascorbate	[no description available]	low	0	0	organic radical	mouse metabolite
vitamin a2	[no description available]	low	0	0	retinoid; vitamin A	human xenobiotic metabolite; marine xenobiotic metabolite; mouse metabolite
1,2-dioleoylphosphatidylserine	[no description available]	low	0	0	phosphatidylserine(18:1/18:1)	mouse metabolite
5-hydroxy-6,8,11,14,17-eicosapentaenoic acid	[no description available]	low	0	0	HEPE	mouse metabolite
1-stearoyl-2-linoleoylphosphatidylcholine	[no description available]	low	0	0	phosphatidylcholine 36:2	mouse metabolite
1-stearoyl-2-linoleoyl-sn-glycerol	[no description available]	low	0	0	1,2-diacyl-sn-glycerol; diacylglycerol 36:2	mouse metabolite
1-palmitoyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine	[no description available]	low	0	0	phosphatidylcholine 38:6	mouse metabolite
13(S)-HODE	[no description available]	low	0	0	HODE	antineoplastic agent; human xenobiotic metabolite; mouse metabolite
1-stearoyl-2-oleoyl-sn-glycerol	[no description available]	low	0	0	1,2-diacyl-sn-glycerol; 1-stearoyl-2-oleoylglycerol; diacylglycerol 36:1	mouse metabolite
1-palmitoyl-2-palmitoleoyl-sn-glycero-3-phosphocholine	[no description available]	low	0	0	1-acyl-2-palmitoleoyl-sn-glycero-3-phosphocholine; phosphatidylcholine 32:1	mouse metabolite
13-oxo-9,11-octadecadienoic acid	[no description available]	low	0	0	13-oxo-9,11-octadecadienoic acid	metabolite; mouse metabolite
n-stearoylsphingomyelin	[no description available]	low	0	0	sphingomyelin 36:1; sphingomyelin d18:1	mouse metabolite
20,22-dihydroxycholesterol	[no description available]	low	0	0	20-hydroxy steroid; 22-hydroxy steroid; 3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; cholestanoid; oxysterol	human metabolite; mouse metabolite
cholesteryl arachidonate	[no description available]	low	0	0	cholesteryl icosatetraenoate	antibacterial agent; mouse metabolite
acryloyl-coenzyme a	[no description available]	low	0	0	2-enoyl-CoA; monounsaturated fatty acyl-CoA	mouse metabolite
samarium	[no description available]	low	0	0	sphingomyelin d18:1/16:0	mouse metabolite
n-palmitoylgalactosylsphingosine	[no description available]	low	0	0	HexCer(d18:1/16:0); N-acyl-beta-D-galactosylsphingosine	mouse metabolite
cytidine diphosphate choline	[no description available]	low	0	0	nucleotide-(amino alcohol)s; phosphocholines	human metabolite; mouse metabolite; neuroprotective agent; psychotropic drug; Saccharomyces cerevisiae metabolite
palmitoylcarnitine	[no description available]	low	0	0	O-palmitoylcarnitine; saturated fatty acyl-L-carnitine	EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor; human metabolite; mouse metabolite
prosomatostatin	[no description available]	low	0	0	heterodetic cyclic peptide; peptide hormone	fungal metabolite; mouse metabolite; rat metabolite
phosphatidylcholines	[no description available]	low	0	0	phosphatidylcholine 40:6	mouse metabolite
2-ketoarginine	[no description available]	low	0	0	2-oxo monocarboxylic acid; zwitterion	human metabolite; mouse metabolite
cyclosporine	[no description available]	low	0	0	keto-disaccharide	mouse metabolite
g(m3) ganglioside	[no description available]	low	0	0	alpha-N-acetylneuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide; sialodiosylceramide; sialotriaosylceramide	mouse metabolite
dyspropterin	[no description available]	low	0	0	biopterins; tetrahydropterin	human metabolite; metabolite; mouse metabolite

Article	Year
The Chinese patent medicine Tongfengding capsule for gout in adults: a systematic review of safety and effectiveness. Advances in rheumatology (London, England), 07-18, Volume: 63, Issue: 1	2023
Origin of pyrimidine deoxyribonucleotide pools in perfused rat heart: implications for 3'-azido-3'-deoxythymidine-dependent cardiotoxicity. The Biochemical journal, Aug-27, Volume: 422, Issue: 3	2009
Validity and safety of sputum induction by inhaled uridine 5'-triphosphate. American journal of respiratory and critical care medicine, Aug-01, Volume: 164, Issue: 3	2001
Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells. Oncology research, Volume: 9, Issue: 2	1997
Acute safety and effects on mucociliary clearance of aerosolized uridine 5'-triphosphate +/- amiloride in normal human adults. American journal of respiratory and critical care medicine, Volume: 154, Issue: 1	1996
Modulation of metabolism and cytotoxicity of cytosine arabinoside with N-(phosphon)-acetyl-L-aspartate in human leukemic blast cells and cell lines. Leukemia research, Volume: 20, Issue: 2	1996
Differentially potentiating effects by dipyridamole on cytotoxicity of 5-fluorouracil against three human maxillary cancer cell lines derived from a single tumor. Anti-cancer drug design, Volume: 8, Issue: 4	1993
Enhanced cytotoxicity with interleukin-1 alpha and 5-fluorouracil in HCT116 colon cancer cells. Oncology research, Volume: 6, Issue: 12	1994
Cytotoxicity and metabolism of 4-methoxy-8-(beta-D-ribofuranosylamino)pyrimido[5,4-d]pyrimidine in HCT 116 colon cancer cells. Biochemical pharmacology, Nov-29, Volume: 48, Issue: 11	1994
Multiple mechanisms of adenosine toxicity in an adenosine sensitive mutant of baby hamster kidney (BHK) cells. Basic life sciences, Volume: 31	1985
Toxicity of D-galactosamine for rat hepatocytes in monolayer culture. Experimental and molecular pathology, Volume: 42, Issue: 1	1985
Prediction of 5-fluorouracil cytotoxicity towards the Walker carcinosarcoma using peak integrals of fluoronucleotides measured by MRS in vivo. British journal of cancer, Volume: 60, Issue: 3	1989
Identification of 6-azauridine triphosphate in L1210 cells and its possible relevance to cytotoxicity. Cancer research, Jan-15, Volume: 49, Issue: 2	1989
Galactosamine hepatotoxicity: effect of galactosamine on glutathione resynthesis in rat primary hepatocyte cultures. Toxicology and applied pharmacology, Volume: 115, Issue: 2	1992
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Article	Year
Population Pharmacokinetics of Intracellular 5-Fluorouridine 5'-Triphosphate and its Relationship with Hand-and-Foot Syndrome in Patients Treated with Capecitabine. The AAPS journal, 01-08, Volume: 23, Issue: 1	2021
Intracellular pharmacokinetics of gemcitabine, its deaminated metabolite 2',2'-difluorodeoxyuridine and their nucleotides. British journal of clinical pharmacology, Volume: 84, Issue: 6	2018
Exploring the intracellular pharmacokinetics of the 5-fluorouracil nucleotides during capecitabine treatment. British journal of clinical pharmacology, Volume: 81, Issue: 5	2016
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature, Sep-10, Volume: 461, Issue: 7261	2009
Uridine 5'-triphosphate stimulates alveolar fluid clearance in the isolated rat lungs. Journal of pharmacological sciences, Volume: 95, Issue: 4	2004
Nucleotide-mediated inhibition of alveolar fluid clearance in BALB/c mice after respiratory syncytial virus infection. American journal of physiology. Lung cellular and molecular physiology, Volume: 286, Issue: 1	2004
P2Y(2) receptor agonists: a new class of medication targeted at improved mucociliary clearance. Chest, Volume: 121, Issue: 5 Suppl	2002
Effect of aerosolized uridine 5'-triphosphate on mucociliary clearance in mild chronic bronchitis. American journal of respiratory and critical care medicine, Jul-15, Volume: 164, Issue: 2	2001
Aerosolization of P2Y(2)-receptor agonists enhances mucociliary clearance in sheep. Journal of applied physiology (Bethesda, Md. : 1985), Volume: 87, Issue: 6	1999
Potentiation of regulatory volume decrease by P2U purinoceptors in HSG-PA cells. The American journal of physiology, Volume: 270, Issue: 1 Pt 1	1996
Acute safety and effects on mucociliary clearance of aerosolized uridine 5'-triphosphate +/- amiloride in normal human adults. American journal of respiratory and critical care medicine, Volume: 154, Issue: 1	1996
Effect of uridine 5'-triphosphate plus amiloride on mucociliary clearance in adult cystic fibrosis. American journal of respiratory and critical care medicine, Volume: 153, Issue: 6 Pt 1	1996
Prediction of 5-fluorouracil cytotoxicity towards the Walker carcinosarcoma using peak integrals of fluoronucleotides measured by MRS in vivo. British journal of cancer, Volume: 60, Issue: 3	1989
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Article	Year
Effects of early diabetes on uridine diphosphosugar synthesis in the rat renal cortex. Kidney international, Volume: 21, Issue: 5	1982
Phosphoribosylpyrophosphate bioavailability in diabetic rat renal cortex in vivo. The American journal of physiology, Volume: 238, Issue: 4	1980
Glomerular uracil nucleotide synthesis: effects of diabetes and protein intake. The American journal of physiology, Volume: 255, Issue: 4 Pt 2	1988
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Article	Year
Do Cyclosporine A, an IL-1 Receptor Antagonist, Uridine Triphosphate, Rebamipide, and/or Bimatoprost Regulate Human Meibomian Gland Epithelial Cells? Investigative ophthalmology & visual science, 08-01, Volume: 57, Issue: 10	2016
Effect of topically applied epithelial sodium channel inhibitors on tear production in normal mice and in mice with induced aqueous tear deficiency. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, Volume: 28, Issue: 4	2012
Cell death induced by uridine 5'-triphosphate (UTP) in contrast to adenosine 5'-triphosphate (ATP) in human epidermoid carcinoma cells (A-431). Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, Volume: 22, Issue: 5-6	2008
Pharmacological properties of P2 receptors on rat otic parasympathetic ganglion neurons. Life sciences, Aug-01, Volume: 83, Issue: 5-6	2008
Hypotensive effect of UDP on intraocular pressure in rabbits. European journal of pharmacology, Jan-28, Volume: 579, Issue: 1-3	2008
Evaluation of reactive blue 2 derivatives as selective antagonists for P2Y receptors. Vascular pharmacology, Volume: 39, Issue: 6	2002
Nucleolar localization of murine nuclear DNA helicase II (RNA helicase A). Journal of cell science, Volume: 112 ( Pt 16)	1999
Evidence for a nucleotide receptor on adrenal medullary endothelial cells linked to phospholipase C and phospholipase D. British journal of pharmacology, Volume: 108, Issue: 4	1993
ADP induces inositol phosphate-independent intracellular Ca2+ mobilization in brain capillary endothelial cells. The Journal of biological chemistry, Apr-25, Volume: 268, Issue: 12	1993
Characterization of ecto-ATPase on human blood cells. A physiological role in platelet aggregation? Biochemical pharmacology, Dec-03, Volume: 46, Issue: 11	1993
Purine- and pyrimidine-stimulated phosphoinositide breakdown and intracellular calcium mobilisation in astrocytes. Brain research, Oct-17, Volume: 660, Issue: 2	1994
Escherichia coli UMP-kinase, a member of the aspartokinase family, is a hexamer regulated by guanine nucleotides and UTP. Biochemistry, Apr-18, Volume: 34, Issue: 15	1995
Ultrasensitive assay for ribonucleoside triphosphates in 50-1000 cells. Application to studies with pyrazofurin and mycophenolic acid. Biochemical pharmacology, Dec-15, Volume: 32, Issue: 24	1983
[Proliferative response of HeLa and Hep2 cell lines to exogenous nucleotides]. Voprosy onkologii, Volume: 31, Issue: 12	1985
Comparison of extracellular ATP and UTP signalling in rat renal mesangial cells. No indications for the involvement of separate purino- and pyrimidino-ceptors. The Biochemical journal, Dec-01, Volume: 272, Issue: 2	1990
Modulation of fluorouracil by N-(phosphonacetyl)-L-asparate: a review. Seminars in oncology, Volume: 19, Issue: 2 Suppl 3	1992
Neuronal "nucleotide" receptor linked to phospholipase C and phospholipase D? Stimulation of PC12 cells by ATP analogues and UTP. Molecular pharmacology, Volume: 41, Issue: 3	1992
Consequences of recurrent phosphate trapping induced by repeated injections of 2-deoxy-D-galactose. Biochemical and morphological studies in rats. Virchows Archiv. B, Cell pathology including molecular pathology, Jun-29, Volume: 30, Issue: 3	1979
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Article	Year
Effect of Huaiqihuang Granules Combined with Comprehensive Nursing on Children with Primary Nephrotic Syndrome. Journal of healthcare engineering, Volume: 2022	2022
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

uridine triphosphate

Description

Cross-References

Synonyms (71)

Actions

Roles (2)

Drug Classes (2)

Pathways (62)

Protein Targets (19)

Potency Measurements

Inhibition Measurements

Activation Measurements

Other Measurements

Biological Processes (82)

Molecular Functions (20)

Ceullar Components (25)

Bioassays (148)

Research

Studies (2,362)

Study Types

Research Highlights

Safety/Toxicity (14)

Pharmacokinetics (13)

Bioavailability (3)

Dosage (20)

Interactions (1)

uridine triphosphate

Description

Cross-References

Synonyms (71)

Actions

Roles (2)

Drug Classes (2)

Pathways (62)

Protein Targets (19)

Potency Measurements

Inhibition Measurements

Activation Measurements

Other Measurements

Biological Processes (82)

Molecular Functions (20)

Ceullar Components (25)

Bioassays (148)

Research

Studies (2,362)

Study Types

Related Drugs (1,525)

Related Conditions (1,648)

Research Highlights

Safety/Toxicity (14)

Pharmacokinetics (13)

Bioavailability (3)

Dosage (20)

Interactions (1)